597308315 | GWAS1404389_H | pulse pressure measurement QTL GWAS1404389 (human) | | 5e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 2 | 100960284 | 100960285 | Human |
597046164 | GWAS1142238_H | atopic asthma QTL GWAS1142238 (human) | | 7e-12 | atopic asthma | | 2 | 102226205 | 102226206 | Human |
597255067 | GWAS1351141_H | age at first sexual intercourse measurement QTL GWAS1351141 (human) | | 3e-15 | age at first sexual intercourse measurement | | 2 | 103444330 | 103444331 | Human |
597308316 | GWAS1404390_H | pulse pressure measurement QTL GWAS1404390 (human) | | 2e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 2 | 105511459 | 105511460 | Human |
596976542 | GWAS1096061_H | ulcerative colitis QTL GWAS1096061 (human) | | 5e-15 | ulcerative colitis | | 2 | 102368211 | 102368212 | Human |
596951940 | GWAS1071459_H | body mass index QTL GWAS1071459 (human) | | 6e-11 | body mass index | | 2 | 100153465 | 100153466 | Human |
1298432 | OSTEAR10_H | Osteoarthritis QTL 10 (human) | 2.34 | 0.0001 | Joint/bone inflammation | distal interphalangeal joint osteoarthritis | 2 | 97592766 | 106657498 | Human |
597164943 | GWAS1261017_H | Nasal Cavity Polyp QTL GWAS1261017 (human) | | 2e-12 | Nasal Cavity Polyp | | 2 | 102332701 | 102332702 | Human |
597046158 | GWAS1142232_H | atopic asthma QTL GWAS1142232 (human) | | 2e-09 | atopic asthma | | 2 | 102510080 | 102510081 | Human |
597046159 | GWAS1142233_H | atopic asthma QTL GWAS1142233 (human) | | 5e-10 | atopic asthma | | 2 | 102562489 | 102562490 | Human |
597595012 | GWAS1651872_H | eosinophil count QTL GWAS1651872 (human) | | 5e-27 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102332010 | 102332011 | Human |
597046156 | GWAS1142230_H | atopic asthma QTL GWAS1142230 (human) | | 6e-29 | atopic asthma | | 2 | 102348282 | 102348283 | Human |
597046157 | GWAS1142231_H | atopic asthma QTL GWAS1142231 (human) | | 1e-12 | atopic asthma | | 2 | 102594085 | 102594086 | Human |
597046154 | GWAS1142228_H | atopic asthma QTL GWAS1142228 (human) | | 3e-11 | atopic asthma | | 2 | 102636570 | 102636571 | Human |
597046155 | GWAS1142229_H | atopic asthma QTL GWAS1142229 (human) | | 1e-09 | atopic asthma | | 2 | 102635468 | 102635469 | Human |
597046153 | GWAS1142227_H | atopic asthma QTL GWAS1142227 (human) | | 7e-10 | atopic asthma | | 2 | 101671373 | 101671374 | Human |
597509053 | GWAS1605127_H | insomnia QTL GWAS1605127 (human) | | 9e-10 | insomnia | | 2 | 104074346 | 104074351 | Human |
597509052 | GWAS1605126_H | insomnia QTL GWAS1605126 (human) | | 3e-08 | insomnia | | 2 | 104054503 | 104054504 | Human |
597369785 | GWAS1465859_H | heel bone mineral density QTL GWAS1465859 (human) | | 1e-08 | heel bone mineral density | bone mineral density (CMO:0001226) | 2 | 100228626 | 100228627 | Human |
597509054 | GWAS1605128_H | insomnia QTL GWAS1605128 (human) | | 3e-13 | insomnia | | 2 | 104077911 | 104077912 | Human |
597509049 | GWAS1605123_H | insomnia QTL GWAS1605123 (human) | | 5e-10 | insomnia | | 2 | 97740700 | 97740701 | Human |
597087155 | GWAS1183229_H | allergic disease, age at onset QTL GWAS1183229 (human) | | 2e-33 | allergic disease, age at onset | | 2 | 102312157 | 102312158 | Human |
597595067 | GWAS1651927_H | eosinophil count QTL GWAS1651927 (human) | | 3e-58 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102341256 | 102341257 | Human |
597509051 | GWAS1605125_H | insomnia QTL GWAS1605125 (human) | | 8e-10 | insomnia | | 2 | 104013691 | 104013692 | Human |
407025765 | GWAS674741_H | self reported educational attainment QTL GWAS674741 (human) | | 5e-11 | self reported educational attainment | | 2 | 100202017 | 100202018 | Human |
597509050 | GWAS1605124_H | insomnia QTL GWAS1605124 (human) | | 2e-08 | insomnia | | 2 | 103935256 | 103935257 | Human |
407128172 | GWAS777148_H | preeclampsia QTL GWAS777148 (human) | | 0.000004 | preeclampsia | | 2 | 105261413 | 105261414 | Human |
597029820 | GWAS1125894_H | self reported educational attainment QTL GWAS1125894 (human) | | 9e-11 | self reported educational attainment | | 2 | 103825088 | 103825089 | Human |
597365681 | GWAS1461755_H | FEV/FVC ratio QTL GWAS1461755 (human) | | 1e-16 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 2 | 102309902 | 102309903 | Human |
597349297 | GWAS1445371_H | lichen planus QTL GWAS1445371 (human) | | 8e-11 | lichen planus | | 2 | 102456671 | 102456676 | Human |
597029819 | GWAS1125893_H | self reported educational attainment QTL GWAS1125893 (human) | | 3e-08 | self reported educational attainment | | 2 | 98199988 | 98199989 | Human |
597074850 | GWAS1170924_H | intelligence, self reported educational attainment QTL GWAS1170924 (human) | | 2e-11 | intelligence, self reported educational attainment | | 2 | 99992378 | 99992379 | Human |
597529513 | GWAS1625587_H | body mass index QTL GWAS1625587 (human) | | 7e-18 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100189534 | 100189535 | Human |
597304238 | GWAS1400312_H | Alzheimer disease QTL GWAS1400312 (human) | | 2e-13 | Alzheimer disease | | 2 | 105749599 | 105749600 | Human |
597066659 | GWAS1162733_H | fear of minor pain measurement QTL GWAS1162733 (human) | | 0.0000002 | fear-related behavior trait (VT:0010715) | | 2 | 98835995 | 98835996 | Human |
597074851 | GWAS1170925_H | intelligence, self reported educational attainment QTL GWAS1170925 (human) | | 3e-08 | intelligence, self reported educational attainment | | 2 | 100703250 | 100703251 | Human |
406911094 | GWAS560070_H | bipolar disorder QTL GWAS560070 (human) | | 0.000003 | bipolar disorder | | 2 | 98849039 | 98849040 | Human |
597529514 | GWAS1625588_H | body mass index QTL GWAS1625588 (human) | | 4e-15 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104838132 | 104838133 | Human |
597074861 | GWAS1170935_H | intelligence QTL GWAS1170935 (human) | | 0.0000006 | intelligence | | 2 | 99992378 | 99992379 | Human |
597271512 | GWAS1367586_H | interleukin 1 receptor-like 1 measurement QTL GWAS1367586 (human) | | 3e-14 | interleukin 1 receptor-like 1 measurement | | 2 | 102635095 | 102635096 | Human |
597271511 | GWAS1367585_H | interleukin 1 receptor-like 1 measurement QTL GWAS1367585 (human) | | 1e-14 | interleukin 1 receptor-like 1 measurement | | 2 | 102457653 | 102457654 | Human |
597271510 | GWAS1367584_H | interleukin 1 receptor-like 1 measurement QTL GWAS1367584 (human) | | 7e-16 | interleukin 1 receptor-like 1 measurement | | 2 | 102371049 | 102371050 | Human |
597246921 | GWAS1342995_H | central corneal thickness QTL GWAS1342995 (human) | | 1e-11 | central corneal thickness | | 2 | 100104588 | 100104589 | Human |
597267404 | GWAS1363478_H | eosinophil count QTL GWAS1363478 (human) | | 4e-33 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102349607 | 102349608 | Human |
597205965 | GWAS1302039_H | sleep apnea measurement QTL GWAS1302039 (human) | | 1e-09 | sleep behavior trait (VT:0001501) | | 2 | 102507453 | 102507454 | Human |
406947863 | GWAS596839_H | PR interval QTL GWAS596839 (human) | | 4e-34 | PR interval | PR interval (CMO:0000233) | 2 | 102799035 | 102799036 | Human |
597599175 | GWAS1656035_H | serum alanine aminotransferase measurement QTL GWAS1656035 (human) | | 5e-16 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 2 | 100997860 | 100997861 | Human |
597038028 | GWAS1134102_H | blood protein measurement QTL GWAS1134102 (human) | | 3e-10 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 2 | 102129816 | 102129817 | Human |
597132278 | GWAS1228352_H | pulse pressure measurement QTL GWAS1228352 (human) | | 4e-11 | pulse pressure measurement | pulse pressure (CMO:0000292) | 2 | 105511000 | 105511001 | Human |
597132277 | GWAS1228351_H | pulse pressure measurement QTL GWAS1228351 (human) | | 1e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 2 | 100962027 | 100962028 | Human |
597439477 | GWAS1535551_H | eosinophil count QTL GWAS1535551 (human) | | 0.000005 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102341256 | 102341257 | Human |
597193715 | GWAS1289789_H | cortical thickness QTL GWAS1289789 (human) | | 3e-13 | cortical thickness | | 2 | 97658891 | 97658892 | Human |
597410800 | GWAS1506874_H | asthma QTL GWAS1506874 (human) | | 4e-21 | asthma | | 2 | 102341256 | 102341257 | Human |
597193716 | GWAS1289790_H | cortical thickness QTL GWAS1289790 (human) | | 8e-12 | cortical thickness | | 2 | 97983036 | 97983037 | Human |
406960173 | GWAS609149_H | pulse pressure measurement QTL GWAS609149 (human) | | 0.0000002 | pulse pressure measurement | pulse pressure (CMO:0000292) | 2 | 100961588 | 100961589 | Human |
597464046 | GWAS1560120_H | maximum cigarettes per day measurement QTL GWAS1560120 (human) | | 0.000003 | maximum cigarettes per day measurement | | 2 | 103985510 | 103985511 | Human |
597382126 | GWAS1478200_H | age at menarche QTL GWAS1478200 (human) | | 5e-32 | age at menarche | | 2 | 105254322 | 105254323 | Human |
597349359 | GWAS1445433_H | body mass index QTL GWAS1445433 (human) | | 9e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 105345882 | 105345883 | Human |
597406688 | GWAS1502762_H | schizophrenia QTL GWAS1502762 (human) | | 0.0000007 | schizophrenia | | 2 | 102925257 | 102925258 | Human |
597255142 | GWAS1351216_H | heel bone mineral density, urate measurement QTL GWAS1351216 (human) | | 4e-09 | heel bone mineral density, urate measurement | blood uric acid level (CMO:0000501) | 2 | 101075518 | 101075519 | Human |
597226264 | GWAS1322338_H | self reported educational attainment QTL GWAS1322338 (human) | | 3e-22 | self reported educational attainment | | 2 | 100308360 | 100308361 | Human |
597320474 | GWAS1416548_H | diastolic blood pressure, systolic blood pressure QTL GWAS1416548 (human) | | 8e-11 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 2 | 105377402 | 105377403 | Human |
597320475 | GWAS1416549_H | diastolic blood pressure, systolic blood pressure QTL GWAS1416549 (human) | | 9e-09 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 2 | 98133007 | 98133008 | Human |
597226265 | GWAS1322339_H | self reported educational attainment QTL GWAS1322339 (human) | | 4e-16 | self reported educational attainment | | 2 | 100511633 | 100511634 | Human |
597226266 | GWAS1322340_H | self reported educational attainment QTL GWAS1322340 (human) | | 2e-16 | self reported educational attainment | | 2 | 100535368 | 100535369 | Human |
597226267 | GWAS1322341_H | self reported educational attainment QTL GWAS1322341 (human) | | 4e-14 | self reported educational attainment | | 2 | 100712266 | 100712267 | Human |
597226268 | GWAS1322342_H | self reported educational attainment QTL GWAS1322342 (human) | | 4e-08 | self reported educational attainment | | 2 | 100956752 | 100956753 | Human |
597041936 | GWAS1138010_H | Parkinson disease QTL GWAS1138010 (human) | | 8e-13 | Parkinson disease | | 2 | 101780501 | 101780502 | Human |
597263135 | GWAS1359209_H | interleukin 18 receptor 1 measurement QTL GWAS1359209 (human) | | 4e-129 | interleukin 18 receptor 1 measurement | | 2 | 102365184 | 102365185 | Human |
597226256 | GWAS1322330_H | self reported educational attainment QTL GWAS1322330 (human) | | 2e-10 | self reported educational attainment | | 2 | 98316517 | 98316518 | Human |
597226257 | GWAS1322331_H | self reported educational attainment QTL GWAS1322331 (human) | | 7e-10 | self reported educational attainment | | 2 | 99364759 | 99364760 | Human |
597226258 | GWAS1322332_H | self reported educational attainment QTL GWAS1322332 (human) | | 8e-12 | self reported educational attainment | | 2 | 99492539 | 99492540 | Human |
597226259 | GWAS1322333_H | self reported educational attainment QTL GWAS1322333 (human) | | 2e-08 | self reported educational attainment | | 2 | 99634927 | 99634928 | Human |
597226260 | GWAS1322334_H | self reported educational attainment QTL GWAS1322334 (human) | | 7e-18 | self reported educational attainment | | 2 | 99689916 | 99689917 | Human |
597508881 | GWAS1604955_H | adult onset asthma QTL GWAS1604955 (human) | | 0.000003 | adult onset asthma | | 2 | 102349850 | 102349851 | Human |
597590803 | GWAS1647663_H | temporal measurement QTL GWAS1647663 (human) | | 1e-12 | temporal measurement | | 2 | 99265027 | 99265028 | Human |
597226261 | GWAS1322335_H | self reported educational attainment QTL GWAS1322335 (human) | | 1e-08 | self reported educational attainment | | 2 | 99806696 | 99806697 | Human |
597226262 | GWAS1322336_H | self reported educational attainment QTL GWAS1322336 (human) | | 8e-22 | self reported educational attainment | | 2 | 99834895 | 99834896 | Human |
597226263 | GWAS1322337_H | self reported educational attainment QTL GWAS1322337 (human) | | 8e-13 | self reported educational attainment | | 2 | 99896691 | 99896692 | Human |
597144344 | GWAS1240418_H | suicidal ideation, suicide behaviour QTL GWAS1240418 (human) | | 3e-08 | suicidal ideation, suicide behaviour | | 2 | 103683405 | 103683411 | Human |
597508878 | GWAS1604952_H | asthma QTL GWAS1604952 (human) | | 8e-17 | asthma | | 2 | 102343750 | 102343751 | Human |
597508874 | GWAS1604948_H | childhood onset asthma QTL GWAS1604948 (human) | | 4e-38 | childhood onset asthma | | 2 | 102349850 | 102349851 | Human |
597205760 | GWAS1301834_H | smoking status measurement, Cannabis use, schizophrenia QTL GWAS1301834 (human) | | 5e-14 | smoking status measurement, Cannabis use, schizophrenia | | 2 | 103481456 | 103481457 | Human |
597144335 | GWAS1240409_H | suicidal ideation, suicide behaviour QTL GWAS1240409 (human) | | 2e-08 | suicidal ideation, suicide behaviour | | 2 | 103651035 | 103651036 | Human |
597472004 | GWAS1568078_H | bronchopulmonary dysplasia QTL GWAS1568078 (human) | | 0.000006 | bronchopulmonary dysplasia | | 2 | 104423229 | 104423230 | Human |
597472005 | GWAS1568079_H | bronchopulmonary dysplasia QTL GWAS1568079 (human) | | 0.000007 | bronchopulmonary dysplasia | | 2 | 104474813 | 104474814 | Human |
596976396 | GWAS1095915_H | body mass index QTL GWAS1095915 (human) | | 3e-12 | body mass index | | 2 | 104849547 | 104849548 | Human |
597594882 | GWAS1651742_H | eosinophil count QTL GWAS1651742 (human) | | 2e-269 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102334362 | 102334363 | Human |
597472003 | GWAS1568077_H | bronchopulmonary dysplasia QTL GWAS1568077 (human) | | 0.000006 | bronchopulmonary dysplasia | | 2 | 104419442 | 104419443 | Human |
597451575 | GWAS1547649_H | rheumatoid arthritis QTL GWAS1547649 (human) | | 0.000002 | rheumatoid arthritis | | 2 | 100219272 | 100219273 | Human |
597054267 | GWAS1150341_H | household income QTL GWAS1150341 (human) | | 3e-10 | household income | | 2 | 100530994 | 100530995 | Human |
596955942 | GWAS1075461_H | lymphocyte measurement, neutrophil measurement QTL GWAS1075461 (human) | | 2e-09 | lymphocyte measurement, neutrophil measurement | | 2 | 101113826 | 101113827 | Human |
597406508 | GWAS1502582_H | cortical thickness QTL GWAS1502582 (human) | | 4e-20 | cortical thickness | | 2 | 104864984 | 104864985 | Human |
597594974 | GWAS1651834_H | eosinophil count QTL GWAS1651834 (human) | | 9e-50 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102341256 | 102341257 | Human |
597177177 | GWAS1273251_H | interleukin-18 receptor 1 measurement QTL GWAS1273251 (human) | | 2e-457 | interleukin-18 receptor 1 measurement | | 2 | 102366416 | 102366417 | Human |
597017424 | GWAS1113498_H | intelligence QTL GWAS1113498 (human) | | 9e-15 | intelligence | | 2 | 100260908 | 100260909 | Human |
406988933 | GWAS637909_H | reticulocyte count QTL GWAS637909 (human) | | 1e-10 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 2 | 101073264 | 101073265 | Human |
407275662 | GWAS924638_H | aspartate aminotransferase measurement QTL GWAS924638 (human) | | 0.000004 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 2 | 97726238 | 97726239 | Human |
597238609 | GWAS1334683_H | electrocardiography QTL GWAS1334683 (human) | | 2e-10 | electrocardiography | | 2 | 102782676 | 102782677 | Human |
597050207 | GWAS1146281_H | uterine fibroid QTL GWAS1146281 (human) | | 0.000001 | uterine fibroid | | 2 | 99428722 | 99428723 | Human |
597238608 | GWAS1334682_H | electrocardiography QTL GWAS1334682 (human) | | 5e-10 | electrocardiography | | 2 | 102782676 | 102782677 | Human |
597238611 | GWAS1334685_H | electrocardiography QTL GWAS1334685 (human) | | 4e-11 | electrocardiography | | 2 | 102782676 | 102782677 | Human |
597238610 | GWAS1334684_H | electrocardiography QTL GWAS1334684 (human) | | 5e-11 | electrocardiography | | 2 | 102782676 | 102782677 | Human |
597238612 | GWAS1334686_H | electrocardiography QTL GWAS1334686 (human) | | 1e-10 | electrocardiography | | 2 | 102782676 | 102782677 | Human |
407234699 | GWAS883675_H | self reported educational attainment QTL GWAS883675 (human) | | 3e-08 | self reported educational attainment | | 2 | 100712266 | 100712267 | Human |
597177175 | GWAS1273249_H | interleukin-18 receptor 1 measurement QTL GWAS1273249 (human) | | 1e-63 | interleukin-18 receptor 1 measurement | | 2 | 102385138 | 102385139 | Human |
597123910 | GWAS1219984_H | cleft lip QTL GWAS1219984 (human) | | 0.000002 | cleft lip | | 2 | 106008276 | 106008277 | Human |
597017423 | GWAS1113497_H | intelligence QTL GWAS1113497 (human) | | 1e-09 | intelligence | | 2 | 100219272 | 100219273 | Human |
597201731 | GWAS1297805_H | body mass index QTL GWAS1297805 (human) | | 3e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100353269 | 100353274 | Human |
597427009 | GWAS1523083_H | gout QTL GWAS1523083 (human) | | 2e-09 | gout | | 2 | 102108553 | 102108554 | Human |
597586755 | GWAS1643615_H | eosinophil count QTL GWAS1643615 (human) | | 2e-167 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102332010 | 102332011 | Human |
597619581 | GWAS1676441_H | nicotine dependence QTL GWAS1676441 (human) | | 2e-13 | nicotine dependence | | 2 | 103853106 | 103853107 | Human |
597508980 | GWAS1605054_H | interleukin-1 receptor type 1 measurement QTL GWAS1605054 (human) | | 1e-29 | interleukin-1 receptor type 1 measurement | | 2 | 102185366 | 102185367 | Human |
597140350 | GWAS1236424_H | educational attainment QTL GWAS1236424 (human) | | 0.000003 | educational attainment | | 2 | 106643677 | 106643678 | Human |
597140349 | GWAS1236423_H | educational attainment QTL GWAS1236423 (human) | | 2e-20 | educational attainment | | 2 | 105308708 | 105308709 | Human |
597140348 | GWAS1236422_H | educational attainment QTL GWAS1236422 (human) | | 6e-34 | educational attainment | | 2 | 103831447 | 103831448 | Human |
597496694 | GWAS1592768_H | disease QTL GWAS1592768 (human) | | 3e-08 | disease | | 2 | 104611894 | 104611895 | Human |
597324661 | GWAS1420735_H | colorectal cancer QTL GWAS1420735 (human) | | 7e-12 | colorectal cancer | | 2 | 97658891 | 97658892 | Human |
597492590 | GWAS1588664_H | smoking initiation QTL GWAS1588664 (human) | | 2e-09 | smoking initiation | | 2 | 104080033 | 104080034 | Human |
406952117 | GWAS601093_H | celiac disease QTL GWAS601093 (human) | | 3e-08 | celiac disease | | 2 | 102476054 | 102476055 | Human |
597513067 | GWAS1609141_H | systemic lupus erythematosus QTL GWAS1609141 (human) | | 1e-10 | systemic lupus erythematosus | | 2 | 100142995 | 100142996 | Human |
597242720 | GWAS1338794_H | smoking status measurement QTL GWAS1338794 (human) | | 1e-17 | smoking status measurement | | 2 | 103657096 | 103657097 | Human |
597332838 | GWAS1428912_H | S-7-hydroxywarfarin measurement QTL GWAS1428912 (human) | | 0.000005 | S-7-hydroxywarfarin measurement | | 2 | 99576067 | 99576068 | Human |
597046123 | GWAS1142197_H | atopic asthma QTL GWAS1142197 (human) | | 8e-17 | atopic asthma | | 2 | 102236342 | 102236343 | Human |
597586590 | GWAS1643450_H | eosinophil count QTL GWAS1643450 (human) | | 1e-201 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102332010 | 102332011 | Human |
597394073 | GWAS1490147_H | allergic rhinitis QTL GWAS1490147 (human) | | 2e-25 | allergic rhinitis | | 2 | 102319699 | 102319700 | Human |
597213855 | GWAS1309929_H | protein measurement QTL GWAS1309929 (human) | | 2e-08 | protein measurement | | 2 | 100391454 | 100391455 | Human |
407099722 | GWAS748698_H | drug dependence QTL GWAS748698 (human) | | 2e-08 | drug dependence | | 2 | 105840835 | 105840836 | Human |
597074566 | GWAS1170640_H | intelligence QTL GWAS1170640 (human) | | 3e-10 | intelligence | | 2 | 99725106 | 99725107 | Human |
597136007 | GWAS1232081_H | response to cranial radiation therapy, short-term memory QTL GWAS1232081 (human) | | 7e-08 | response to cranial radiation therapy, short-term memory | | 2 | 102061084 | 102061085 | Human |
597074567 | GWAS1170641_H | intelligence QTL GWAS1170641 (human) | | 1e-11 | intelligence | | 2 | 100296001 | 100296002 | Human |
597074564 | GWAS1170638_H | intelligence QTL GWAS1170638 (human) | | 4e-10 | intelligence | | 2 | 100054283 | 100054284 | Human |
597074565 | GWAS1170639_H | intelligence QTL GWAS1170639 (human) | | 5e-13 | intelligence | | 2 | 100308360 | 100308361 | Human |
597074562 | GWAS1170636_H | intelligence QTL GWAS1170636 (human) | | 3e-09 | intelligence | | 2 | 99672640 | 99672641 | Human |
597074563 | GWAS1170637_H | intelligence QTL GWAS1170637 (human) | | 3e-09 | intelligence | | 2 | 99575083 | 99575084 | Human |
406935892 | GWAS584868_H | Creutzfeldt Jacob Disease QTL GWAS584868 (human) | | 4e-08 | Creutzfeldt Jacob Disease | | 2 | 100807869 | 100807870 | Human |
597344908 | GWAS1440982_H | eosinophil measurement QTL GWAS1440982 (human) | | 8e-18 | eosinophil measurement | | 2 | 97900718 | 97900719 | Human |
597074560 | GWAS1170634_H | intelligence QTL GWAS1170634 (human) | | 2e-14 | intelligence | | 2 | 99960959 | 99960960 | Human |
596968067 | GWAS1087586_H | body mass index QTL GWAS1087586 (human) | | 4e-16 | body mass index | | 2 | 100220664 | 100220665 | Human |
597107328 | GWAS1203402_H | reticulocyte measurement QTL GWAS1203402 (human) | | 3e-14 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 2 | 99145424 | 99145425 | Human |
597074561 | GWAS1170635_H | intelligence QTL GWAS1170635 (human) | | 3e-19 | intelligence | | 2 | 100260327 | 100260328 | Human |
597152396 | GWAS1248470_H | Alzheimer disease, educational attainment QTL GWAS1248470 (human) | | 4e-08 | Alzheimer disease, educational attainment | | 2 | 100397901 | 100397902 | Human |
597074570 | GWAS1170644_H | intelligence QTL GWAS1170644 (human) | | 9e-11 | intelligence | | 2 | 100342342 | 100342343 | Human |
597045896 | GWAS1141970_H | lifestyle measurement QTL GWAS1141970 (human) | | 6e-17 | lifestyle measurement | | 2 | 100203959 | 100203960 | Human |
597074568 | GWAS1170642_H | intelligence QTL GWAS1170642 (human) | | 3e-09 | intelligence | | 2 | 100319907 | 100319908 | Human |
597074569 | GWAS1170643_H | intelligence QTL GWAS1170643 (human) | | 3e-10 | intelligence | | 2 | 99988291 | 99988292 | Human |
407378280 | GWAS1027256_H | smoking behavior QTL GWAS1027256 (human) | | 1e-21 | smoking behavior | | 2 | 103462197 | 103462198 | Human |
597463743 | GWAS1559817_H | rheumatoid arthritis QTL GWAS1559817 (human) | | 3e-11 | rheumatoid arthritis | | 2 | 100190052 | 100190053 | Human |
597615287 | GWAS1672147_H | spermatocele QTL GWAS1672147 (human) | | 9e-12 | spermatocele | | 2 | 104072432 | 104072433 | Human |
597390006 | GWAS1486080_H | Parkinson disease QTL GWAS1486080 (human) | | 0.0000005 | Parkinson disease | | 2 | 101988187 | 101988188 | Human |
597164727 | GWAS1260801_H | gut microbiome measurement QTL GWAS1260801 (human) | | 3e-08 | gut microbiome measurement | | 2 | 100665728 | 100665729 | Human |
597103271 | GWAS1199345_H | serum alanine aminotransferase measurement QTL GWAS1199345 (human) | | 1e-08 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 2 | 102130853 | 102130854 | Human |
597426862 | GWAS1522936_H | urate measurement QTL GWAS1522936 (human) | | 1e-08 | urate measurement | blood uric acid level (CMO:0000501) | 2 | 101019948 | 101019949 | Human |
597426863 | GWAS1522937_H | urate measurement QTL GWAS1522937 (human) | | 2e-08 | urate measurement | blood uric acid level (CMO:0000501) | 2 | 102448043 | 102448044 | Human |
597389992 | GWAS1486066_H | blood protein measurement QTL GWAS1486066 (human) | | 2e-09 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 2 | 106219586 | 106219587 | Human |
597271257 | GWAS1367331_H | interleukin 1 receptor-like 1 measurement QTL GWAS1367331 (human) | | 1e-22 | interleukin 1 receptor-like 1 measurement | | 2 | 102238605 | 102238606 | Human |
597271256 | GWAS1367330_H | interleukin 1 receptor-like 1 measurement QTL GWAS1367330 (human) | | 2e-23 | interleukin 1 receptor-like 1 measurement | | 2 | 102359021 | 102359022 | Human |
597234392 | GWAS1330466_H | major depressive disorder QTL GWAS1330466 (human) | | 0.000001 | major depressive disorder | | 2 | 103835877 | 103835878 | Human |
597304024 | GWAS1400098_H | level of interleukin-18 receptor 1 in blood serum QTL GWAS1400098 (human) | | 3e-16 | level of interleukin-18 receptor 1 in blood serum | | 2 | 102435746 | 102435747 | Human |
407079168 | GWAS728144_H | gut microbiome measurement QTL GWAS728144 (human) | | 3e-08 | gut microbiome measurement | | 2 | 101736796 | 101736797 | Human |
597271258 | GWAS1367332_H | interleukin 1 receptor-like 1 measurement QTL GWAS1367332 (human) | | 5e-21 | interleukin 1 receptor-like 1 measurement | | 2 | 102623087 | 102623088 | Human |
597058261 | GWAS1154335_H | eosinophil count QTL GWAS1154335 (human) | | 3e-12 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 105815399 | 105815400 | Human |
597025502 | GWAS1121576_H | waist-hip ratio QTL GWAS1121576 (human) | | 6e-13 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 2 | 100278425 | 100278426 | Human |
597394135 | GWAS1490209_H | high density lipoprotein cholesterol measurement QTL GWAS1490209 (human) | | 7e-11 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 2 | 100180388 | 100180389 | Human |
597271253 | GWAS1367327_H | interleukin 1 receptor-like 1 measurement QTL GWAS1367327 (human) | | 2e-74 | interleukin 1 receptor-like 1 measurement | | 2 | 102340831 | 102340832 | Human |
597271255 | GWAS1367329_H | interleukin 1 receptor-like 1 measurement QTL GWAS1367329 (human) | | 2e-29 | interleukin 1 receptor-like 1 measurement | | 2 | 102235248 | 102235249 | Human |
597271254 | GWAS1367328_H | interleukin 1 receptor-like 1 measurement QTL GWAS1367328 (human) | | 1e-36 | interleukin 1 receptor-like 1 measurement | | 2 | 102370901 | 102370902 | Human |
597340875 | GWAS1436949_H | serum gamma-glutamyl transferase measurement QTL GWAS1436949 (human) | | 2e-17 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 2 | 102538616 | 102538617 | Human |
597471950 | GWAS1568024_H | self reported educational attainment QTL GWAS1568024 (human) | | 9e-40 | self reported educational attainment | | 2 | 100208905 | 100208906 | Human |
597213898 | GWAS1309972_H | schizophrenia QTL GWAS1309972 (human) | | 0.0000006 | schizophrenia | | 2 | 104367929 | 104367930 | Human |
597373647 | GWAS1469721_H | body mass index QTL GWAS1469721 (human) | | 1e-15 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100198396 | 100198397 | Human |
597435080 | GWAS1531154_H | eosinophil count QTL GWAS1531154 (human) | | 8e-35 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102353347 | 102353348 | Human |
597373646 | GWAS1469720_H | body mass index QTL GWAS1469720 (human) | | 9e-17 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100181450 | 100181451 | Human |
597488321 | GWAS1584395_H | Cleft palate, cleft lip QTL GWAS1584395 (human) | | 0.000008 | Cleft palate, cleft lip | | 2 | 104738501 | 104738502 | Human |
597488322 | GWAS1584396_H | Cleft palate, cleft lip QTL GWAS1584396 (human) | | 0.000008 | Cleft palate, cleft lip | | 2 | 104603235 | 104603236 | Human |
597115639 | GWAS1211713_H | self reported educational attainment QTL GWAS1211713 (human) | | 2e-18 | self reported educational attainment | | 2 | 103825088 | 103825089 | Human |
597508860 | GWAS1604934_H | childhood onset asthma QTL GWAS1604934 (human) | | 3e-46 | childhood onset asthma | | 2 | 102319699 | 102319700 | Human |
597115638 | GWAS1211712_H | self reported educational attainment QTL GWAS1211712 (human) | | 2e-14 | self reported educational attainment | | 2 | 103443545 | 103443546 | Human |
597115637 | GWAS1211711_H | self reported educational attainment QTL GWAS1211711 (human) | | 1e-08 | self reported educational attainment | | 2 | 100956752 | 100956753 | Human |
597115636 | GWAS1211710_H | self reported educational attainment QTL GWAS1211710 (human) | | 2e-16 | self reported educational attainment | | 2 | 100712266 | 100712267 | Human |
597115635 | GWAS1211709_H | self reported educational attainment QTL GWAS1211709 (human) | | 8e-18 | self reported educational attainment | | 2 | 100535368 | 100535369 | Human |
597115634 | GWAS1211708_H | self reported educational attainment QTL GWAS1211708 (human) | | 2e-17 | self reported educational attainment | | 2 | 100433891 | 100433892 | Human |
597115633 | GWAS1211707_H | self reported educational attainment QTL GWAS1211707 (human) | | 1e-24 | self reported educational attainment | | 2 | 100308360 | 100308361 | Human |
597345020 | GWAS1441094_H | smoking initiation QTL GWAS1441094 (human) | | 1e-19 | smoking initiation | | 2 | 103468450 | 103468451 | Human |
597115632 | GWAS1211706_H | self reported educational attainment QTL GWAS1211706 (human) | | 3e-23 | self reported educational attainment | | 2 | 99834895 | 99834896 | Human |
597365490 | GWAS1461564_H | intelligence QTL GWAS1461564 (human) | | 0.000004 | intelligence | | 2 | 105326668 | 105326669 | Human |
406989096 | GWAS638072_H | reticulocyte count QTL GWAS638072 (human) | | 2e-09 | autoimmune disease | | 2 | 97756543 | 97756544 | Human |
597258997 | GWAS1355071_H | total cholesterol measurement QTL GWAS1355071 (human) | | 4e-14 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 2 | 101015426 | 101015427 | Human |
597115640 | GWAS1211714_H | self reported educational attainment QTL GWAS1211714 (human) | | 8e-14 | self reported educational attainment | | 2 | 105306623 | 105306624 | Human |
597205741 | GWAS1301815_H | grip strength measurement QTL GWAS1301815 (human) | | 6e-09 | grip strength measurement | | 2 | 100203959 | 100203960 | Human |
597115631 | GWAS1211705_H | self reported educational attainment QTL GWAS1211705 (human) | | 2e-17 | self reported educational attainment | | 2 | 99689916 | 99689917 | Human |
597115630 | GWAS1211704_H | self reported educational attainment QTL GWAS1211704 (human) | | 1e-15 | self reported educational attainment | | 2 | 99492539 | 99492540 | Human |
597115628 | GWAS1211702_H | self reported educational attainment QTL GWAS1211702 (human) | | 6e-09 | self reported educational attainment | | 2 | 99364759 | 99364760 | Human |
597480167 | GWAS1576241_H | disease recurrence, response to allogeneic hematopoietic stem cell transplant, donor genotype effect measurement QTL GWAS1576241 (human) | | 0.0000004 | disease recurrence, response to allogeneic hematopoietic stem cell transplant, donor genotype effect measurement | | 2 | 104081974 | 104081975 | Human |
597115627 | GWAS1211701_H | self reported educational attainment QTL GWAS1211701 (human) | | 3e-10 | self reported educational attainment | | 2 | 98316517 | 98316518 | Human |
597115626 | GWAS1211700_H | self reported educational attainment QTL GWAS1211700 (human) | | 1e-11 | self reported educational attainment | | 2 | 97716827 | 97716828 | Human |
597533408 | GWAS1629482_H | creativity measurement QTL GWAS1629482 (human) | | 7e-12 | behavior trait (VT:0010442) | | 2 | 100186429 | 100186430 | Human |
597529312 | GWAS1625386_H | systemic lupus erythematosus QTL GWAS1625386 (human) | | 0.000005 | systemic lupus erythematosus | | 2 | 105629285 | 105629286 | Human |
597053970 | GWAS1150044_H | household income QTL GWAS1150044 (human) | | 6e-17 | intelligence | | 2 | 100112831 | 100112832 | Human |
597467675 | GWAS1563749_H | body mass index QTL GWAS1563749 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104849547 | 104849548 | Human |
597520918 | GWAS1616992_H | Tinnitus QTL GWAS1616992 (human) | | 0.000007 | Tinnitus | | 2 | 97740700 | 97740701 | Human |
597275159 | GWAS1371233_H | beverage consumption measurement QTL GWAS1371233 (human) | | 8e-14 | beverage consumption measurement | drink intake measurement (CMO:0000771) | 2 | 103542744 | 103542745 | Human |
597365261 | GWAS1461335_H | spontaneous preterm birth QTL GWAS1461335 (human) | | 0.000005 | spontaneous preterm birth | | 2 | 100603913 | 100603914 | Human |
597053964 | GWAS1150038_H | household income QTL GWAS1150038 (human) | | 2e-20 | household income | | 2 | 100260327 | 100260328 | Human |
597582336 | GWAS1639196_H | amyloid-beta measurement QTL GWAS1639196 (human) | | 0.000001 | amyloid-beta measurement | | 2 | 97738387 | 97738388 | Human |
596955701 | GWAS1075220_H | lymphocyte measurement, neutrophil measurement QTL GWAS1075220 (human) | | 8e-17 | lymphocyte measurement, neutrophil measurement | | 2 | 102431643 | 102431644 | Human |
597054004 | GWAS1150078_H | household income QTL GWAS1150078 (human) | | 1e-14 | household income | | 2 | 100070024 | 100070025 | Human |
597361215 | GWAS1457289_H | eosinophil percentage of granulocytes QTL GWAS1457289 (human) | | 1e-86 | eosinophil quantity (VT:0002602) | | 2 | 102352407 | 102352410 | Human |
597426745 | GWAS1522819_H | gout QTL GWAS1522819 (human) | | 7e-20 | gout | | 2 | 102108553 | 102108554 | Human |
596963902 | GWAS1083421_H | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder QTL GWAS1083421 (human) | | 0.000003 | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | | 2 | 102047167 | 102047168 | Human |
597475881 | GWAS1571955_H | platelet component distribution width QTL GWAS1571955 (human) | | 7e-20 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 2 | 105898455 | 105898456 | Human |
597520939 | GWAS1617013_H | smoking initiation QTL GWAS1617013 (human) | | 3e-18 | smoking initiation | | 2 | 100007696 | 100007697 | Human |
406989308 | GWAS638284_H | gentisic acid measurement QTL GWAS638284 (human) | | 0.000007 | gentisic acid measurement | | 2 | 100687696 | 100687697 | Human |
406993405 | GWAS642381_H | intelligence QTL GWAS642381 (human) | | 0.000006 | intelligence | | 2 | 98576424 | 98576425 | Human |
597094998 | GWAS1191072_H | 3-hydroxy-1-methylpropylmercapturic acid measurement QTL GWAS1191072 (human) | | 0.0000002 | 3-hydroxy-1-methylpropylmercapturic acid measurement | | 2 | 100730839 | 100730840 | Human |
597361243 | GWAS1457317_H | neutrophil count, eosinophil count QTL GWAS1457317 (human) | | 6e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 101160470 | 101160471 | Human |
597045846 | GWAS1141920_H | lifestyle measurement QTL GWAS1141920 (human) | | 2e-13 | lifestyle measurement | | 2 | 103830594 | 103830595 | Human |
597045844 | GWAS1141918_H | lifestyle measurement QTL GWAS1141918 (human) | | 7e-09 | lifestyle measurement | | 2 | 99329966 | 99329967 | Human |
406993281 | GWAS642257_H | reticulocyte measurement QTL GWAS642257 (human) | | 2e-10 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 2 | 97756543 | 97756544 | Human |
407374220 | GWAS1023196_H | unipolar depression QTL GWAS1023196 (human) | | 0.0000001 | unipolar depression | | 2 | 103852954 | 103852955 | Human |
407374221 | GWAS1023197_H | unipolar depression QTL GWAS1023197 (human) | | 9e-08 | unipolar depression | | 2 | 105482561 | 105482562 | Human |
597074527 | GWAS1170601_H | intelligence QTL GWAS1170601 (human) | | 7e-11 | intelligence | | 2 | 100704613 | 100704614 | Human |
597369424 | GWAS1465498_H | asthma QTL GWAS1465498 (human) | | 2e-60 | asthma | | 2 | 102319699 | 102319700 | Human |
597213769 | GWAS1309843_H | mathematical ability QTL GWAS1309843 (human) | | 2e-09 | mathematical ability | | 2 | 103284125 | 103284126 | Human |
597213770 | GWAS1309844_H | mathematical ability QTL GWAS1309844 (human) | | 3e-09 | mathematical ability | | 2 | 103538956 | 103538957 | Human |
597213771 | GWAS1309845_H | mathematical ability QTL GWAS1309845 (human) | | 8e-15 | mathematical ability | | 2 | 103827484 | 103827485 | Human |
597459528 | GWAS1555602_H | asthma, endometriosis QTL GWAS1555602 (human) | | 0.000004 | asthma, endometriosis | | 2 | 102055220 | 102055221 | Human |
597213772 | GWAS1309846_H | mathematical ability QTL GWAS1309846 (human) | | 3e-08 | mathematical ability | | 2 | 105306623 | 105306624 | Human |
597033548 | GWAS1129622_H | blood protein measurement QTL GWAS1129622 (human) | | 9e-32 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 2 | 102162001 | 102162002 | Human |
597361216 | GWAS1457290_H | eosinophil percentage of granulocytes QTL GWAS1457290 (human) | | 6e-27 | eosinophil quantity (VT:0002602) | | 2 | 102435014 | 102435015 | Human |
597058164 | GWAS1154238_H | metabolic syndrome QTL GWAS1154238 (human) | | 2e-08 | metabolic syndrome | | 2 | 105321650 | 105321651 | Human |
597582461 | GWAS1639321_H | neutrophil count QTL GWAS1639321 (human) | | 1e-11 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 2 | 102334362 | 102334363 | Human |
597058165 | GWAS1154239_H | metabolic syndrome QTL GWAS1154239 (human) | | 8e-16 | metabolic syndrome | | 2 | 105322780 | 105322781 | Human |
597512825 | GWAS1608899_H | body mass index QTL GWAS1608899 (human) | | 2e-22 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100213578 | 100213579 | Human |
597058162 | GWAS1154236_H | metabolic syndrome QTL GWAS1154236 (human) | | 3e-21 | metabolic syndrome | | 2 | 100276651 | 100276652 | Human |
597140083 | GWAS1236157_H | interleukin-1 receptor type 2 measurement QTL GWAS1236157 (human) | | 3e-86 | interleukin-1 receptor type 2 measurement | | 2 | 102000516 | 102000517 | Human |
597058163 | GWAS1154237_H | metabolic syndrome QTL GWAS1154237 (human) | | 6e-11 | metabolic syndrome | | 2 | 103805234 | 103805235 | Human |
597512827 | GWAS1608901_H | body mass index QTL GWAS1608901 (human) | | 1e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104974032 | 104974033 | Human |
597029490 | GWAS1125564_H | sugar consumption measurement QTL GWAS1125564 (human) | | 0.0000008 | sugar consumption measurement | sucrose drink intake volume (CMO:0002200) | 2 | 98918463 | 98918464 | Human |
597058161 | GWAS1154235_H | metabolic syndrome QTL GWAS1154235 (human) | | 3e-19 | metabolic syndrome | | 2 | 100134688 | 100134689 | Human |
597512826 | GWAS1608900_H | body mass index QTL GWAS1608900 (human) | | 4e-17 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104835868 | 104835869 | Human |
597107327 | GWAS1203401_H | reticulocyte measurement QTL GWAS1203401 (human) | | 1e-15 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 2 | 97756543 | 97756544 | Human |
597074558 | GWAS1170632_H | intelligence QTL GWAS1170632 (human) | | 9e-10 | intelligence | | 2 | 99732211 | 99732212 | Human |
406989227 | GWAS638203_H | gestational age QTL GWAS638203 (human) | | 0.000001 | gestational age | | 2 | 98186562 | 98186563 | Human |
597074559 | GWAS1170633_H | intelligence QTL GWAS1170633 (human) | | 5e-10 | intelligence | | 2 | 100700798 | 100700799 | Human |
597074557 | GWAS1170631_H | intelligence QTL GWAS1170631 (human) | | 4e-08 | intelligence | | 2 | 100436121 | 100436122 | Human |
597344873 | GWAS1440947_H | neutrophil measurement QTL GWAS1440947 (human) | | 1e-11 | neutrophil measurement | | 2 | 102403459 | 102403460 | Human |
597238381 | GWAS1334455_H | Stuttering QTL GWAS1334455 (human) | | 0.000003 | Stuttering | | 2 | 98486856 | 98486857 | Human |
597480042 | GWAS1576116_H | intelligence QTL GWAS1576116 (human) | | 5e-11 | intelligence | | 2 | 100236272 | 100236273 | Human |
597074528 | GWAS1170602_H | intelligence QTL GWAS1170602 (human) | | 6e-16 | intelligence | | 2 | 100412540 | 100412541 | Human |
597074529 | GWAS1170603_H | intelligence QTL GWAS1170603 (human) | | 1e-12 | intelligence | | 2 | 99986297 | 99986298 | Human |
597213592 | GWAS1309666_H | mathematical ability QTL GWAS1309666 (human) | | 6e-13 | mathematical ability | | 2 | 100308360 | 100308361 | Human |
407222853 | GWAS871829_H | eosinophil percentage of granulocytes QTL GWAS871829 (human) | | 6e-27 | eosinophil percentage of granulocytes | | 2 | 102435014 | 102435015 | Human |
597213593 | GWAS1309667_H | mathematical ability QTL GWAS1309667 (human) | | 2e-09 | mathematical ability | | 2 | 100433891 | 100433892 | Human |
597213594 | GWAS1309668_H | mathematical ability QTL GWAS1309668 (human) | | 9e-10 | mathematical ability | | 2 | 100535368 | 100535369 | Human |
597053842 | GWAS1149916_H | household income QTL GWAS1149916 (human) | | 6e-09 | household income | | 2 | 100424768 | 100424769 | Human |
597053840 | GWAS1149914_H | household income QTL GWAS1149914 (human) | | 3e-09 | household income | | 2 | 100313672 | 100313673 | Human |
597053841 | GWAS1149915_H | household income QTL GWAS1149915 (human) | | 3e-09 | household income | | 2 | 100322455 | 100322456 | Human |
597418386 | GWAS1514460_H | rheumatoid arthritis QTL GWAS1514460 (human) | | 2e-18 | rheumatoid arthritis | | 2 | 100143710 | 100143711 | Human |
597057948 | GWAS1154022_H | intelligence QTL GWAS1154022 (human) | | 0.000001 | intelligence | | 2 | 99346967 | 99346968 | Human |
597213588 | GWAS1309662_H | mathematical ability QTL GWAS1309662 (human) | | 1e-18 | mathematical ability | | 2 | 97716827 | 97716828 | Human |
597213589 | GWAS1309663_H | mathematical ability QTL GWAS1309663 (human) | | 5e-17 | mathematical ability | | 2 | 99492539 | 99492540 | Human |
597213590 | GWAS1309664_H | mathematical ability QTL GWAS1309664 (human) | | 2e-14 | mathematical ability | | 2 | 99649474 | 99649475 | Human |
597213591 | GWAS1309665_H | mathematical ability QTL GWAS1309665 (human) | | 1e-09 | mathematical ability | | 2 | 100067088 | 100067089 | Human |
597098884 | GWAS1194958_H | gut microbiome measurement QTL GWAS1194958 (human) | | 0.000004 | gut microbiome measurement | | 2 | 105321650 | 105321651 | Human |
597512587 | GWAS1608661_H | uterine fibroid, age at menopause QTL GWAS1608661 (human) | | 2e-13 | uterine fibroid, age at menopause | | 2 | 99406310 | 99406311 | Human |
597062016 | GWAS1158090_H | susceptibility to chronic sinus infection measurement QTL GWAS1158090 (human) | | 0.0000008 | response to infection trait (VT:0010434) | | 2 | 99429576 | 99429577 | Human |
597082496 | GWAS1178570_H | reticulocyte measurement QTL GWAS1178570 (human) | | 9e-13 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 2 | 99574445 | 99574446 | Human |
597528965 | GWAS1625039_H | asthma QTL GWAS1625039 (human) | | 8e-34 | asthma | | 2 | 102275879 | 102275880 | Human |
597053839 | GWAS1149913_H | household income QTL GWAS1149913 (human) | | 1e-10 | household income | | 2 | 100260166 | 100260167 | Human |
597528967 | GWAS1625041_H | asthma QTL GWAS1625041 (human) | | 5e-37 | asthma | | 2 | 102343750 | 102343751 | Human |
597528966 | GWAS1625040_H | asthma QTL GWAS1625040 (human) | | 9e-34 | asthma | | 2 | 102309902 | 102309903 | Human |
597246343 | GWAS1342417_H | central corneal thickness QTL GWAS1342417 (human) | | 4e-09 | central corneal thickness | | 2 | 99638340 | 99638341 | Human |
597168569 | GWAS1264643_H | body mass index QTL GWAS1264643 (human) | | 6e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 103796466 | 103796467 | Human |
597475768 | GWAS1571842_H | pulse pressure measurement QTL GWAS1571842 (human) | | 1e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 2 | 105510423 | 105510424 | Human |
597053886 | GWAS1149960_H | intelligence QTL GWAS1149960 (human) | | 4e-12 | intelligence | | 2 | 100313064 | 100313065 | Human |
597053887 | GWAS1149961_H | intelligence QTL GWAS1149961 (human) | | 3e-10 | intelligence | | 2 | 100342342 | 100342343 | Human |
597508518 | GWAS1604592_H | asthma QTL GWAS1604592 (human) | | 1e-15 | asthma | | 2 | 102349850 | 102349851 | Human |
597266854 | GWAS1362928_H | interleukin-1 receptor type 2 measurement QTL GWAS1362928 (human) | | 1e-110 | interleukin-1 receptor type 2 measurement | | 2 | 102000990 | 102000991 | Human |
597402020 | GWAS1498094_H | interleukin 18 receptor 1 measurement QTL GWAS1498094 (human) | | 5e-38 | interleukin 18 receptor 1 measurement | | 2 | 102293872 | 102293873 | Human |
597594529 | GWAS1651389_H | eosinophil count QTL GWAS1651389 (human) | | 9e-116 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102341256 | 102341257 | Human |
407075330 | GWAS724306_H | risk-taking behaviour QTL GWAS724306 (human) | | 3e-11 | risk-taking behaviour | | 2 | 103442825 | 103442826 | Human |
597062101 | GWAS1158175_H | lung carcinoma QTL GWAS1158175 (human) | | 0.000009 | lung carcinoma | | 2 | 105454164 | 105454165 | Human |
597103057 | GWAS1199131_H | platelet crit QTL GWAS1199131 (human) | | 7e-10 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 2 | 102636669 | 102636670 | Human |
597250504 | GWAS1346578_H | corneal resistance factor QTL GWAS1346578 (human) | | 3e-10 | corneal resistance factor | | 2 | 99651346 | 99651347 | Human |
407153168 | GWAS802144_H | gut microbiome measurement QTL GWAS802144 (human) | | 0.000001 | gut microbiome measurement | | 2 | 99888965 | 99888966 | Human |
597225934 | GWAS1322008_H | self reported educational attainment QTL GWAS1322008 (human) | | 6e-32 | self reported educational attainment | | 2 | 100264313 | 100264314 | Human |
597225935 | GWAS1322009_H | self reported educational attainment QTL GWAS1322009 (human) | | 3e-13 | self reported educational attainment | | 2 | 105354559 | 105354560 | Human |
597520893 | GWAS1616967_H | Tinnitus, wellbeing measurement QTL GWAS1616967 (human) | | 0.000002 | wellness/fitness trait (VT:1000152) | | 2 | 97740700 | 97740701 | Human |
597205496 | GWAS1301570_H | handedness QTL GWAS1301570 (human) | | 5e-09 | handedness | | 2 | 103821391 | 103821392 | Human |
597123574 | GWAS1219648_H | sun exposure measurement QTL GWAS1219648 (human) | | 2e-08 | sun exposure measurement | | 2 | 103825088 | 103825089 | Human |
596972016 | GWAS1091535_H | major depressive disorder QTL GWAS1091535 (human) | | 9e-08 | major depressive disorder | | 2 | 105482561 | 105482562 | Human |
597049840 | GWAS1145914_H | polymyositis QTL GWAS1145914 (human) | | 0.000006 | polymyositis | | 2 | 102396442 | 102396443 | Human |
597389809 | GWAS1485883_H | Eczematoid dermatitis, allergic rhinitis QTL GWAS1485883 (human) | | 1e-63 | Eczematoid dermatitis, allergic rhinitis | | 2 | 102319699 | 102319700 | Human |
597160443 | GWAS1256517_H | BMI-adjusted waist-hip ratio QTL GWAS1256517 (human) | | 4e-10 | body size trait (VT:0100005) | | 2 | 99771097 | 99771098 | Human |
597299702 | GWAS1395776_H | serum alanine aminotransferase measurement QTL GWAS1395776 (human) | | 5e-08 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 2 | 101047122 | 101047123 | Human |
597086714 | GWAS1182788_H | atopic eczema QTL GWAS1182788 (human) | | 6e-11 | atopic eczema | | 2 | 102477754 | 102477755 | Human |
597160442 | GWAS1256516_H | BMI-adjusted waist-hip ratio QTL GWAS1256516 (human) | | 1e-12 | body size trait (VT:0100005) | | 2 | 99663560 | 99663561 | Human |
407222837 | GWAS871813_H | lymphocyte count QTL GWAS871813 (human) | | 3e-31 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 2 | 102428560 | 102428561 | Human |
597533164 | GWAS1629238_H | smoking initiation QTL GWAS1629238 (human) | | 7e-18 | smoking initiation | | 2 | 103531036 | 103531037 | Human |
597336552 | GWAS1432626_H | dyslexia QTL GWAS1432626 (human) | | 2e-08 | dyslexia | | 2 | 102816510 | 102816514 | Human |
597533163 | GWAS1629237_H | smoking initiation QTL GWAS1629237 (human) | | 2e-15 | smoking initiation | | 2 | 103528717 | 103528718 | Human |
597451243 | GWAS1547317_H | rheumatoid arthritis QTL GWAS1547317 (human) | | 1e-14 | rheumatoid arthritis | | 2 | 100190478 | 100190479 | Human |
597348834 | GWAS1444908_H | body fat percentage QTL GWAS1444908 (human) | | 3e-09 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 2 | 100316335 | 100316340 | Human |
597225953 | GWAS1322027_H | heel bone mineral density QTL GWAS1322027 (human) | | 2e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 2 | 99318250 | 99318251 | Human |
597348835 | GWAS1444909_H | body fat percentage QTL GWAS1444909 (human) | | 4e-08 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 2 | 100798034 | 100798035 | Human |
596972015 | GWAS1091534_H | major depressive disorder QTL GWAS1091534 (human) | | 0.0000001 | major depressive disorder | | 2 | 103852954 | 103852955 | Human |
597451238 | GWAS1547312_H | mean arterial pressure QTL GWAS1547312 (human) | | 0.000006 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 2 | 104834075 | 104834076 | Human |
407231032 | GWAS880008_H | asthma, seasonal allergic rhinitis QTL GWAS880008 (human) | | 4e-11 | asthma, seasonal allergic rhinitis | | 2 | 102350089 | 102350090 | Human |
597225752 | GWAS1321826_H | self reported educational attainment QTL GWAS1321826 (human) | | 4e-11 | self reported educational attainment | | 2 | 99790270 | 99790271 | Human |
597246232 | GWAS1342306_H | aspartate aminotransferase measurement QTL GWAS1342306 (human) | | 1e-08 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 2 | 101027044 | 101027045 | Human |
597266705 | GWAS1362779_H | pulse pressure measurement QTL GWAS1362779 (human) | | 7e-10 | pulse pressure measurement | pulse pressure (CMO:0000292) | 2 | 100963349 | 100963350 | Human |
597336330 | GWAS1432404_H | COVID-19 QTL GWAS1432404 (human) | | 0.000009 | COVID-19 | | 2 | 103447910 | 103447911 | Human |
407153374 | GWAS802350_H | gut microbiome measurement QTL GWAS802350 (human) | | 0.000004 | gut microbiome measurement | | 2 | 99888965 | 99888966 | Human |
597397817 | GWAS1493891_H | diastolic blood pressure QTL GWAS1493891 (human) | | 3e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 2 | 104974455 | 104974456 | Human |
597053749 | GWAS1149823_H | household income QTL GWAS1149823 (human) | | 1e-09 | household income | | 2 | 99900176 | 99900177 | Human |
597430591 | GWAS1526665_H | eosinophilic esophagitis QTL GWAS1526665 (human) | | 4e-10 | eosinophilic esophagitis | | 2 | 102908473 | 102908474 | Human |
597111090 | GWAS1207164_H | Thyroid preparation use measurement QTL GWAS1207164 (human) | | 5e-10 | Thyroid preparation use measurement | | 2 | 97756543 | 97756544 | Human |
597459253 | GWAS1555327_H | body mass index QTL GWAS1555327 (human) | | 6e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100153465 | 100153466 | Human |
597459255 | GWAS1555329_H | corneal resistance factor QTL GWAS1555329 (human) | | 2e-12 | corneal resistance factor | | 2 | 100219272 | 100219273 | Human |
597500209 | GWAS1596283_H | juvenile dermatomyositis QTL GWAS1596283 (human) | | 8e-09 | juvenile dermatomyositis | | 2 | 104979261 | 104979262 | Human |
597414196 | GWAS1510270_H | allergic sensitization measurement QTL GWAS1510270 (human) | | 3e-09 | allergic sensitization measurement | | 2 | 102344364 | 102344365 | Human |
597389615 | GWAS1485689_H | lifestyle measurement QTL GWAS1485689 (human) | | 1e-10 | lifestyle measurement | | 2 | 104849547 | 104849548 | Human |
597098785 | GWAS1194859_H | asthma exacerbation measurement QTL GWAS1194859 (human) | | 3e-11 | asthma exacerbation measurement | | 2 | 102441432 | 102441433 | Human |
597098784 | GWAS1194858_H | asthma exacerbation measurement QTL GWAS1194858 (human) | | 2e-09 | asthma exacerbation measurement | | 2 | 102120407 | 102120408 | Human |
597340506 | GWAS1436580_H | neuroticism measurement, cognitive function measurement QTL GWAS1436580 (human) | | 7e-16 | cognitive behavior trait (VT:0010450) | | 2 | 100254727 | 100254728 | Human |
597397849 | GWAS1493923_H | vaginal microbiome measurement QTL GWAS1493923 (human) | | 0.0000008 | vaginal microbiome measurement | | 2 | 102330901 | 102330902 | Human |
597590357 | GWAS1647217_H | hyperpituitarism QTL GWAS1647217 (human) | | 4e-12 | hyperpituitarism | | 2 | 102163518 | 102163519 | Human |
597393744 | GWAS1489818_H | eosinophil count QTL GWAS1489818 (human) | | 4e-11 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 105900469 | 105900470 | Human |
597164373 | GWAS1260447_H | serum metabolite measurement QTL GWAS1260447 (human) | | 0.0000007 | serum metabolite measurement | | 2 | 105550471 | 105550472 | Human |
596951364 | GWAS1070883_H | dementia QTL GWAS1070883 (human) | | 0.000003 | dementia | | 2 | 105852811 | 105852812 | Human |
407128725 | GWAS777701_H | eosinophil count QTL GWAS777701 (human) | | 5e-32 | eosinophil count | | 2 | 102435014 | 102435015 | Human |
597508430 | GWAS1604504_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1604504 (human) | | 6e-15 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 2 | 100144643 | 100144644 | Human |
597393743 | GWAS1489817_H | eosinophil count QTL GWAS1489817 (human) | | 3e-152 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102349850 | 102349851 | Human |
597393742 | GWAS1489816_H | eosinophil count QTL GWAS1489816 (human) | | 6e-11 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 97996712 | 97996713 | Human |
597188943 | GWAS1285017_H | major depressive disorder QTL GWAS1285017 (human) | | 2e-11 | major depressive disorder | | 2 | 103848009 | 103848010 | Human |
597340480 | GWAS1436554_H | sarcoidosis QTL GWAS1436554 (human) | | 0.000006 | sarcoidosis | | 2 | 98693451 | 98693452 | Human |
596959567 | GWAS1079086_H | glomerular filtration rate QTL GWAS1079086 (human) | | 3e-13 | glomerular filtration rate | | 2 | 101045434 | 101045435 | Human |
597225841 | GWAS1321915_H | smoking status measurement QTL GWAS1321915 (human) | | 4e-08 | smoking status measurement | | 2 | 97658891 | 97658892 | Human |
597123454 | GWAS1219528_H | blood protein measurement QTL GWAS1219528 (human) | | 7e-60 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 2 | 102162001 | 102162002 | Human |
597225842 | GWAS1321916_H | smoking status measurement QTL GWAS1321916 (human) | | 2e-10 | smoking status measurement | | 2 | 100055946 | 100055947 | Human |
597123453 | GWAS1219527_H | blood protein measurement QTL GWAS1219527 (human) | | 3e-42 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 2 | 102179403 | 102179404 | Human |
597123452 | GWAS1219526_H | blood protein measurement QTL GWAS1219526 (human) | | 1e-296 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 2 | 102324878 | 102324879 | Human |
597225843 | GWAS1321917_H | smoking status measurement QTL GWAS1321917 (human) | | 2e-31 | smoking status measurement | | 2 | 103510525 | 103510526 | Human |
597225844 | GWAS1321918_H | smoking status measurement QTL GWAS1321918 (human) | | 3e-08 | smoking status measurement | | 2 | 103816036 | 103816037 | Human |
597287278 | GWAS1383352_H | ulcerative colitis QTL GWAS1383352 (human) | | 5e-15 | ulcerative colitis | | 2 | 102368211 | 102368212 | Human |
597368984 | GWAS1465058_H | intelligence QTL GWAS1465058 (human) | | 5e-09 | intelligence | | 2 | 100425660 | 100425661 | Human |
596979857 | GWAS1099376_H | hypothyroidism QTL GWAS1099376 (human) | | 1e-10 | hypothyroidism | | 2 | 97890066 | 97890067 | Human |
597291164 | GWAS1387238_H | forced expiratory volume, inflammatory bowel disease QTL GWAS1387238 (human) | | 3e-08 | forced expiratory volume, inflammatory bowel disease | forced expiratory volume (CMO:0000254) | 2 | 99947131 | 99947132 | Human |
597074054 | GWAS1170128_H | childhood onset asthma QTL GWAS1170128 (human) | | 5e-13 | childhood onset asthma | | 2 | 102351825 | 102351826 | Human |
597176460 | GWAS1272534_H | interleukin-1 receptor type 2 measurement QTL GWAS1272534 (human) | | 5e-255 | interleukin-1 receptor type 2 measurement | | 2 | 101999692 | 101999693 | Human |
597176461 | GWAS1272535_H | interleukin-1 receptor type 2 measurement QTL GWAS1272535 (human) | | 3e-31 | interleukin-1 receptor type 2 measurement | | 2 | 101991888 | 101991889 | Human |
597278860 | GWAS1374934_H | risk-taking behaviour QTL GWAS1374934 (human) | | 2e-16 | risk-taking behaviour | | 2 | 103440906 | 103440907 | Human |
597274757 | GWAS1370831_H | physical activity measurement QTL GWAS1370831 (human) | | 4e-09 | wellness/fitness trait (VT:1000152) | voluntary body mobility/immobility measurement (CMO:0000954) | 2 | 103816798 | 103816799 | Human |
597250232 | GWAS1346306_H | triglyceride measurement QTL GWAS1346306 (human) | | 0.0000005 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 2 | 100042282 | 100042283 | Human |
597348537 | GWAS1444611_H | Abdominal Aortic Aneurysm QTL GWAS1444611 (human) | | 1e-08 | Abdominal Aortic Aneurysm | | 2 | 105294801 | 105294802 | Human |
597360819 | GWAS1456893_H | rheumatoid arthritis, celiac disease QTL GWAS1456893 (human) | | 7e-12 | rheumatoid arthritis, celiac disease | | 2 | 100142823 | 100142824 | Human |
406924139 | GWAS573115_H | celiac disease QTL GWAS573115 (human) | | 1e-15 | celiac disease | | 2 | 102454108 | 102454109 | Human |
597266610 | GWAS1362684_H | interleukin 18 receptor accessory protein measurement QTL GWAS1362684 (human) | | 1e-40 | interleukin 18 receptor accessory protein measurement | | 2 | 102445715 | 102445716 | Human |
597266613 | GWAS1362687_H | interleukin 1 receptor-like 2 measurement QTL GWAS1362687 (human) | | 2e-18 | interleukin 1 receptor-like 2 measurement | | 2 | 102200076 | 102200077 | Human |
597106873 | GWAS1202947_H | testosterone measurement QTL GWAS1202947 (human) | | 5e-09 | testosterone measurement | serum testosterone level (CMO:0000568) | 2 | 102722213 | 102722214 | Human |
597041312 | GWAS1137386_H | soluble triggering receptor expressed on myeloid cells 2 measurement QTL GWAS1137386 (human) | | 0.0000007 | soluble triggering receptor expressed on myeloid cells 2 measurement | | 2 | 103841822 | 103841823 | Human |
597364958 | GWAS1461032_H | bipolar disorder QTL GWAS1461032 (human) | | 0.000005 | bipolar disorder | | 2 | 98773244 | 98773245 | Human |
597123293 | GWAS1219367_H | blood protein measurement QTL GWAS1219367 (human) | | 4e-129 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 2 | 102340831 | 102340832 | Human |
596975838 | GWAS1095357_H | body height QTL GWAS1095357 (human) | | 1e-23 | body height | | 2 | 106073280 | 106073281 | Human |
597520593 | GWAS1616667_H | Tinnitus QTL GWAS1616667 (human) | | 0.000009 | Tinnitus | | 2 | 104021720 | 104021721 | Human |
597323989 | GWAS1420063_H | 2-palmitoylglycerophosphocholine measurement QTL GWAS1420063 (human) | | 0.0000009 | 2-palmitoylglycerophosphocholine measurement | | 2 | 101994259 | 101994260 | Human |
596988097 | GWAS1107616_H | memory performance, sex interaction measurement QTL GWAS1107616 (human) | | 0.000007 | memory performance, sex interaction measurement | | 2 | 106505496 | 106505497 | Human |
407079711 | GWAS728687_H | waist-hip ratio QTL GWAS728687 (human) | | 5e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 2 | 99663560 | 99663561 | Human |
597053640 | GWAS1149714_H | household income QTL GWAS1149714 (human) | | 2e-08 | cognitive behavior trait (VT:0010450) | | 2 | 99725106 | 99725107 | Human |
597360887 | GWAS1456961_H | granulocyte count QTL GWAS1456961 (human) | | 3e-09 | granulocyte quantity (VT:0000334) | blood granulocyte count (CMO:0000111) | 2 | 101160470 | 101160471 | Human |
407305000 | GWAS953976_H | intelligence QTL GWAS953976 (human) | | 0.000009 | intelligence | | 2 | 100705731 | 100705732 | Human |
597151975 | GWAS1248049_H | colorectal cancer QTL GWAS1248049 (human) | | 2e-08 | colorectal cancer | | 2 | 97954621 | 97954622 | Human |
597348590 | GWAS1444664_H | atopic eczema QTL GWAS1444664 (human) | | 7e-40 | atopic eczema | | 2 | 102410643 | 102410644 | Human |
597168154 | GWAS1264228_H | aspartate aminotransferase measurement QTL GWAS1264228 (human) | | 7e-12 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 2 | 100975248 | 100975249 | Human |
597393439 | GWAS1489513_H | eosinophil percentage of leukocytes QTL GWAS1489513 (human) | | 6e-10 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 2 | 105900469 | 105900470 | Human |
597393438 | GWAS1489512_H | eosinophil percentage of leukocytes QTL GWAS1489512 (human) | | 5e-48 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 2 | 102354740 | 102354741 | Human |
597393437 | GWAS1489511_H | eosinophil percentage of leukocytes QTL GWAS1489511 (human) | | 1e-25 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 2 | 102337157 | 102337158 | Human |
596959263 | GWAS1078782_H | glomerular filtration rate QTL GWAS1078782 (human) | | 2e-14 | glomerular filtration rate | | 2 | 102538616 | 102538617 | Human |
597401620 | GWAS1497694_H | platelet crit QTL GWAS1497694 (human) | | 3e-24 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 2 | 100145753 | 100145754 | Human |
597598215 | GWAS1655075_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1655075 (human) | | 4e-19 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 2 | 100990049 | 100990050 | Human |
406961120 | GWAS610096_H | gut microbiome measurement, taxonomic microbiome measurement QTL GWAS610096 (human) | | 8e-11 | gut microbiome measurement, taxonomic microbiome measurement | | 2 | 102598951 | 102598952 | Human |
597479483 | GWAS1575557_H | biological sex QTL GWAS1575557 (human) | | 1e-09 | biological sex | | 2 | 102859139 | 102859140 | Human |
597291056 | GWAS1387130_H | asthma, endometriosis QTL GWAS1387130 (human) | | 4e-11 | asthma, endometriosis | | 2 | 102661403 | 102661404 | Human |
596967481 | GWAS1087000_H | diastolic blood pressure QTL GWAS1087000 (human) | | 3e-08 | diastolic blood pressure | | 2 | 104974455 | 104974456 | Human |
597192757 | GWAS1288831_H | cortical thickness QTL GWAS1288831 (human) | | 1e-13 | cortical thickness | | 2 | 97658891 | 97658892 | Human |
597192758 | GWAS1288832_H | cortical thickness QTL GWAS1288832 (human) | | 2e-11 | cortical thickness | | 2 | 97918271 | 97918272 | Human |
597303348 | GWAS1399422_H | interleukin-1 receptor type 2 measurement QTL GWAS1399422 (human) | | 4e-35 | interleukin-1 receptor type 2 measurement | | 2 | 102000825 | 102000826 | Human |
597135397 | GWAS1231471_H | memory performance, sex interaction measurement QTL GWAS1231471 (human) | | 0.000007 | memory performance, sex interaction measurement | | 2 | 106505496 | 106505497 | Human |
597532715 | GWAS1628789_H | pain QTL GWAS1628789 (human) | | 2e-09 | pain | | 2 | 103809919 | 103809920 | Human |
597213218 | GWAS1309292_H | celiac disease QTL GWAS1309292 (human) | | 2e-16 | celiac disease | | 2 | 102476784 | 102476785 | Human |
597237798 | GWAS1333872_H | lymphocyte count QTL GWAS1333872 (human) | | 1e-09 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 2 | 102431643 | 102431644 | Human |
597119067 | GWAS1215141_H | biological sex QTL GWAS1215141 (human) | | 3e-08 | biological sex | | 2 | 99972127 | 99972128 | Human |
407133064 | GWAS782040_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS782040 (human) | | 1e-14 | intestine integrity trait (VT:0010554) | | 2 | 102030838 | 102030839 | Human |
597143623 | GWAS1239697_H | chronic obstructive pulmonary disease QTL GWAS1239697 (human) | | 8e-12 | lung integrity trait (VT:0010906) | | 2 | 99947561 | 99947562 | Human |
597385288 | GWAS1481362_H | platelet count QTL GWAS1481362 (human) | | 4e-13 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 2 | 105583173 | 105583174 | Human |
597504068 | GWAS1600142_H | diastolic blood pressure, systolic blood pressure QTL GWAS1600142 (human) | | 6e-11 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 2 | 101001169 | 101001170 | Human |
407366557 | GWAS1015533_H | ST2 protein measurement QTL GWAS1015533 (human) | | 7e-1635 | ST2 protein measurement | | 2 | 102315366 | 102315367 | Human |
597213251 | GWAS1309325_H | circadian rhythm QTL GWAS1309325 (human) | | 0.0000003 | circadian rhythm | | 2 | 105687806 | 105687807 | Human |
597213252 | GWAS1309326_H | circadian rhythm QTL GWAS1309326 (human) | | 0.000005 | circadian rhythm | | 2 | 106646784 | 106646785 | Human |
597372997 | GWAS1469071_H | asthma QTL GWAS1469071 (human) | | 6e-116 | asthma | | 2 | 102337157 | 102337158 | Human |
597057649 | GWAS1153723_H | intelligence QTL GWAS1153723 (human) | | 4e-10 | intelligence | | 2 | 100052995 | 100052996 | Human |
596959356 | GWAS1078875_H | glomerular filtration rate QTL GWAS1078875 (human) | | 3e-14 | glomerular filtration rate | | 2 | 101045434 | 101045435 | Human |
597614711 | GWAS1671571_H | actinic keratosis QTL GWAS1671571 (human) | | 3e-11 | actinic keratosis | | 2 | 102477754 | 102477755 | Human |
596959357 | GWAS1078876_H | glomerular filtration rate QTL GWAS1078876 (human) | | 0.0000004 | glomerular filtration rate | | 2 | 102538616 | 102538617 | Human |
597237872 | GWAS1333946_H | leprosy, Crohn's disease QTL GWAS1333946 (human) | | 9e-10 | intestine integrity trait (VT:0010554) | | 2 | 102554607 | 102554608 | Human |
597500016 | GWAS1596090_H | 1-methylxanthine measurement QTL GWAS1596090 (human) | | 2e-08 | 1-methylxanthine measurement | | 2 | 105546047 | 105546048 | Human |
597057633 | GWAS1153707_H | Eczematoid dermatitis, allergic rhinitis QTL GWAS1153707 (human) | | 2e-33 | Eczematoid dermatitis, allergic rhinitis | | 2 | 102315366 | 102315367 | Human |
597373029 | GWAS1469103_H | Nasal Cavity Polyp QTL GWAS1469103 (human) | | 4e-09 | Nasal Cavity Polyp | | 2 | 102341256 | 102341257 | Human |
597137303 | GWAS1233377_H | educational attainment QTL GWAS1233377 (human) | | 5e-16 | educational attainment | | 2 | 100437687 | 100437688 | Human |
597137302 | GWAS1233376_H | educational attainment QTL GWAS1233376 (human) | | 6e-10 | educational attainment | | 2 | 100432653 | 100432654 | Human |
597137301 | GWAS1233375_H | educational attainment QTL GWAS1233375 (human) | | 2e-10 | educational attainment | | 2 | 100366717 | 100366718 | Human |
597137300 | GWAS1233374_H | educational attainment QTL GWAS1233374 (human) | | 9e-10 | educational attainment | | 2 | 100278700 | 100278701 | Human |
597137299 | GWAS1233373_H | educational attainment QTL GWAS1233373 (human) | | 3e-49 | educational attainment | | 2 | 100260231 | 100260232 | Human |
597137298 | GWAS1233372_H | educational attainment QTL GWAS1233372 (human) | | 1e-39 | educational attainment | | 2 | 100111794 | 100111795 | Human |
597018525 | GWAS1114599_H | household income QTL GWAS1114599 (human) | | 6e-12 | household income | | 2 | 100185497 | 100185498 | Human |
597067678 | GWAS1163752_H | eosinophil count QTL GWAS1163752 (human) | | 6e-25 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102346612 | 102346613 | Human |
597018527 | GWAS1114601_H | household income QTL GWAS1114601 (human) | | 3e-09 | household income | | 2 | 100208905 | 100208906 | Human |
597137309 | GWAS1233383_H | educational attainment QTL GWAS1233383 (human) | | 5e-10 | educational attainment | | 2 | 101404308 | 101404309 | Human |
597018526 | GWAS1114600_H | household income QTL GWAS1114600 (human) | | 2e-08 | household income | | 2 | 100188811 | 100188812 | Human |
597137308 | GWAS1233382_H | educational attainment QTL GWAS1233382 (human) | | 1e-17 | educational attainment | | 2 | 101139673 | 101139674 | Human |
597137307 | GWAS1233381_H | educational attainment QTL GWAS1233381 (human) | | 7e-15 | educational attainment | | 2 | 100956752 | 100956753 | Human |
597018520 | GWAS1114594_H | household income QTL GWAS1114594 (human) | | 8e-11 | household income | | 2 | 100210110 | 100210111 | Human |
597137306 | GWAS1233380_H | educational attainment QTL GWAS1233380 (human) | | 1e-17 | educational attainment | | 2 | 100712266 | 100712267 | Human |
597137305 | GWAS1233379_H | educational attainment QTL GWAS1233379 (human) | | 4e-17 | educational attainment | | 2 | 100705731 | 100705732 | Human |
597137304 | GWAS1233378_H | educational attainment QTL GWAS1233378 (human) | | 1e-22 | educational attainment | | 2 | 100514358 | 100514359 | Human |
597346187 | GWAS1442261_H | alcohol use disorder measurement QTL GWAS1442261 (human) | | 5e-13 | alcohol use disorder measurement | | 2 | 103618170 | 103618171 | Human |
407034963 | GWAS683939_H | unipolar depression QTL GWAS683939 (human) | | 2e-11 | unipolar depression | | 2 | 103848009 | 103848010 | Human |
597477262 | GWAS1573336_H | diastolic blood pressure QTL GWAS1573336 (human) | | 6e-13 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 2 | 97740700 | 97740701 | Human |
597501839 | GWAS1597913_H | rheumatoid arthritis QTL GWAS1597913 (human) | | 8e-25 | rheumatoid arthritis | | 2 | 100144643 | 100144644 | Human |
597333897 | GWAS1429971_H | smoking cessation QTL GWAS1429971 (human) | | 4e-09 | smoking cessation | | 2 | 103830594 | 103830595 | Human |
597145475 | GWAS1241549_H | self reported educational attainment QTL GWAS1241549 (human) | | 0.0000007 | self reported educational attainment | | 2 | 99672640 | 99672641 | Human |
597616521 | GWAS1673381_H | Genu varum, Genu valgum QTL GWAS1673381 (human) | | 1e-12 | Genu varum, Genu valgum | | 2 | 101474547 | 101474548 | Human |
597018509 | GWAS1114583_H | household income QTL GWAS1114583 (human) | | 7e-12 | household income | | 2 | 100370502 | 100370503 | Human |
407022692 | GWAS671668_H | serum IgG glycosylation measurement QTL GWAS671668 (human) | | 0.000005 | serum IgG glycosylation measurement | | 2 | 102772135 | 102772136 | Human |
597116863 | GWAS1212937_H | atopic eczema QTL GWAS1212937 (human) | | 4e-16 | atopic eczema | | 2 | 102426431 | 102426432 | Human |
597018528 | GWAS1114602_H | household income QTL GWAS1114602 (human) | | 5e-13 | household income | | 2 | 100232879 | 100232880 | Human |
597137313 | GWAS1233387_H | educational attainment QTL GWAS1233387 (human) | | 2e-09 | educational attainment | | 2 | 103278968 | 103278969 | Human |
597137312 | GWAS1233386_H | educational attainment QTL GWAS1233386 (human) | | 1e-10 | educational attainment | | 2 | 99936748 | 99936749 | Human |
597387171 | GWAS1483245_H | neuritic plaque measurement, neurofibrillary tangles measurement QTL GWAS1483245 (human) | | 2e-08 | neuritic plaque measurement, neurofibrillary tangles measurement | | 2 | 106026098 | 106026099 | Human |
597387169 | GWAS1483243_H | neuritic plaque measurement, cerebral amyloid angiopathy, neurofibrillary tangles measurement QTL GWAS1483243 (human) | | 0.0000002 | neuritic plaque measurement, cerebral amyloid angiopathy, neurofibrillary tangles measurement | | 2 | 106026098 | 106026099 | Human |
597092269 | GWAS1188343_H | progression free survival, metastatic colorectal cancer, response to cetuximab, response to CAPOX-B QTL GWAS1188343 (human) | | 2e-08 | progression free survival, metastatic colorectal cancer, response to cetuximab, response to CAPOX-B | survival measurement (CMO:0001021) | 2 | 98688331 | 98688332 | Human |
597231525 | GWAS1327599_H | smoking cessation QTL GWAS1327599 (human) | | 5e-14 | smoking cessation | | 2 | 103686853 | 103686854 | Human |
597264295 | GWAS1360369_H | taste liking measurement QTL GWAS1360369 (human) | | 1e-08 | taste liking measurement | | 2 | 103543925 | 103543926 | Human |
597387172 | GWAS1483246_H | neuritic plaque measurement, cerebral amyloid angiopathy QTL GWAS1483246 (human) | | 0.000003 | neuritic plaque measurement, cerebral amyloid angiopathy | | 2 | 106026098 | 106026099 | Human |
597325788 | GWAS1421862_H | FEV/FVC ratio QTL GWAS1421862 (human) | | 5e-11 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 2 | 98776282 | 98776283 | Human |
597137361 | GWAS1233435_H | ST2 protein measurement QTL GWAS1233435 (human) | | 2e-20 | ST2 protein measurement | | 2 | 102324878 | 102324879 | Human |
597510100 | GWAS1606174_H | C-reactive protein measurement QTL GWAS1606174 (human) | | 9e-12 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 2 | 102315342 | 102315343 | Human |
597362641 | GWAS1458715_H | basophil count, eosinophil count QTL GWAS1458715 (human) | | 8e-32 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102435014 | 102435015 | Human |
597362640 | GWAS1458714_H | basophil count, eosinophil count QTL GWAS1458714 (human) | | 7e-76 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102352407 | 102352410 | Human |
597338068 | GWAS1434142_H | ST2 protein measurement QTL GWAS1434142 (human) | | 4e-10 | ST2 protein measurement | | 2 | 101575616 | 101575617 | Human |
597223383 | GWAS1319457_H | heel bone mineral density, urate measurement QTL GWAS1319457 (human) | | 4e-10 | heel bone mineral density, urate measurement | blood uric acid level (CMO:0000501) | 2 | 99851535 | 99851536 | Human |
597243862 | GWAS1339936_H | blood protein measurement QTL GWAS1339936 (human) | | 3e-22 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 2 | 101495481 | 101495482 | Human |
597215176 | GWAS1311250_H | ST2 protein measurement QTL GWAS1311250 (human) | | 7e-1635 | ST2 protein measurement | | 2 | 102315366 | 102315367 | Human |
597206984 | GWAS1303058_H | major depressive disorder QTL GWAS1303058 (human) | | 0.0000001 | major depressive disorder | | 2 | 103852954 | 103852955 | Human |
597206985 | GWAS1303059_H | major depressive disorder QTL GWAS1303059 (human) | | 9e-08 | major depressive disorder | | 2 | 105482561 | 105482562 | Human |
597080001 | GWAS1176075_H | cognitive function measurement QTL GWAS1176075 (human) | | 0.000003 | cognitive behavior trait (VT:0010450) | | 2 | 102563483 | 102563484 | Human |
597215173 | GWAS1311247_H | ST2 protein measurement QTL GWAS1311247 (human) | | 2e-23 | ST2 protein measurement | | 2 | 102064141 | 102064142 | Human |
597116873 | GWAS1212947_H | atopic eczema QTL GWAS1212947 (human) | | 1e-25 | atopic eczema | | 2 | 102312157 | 102312158 | Human |
597596156 | GWAS1653016_H | drug use measurement, asthma QTL GWAS1653016 (human) | | 9e-22 | drug use measurement, asthma | | 2 | 102332010 | 102332011 | Human |
597100531 | GWAS1196605_H | protein measurement QTL GWAS1196605 (human) | | 4e-09 | protein measurement | | 2 | 105971419 | 105971420 | Human |
406973480 | GWAS622456_H | trait in response to paliperidone, schizophrenia symptom severity measurement QTL GWAS622456 (human) | | 0.000002 | trait in response to paliperidone, schizophrenia symptom severity measurement | | 2 | 99936050 | 99936051 | Human |
597526518 | GWAS1622592_H | glucose-6-phosphate measurement QTL GWAS1622592 (human) | | 3e-08 | blood carbohydrate or carbohydrate derivative amount (VT:0010903) | | 2 | 101204751 | 101204752 | Human |
597161980 | GWAS1258054_H | lipid measurement QTL GWAS1258054 (human) | | 0.000002 | lipid measurement | blood lipid measurement (CMO:0000050) | 2 | 102473668 | 102473669 | Human |
597161979 | GWAS1258053_H | lipid measurement QTL GWAS1258053 (human) | | 0.0000006 | lipid measurement | blood lipid measurement (CMO:0000050) | 2 | 102369694 | 102369695 | Human |
597129211 | GWAS1225285_H | memory performance, sex interaction measurement QTL GWAS1225285 (human) | | 0.000005 | memory performance, sex interaction measurement | | 2 | 106015278 | 106015279 | Human |
597018597 | GWAS1114671_H | household income QTL GWAS1114671 (human) | | 1e-11 | household income | | 2 | 100188666 | 100188667 | Human |
597088230 | GWAS1184304_H | monocyte count QTL GWAS1184304 (human) | | 9e-17 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 2 | 101504114 | 101504115 | Human |
597088231 | GWAS1184305_H | monocyte count QTL GWAS1184305 (human) | | 5e-09 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 2 | 101678030 | 101678033 | Human |
597141477 | GWAS1237551_H | major depressive disorder QTL GWAS1237551 (human) | | 2e-08 | major depressive disorder | | 2 | 103835877 | 103835878 | Human |
597620717 | GWAS1677577_H | endocarditis QTL GWAS1677577 (human) | | 2e-11 | endocarditis | | 2 | 101032963 | 101032964 | Human |
597055458 | GWAS1151532_H | age at menarche QTL GWAS1151532 (human) | | 3e-08 | age at menarche | | 2 | 99990959 | 99990960 | Human |
597420001 | GWAS1516075_H | childhood onset asthma QTL GWAS1516075 (human) | | 9e-59 | childhood onset asthma | | 2 | 102265892 | 102265893 | Human |
597293026 | GWAS1389100_H | FEV/FVC ratio, inflammatory bowel disease QTL GWAS1389100 (human) | | 4e-09 | FEV/FVC ratio, inflammatory bowel disease | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 2 | 102315366 | 102315367 | Human |
596969449 | GWAS1088968_H | intelligence QTL GWAS1088968 (human) | | 1e-11 | intelligence | | 2 | 100003511 | 100003512 | Human |
597276647 | GWAS1372721_H | Uterine leiomyoma QTL GWAS1372721 (human) | | 5e-10 | Uterine leiomyoma | | 2 | 99447821 | 99447822 | Human |
597420005 | GWAS1516079_H | adult onset asthma QTL GWAS1516079 (human) | | 1e-31 | adult onset asthma | | 2 | 102309902 | 102309903 | Human |
597420004 | GWAS1516078_H | adult onset asthma QTL GWAS1516078 (human) | | 1e-32 | adult onset asthma | | 2 | 102275879 | 102275880 | Human |
597452568 | GWAS1548642_H | IGA glomerulonephritis QTL GWAS1548642 (human) | | 0.000007 | IGA glomerulonephritis | | 2 | 100184736 | 100184737 | Human |
597485329 | GWAS1581403_H | serum alanine aminotransferase measurement QTL GWAS1581403 (human) | | 8e-12 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 2 | 101009197 | 101009198 | Human |
597382914 | GWAS1478988_H | erythrocyte count QTL GWAS1478988 (human) | | 3e-24 | erythrocyte count | red blood cell count (CMO:0000025) | 2 | 100147542 | 100147543 | Human |
597206845 | GWAS1302919_H | protein measurement QTL GWAS1302919 (human) | | 5e-09 | protein measurement | | 2 | 105309070 | 105309071 | Human |
597243711 | GWAS1339785_H | serum alanine aminotransferase measurement QTL GWAS1339785 (human) | | 4e-10 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 2 | 101027044 | 101027045 | Human |
597092144 | GWAS1188218_H | inflammatory bowel disease QTL GWAS1188218 (human) | | 9e-14 | inflammatory bowel disease | | 2 | 102446909 | 102446910 | Human |
597342013 | GWAS1438087_H | sarcoidosis QTL GWAS1438087 (human) | | 0.0000005 | sarcoidosis | | 2 | 98693451 | 98693452 | Human |
597337898 | GWAS1433972_H | ST2 protein measurement QTL GWAS1433972 (human) | | 9e-36 | ST2 protein measurement | | 2 | 102448052 | 102448053 | Human |
597337897 | GWAS1433971_H | ST2 protein measurement QTL GWAS1433971 (human) | | 5e-21 | ST2 protein measurement | | 2 | 102558917 | 102558918 | Human |
597301038 | GWAS1397112_H | body mass index QTL GWAS1397112 (human) | | 7e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 101820276 | 101820277 | Human |
597145377 | GWAS1241451_H | body mass index QTL GWAS1241451 (human) | | 4e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 103796466 | 103796467 | Human |
597145376 | GWAS1241450_H | body mass index QTL GWAS1241450 (human) | | 4e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100115984 | 100115985 | Human |
597301037 | GWAS1397111_H | body mass index QTL GWAS1397111 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100130111 | 100130112 | Human |
406994172 | GWAS643148_H | Eczematoid dermatitis, allergic rhinitis QTL GWAS643148 (human) | | 2e-33 | Eczematoid dermatitis, allergic rhinitis | | 2 | 102315366 | 102315367 | Human |
597436194 | GWAS1532268_H | childhood onset asthma QTL GWAS1532268 (human) | | 1e-33 | childhood onset asthma | | 2 | 102319699 | 102319700 | Human |
407039104 | GWAS688080_H | anterior uveitis QTL GWAS688080 (human) | | 0.000002 | anterior uveitis | | 2 | 102366243 | 102366244 | Human |
597116756 | GWAS1212830_H | mathematical ability QTL GWAS1212830 (human) | | 1e-16 | mathematical ability | | 2 | 97716827 | 97716828 | Human |
406957192 | GWAS606168_H | response to xenobiotic stimulus QTL GWAS606168 (human) | | 0.000005 | response to xenobiotic stimulus | | 2 | 102718982 | 102718983 | Human |
597583698 | GWAS1640558_H | mean corpuscular hemoglobin concentration QTL GWAS1640558 (human) | | 4e-15 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 2 | 102538616 | 102538617 | Human |
597370711 | GWAS1466785_H | attention deficit hyperactivity disorder QTL GWAS1466785 (human) | | 0.000004 | attention deficit hyperactivity disorder | | 2 | 103962075 | 103962076 | Human |
597329751 | GWAS1425825_H | neuroticism measurement, cognitive function measurement QTL GWAS1425825 (human) | | 3e-09 | cognitive behavior trait (VT:0010450) | | 2 | 100705731 | 100705732 | Human |
597370710 | GWAS1466784_H | attention deficit hyperactivity disorder QTL GWAS1466784 (human) | | 0.000004 | attention deficit hyperactivity disorder | | 2 | 103970893 | 103970894 | Human |
597370709 | GWAS1466783_H | attention deficit hyperactivity disorder QTL GWAS1466783 (human) | | 0.000004 | attention deficit hyperactivity disorder | | 2 | 103964045 | 103964046 | Human |
597370708 | GWAS1466782_H | attention deficit hyperactivity disorder QTL GWAS1466782 (human) | | 0.000004 | attention deficit hyperactivity disorder | | 2 | 103972680 | 103972681 | Human |
597505871 | GWAS1601945_H | age of onset of asthma QTL GWAS1601945 (human) | | 3e-08 | age of onset of asthma | | 2 | 100188666 | 100188667 | Human |
597030726 | GWAS1126800_H | tobacco smoke exposure measurement QTL GWAS1126800 (human) | | 2e-09 | tobacco smoke exposure measurement | | 2 | 105352905 | 105352906 | Human |
597366595 | GWAS1462669_H | heel bone mineral density QTL GWAS1462669 (human) | | 7e-10 | heel bone mineral density | bone mineral density (CMO:0001226) | 2 | 100228626 | 100228627 | Human |
597391170 | GWAS1487244_H | intelligence QTL GWAS1487244 (human) | | 2e-13 | intelligence | | 2 | 100180388 | 100180389 | Human |
597501823 | GWAS1597897_H | rheumatoid arthritis QTL GWAS1597897 (human) | | 1e-09 | rheumatoid arthritis | | 2 | 100144643 | 100144644 | Human |
597456763 | GWAS1552837_H | inflammatory bowel disease QTL GWAS1552837 (human) | | 2e-17 | inflammatory bowel disease | | 2 | 102435014 | 102435015 | Human |
596957053 | GWAS1076572_H | behavioural disinhibition measurement QTL GWAS1076572 (human) | | 0.0000009 | behavioural disinhibition measurement | | 2 | 101037928 | 101037929 | Human |
597313398 | GWAS1409472_H | cognitive function measurement QTL GWAS1409472 (human) | | 0.000002 | cognitive behavior trait (VT:0010450) | | 2 | 98067644 | 98067645 | Human |
597391211 | GWAS1487285_H | apolipoprotein A 1 measurement QTL GWAS1487285 (human) | | 9e-10 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 2 | 100179720 | 100179721 | Human |
597018469 | GWAS1114543_H | intelligence QTL GWAS1114543 (human) | | 1e-15 | intelligence | | 2 | 100253240 | 100253241 | Human |
407252151 | GWAS901127_H | reticulocyte count QTL GWAS901127 (human) | | 1e-09 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 2 | 99248465 | 99248466 | Human |
597071714 | GWAS1167788_H | schizophrenia QTL GWAS1167788 (human) | | 0.000001 | schizophrenia | | 2 | 104353789 | 104353790 | Human |
597108578 | GWAS1204652_H | C-reactive protein measurement QTL GWAS1204652 (human) | | 1e-09 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 2 | 102140679 | 102140680 | Human |
407129265 | GWAS778241_H | type 2 diabetes mellitus QTL GWAS778241 (human) | | 0.000006 | type 2 diabetes mellitus | | 2 | 105221141 | 105221142 | Human |
597301090 | GWAS1397164_H | interleukin-1 receptor-like 1 measurement QTL GWAS1397164 (human) | | 4e-168 | interleukin-1 receptor-like 1 measurement | | 2 | 102356208 | 102356211 | Human |
597301091 | GWAS1397165_H | interleukin-1 receptor-like 1 measurement QTL GWAS1397165 (human) | | 7e-76 | interleukin-1 receptor-like 1 measurement | | 2 | 102340831 | 102340832 | Human |
597030761 | GWAS1126835_H | smoking initiation QTL GWAS1126835 (human) | | 6e-16 | smoking initiation | | 2 | 103534333 | 103534334 | Human |
597301092 | GWAS1397166_H | interleukin-1 receptor-like 2 measurement QTL GWAS1397166 (human) | | 2e-18 | interleukin-1 receptor-like 2 measurement | | 2 | 102165189 | 102165190 | Human |
406986049 | GWAS635025_H | intelligence QTL GWAS635025 (human) | | 3e-09 | intelligence | | 2 | 99982264 | 99982265 | Human |
597059216 | GWAS1155290_H | FEV/FVC ratio QTL GWAS1155290 (human) | | 4e-08 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 2 | 99980403 | 99980404 | Human |
596977298 | GWAS1096817_H | body height QTL GWAS1096817 (human) | | 3e-09 | body height | | 2 | 98564852 | 98564853 | Human |
597223071 | GWAS1319145_H | gastroesophageal reflux disease QTL GWAS1319145 (human) | | 3e-11 | gastroesophageal reflux disease | | 2 | 99873504 | 99873505 | Human |
597059217 | GWAS1155291_H | FEV/FVC ratio QTL GWAS1155291 (human) | | 3e-20 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 2 | 102349607 | 102349608 | Human |
597169809 | GWAS1265883_H | asthma QTL GWAS1265883 (human) | | 2e-09 | asthma | | 2 | 102357669 | 102357670 | Human |
597448337 | GWAS1544411_H | body mass index QTL GWAS1544411 (human) | | 3e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100198396 | 100198397 | Human |
597448339 | GWAS1544413_H | body mass index QTL GWAS1544413 (human) | | 1e-16 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104838132 | 104838133 | Human |
597411459 | GWAS1507533_H | age at menopause QTL GWAS1507533 (human) | | 0.0000004 | age at menopause | | 2 | 105254322 | 105254323 | Human |
597059215 | GWAS1155289_H | FEV/FVC ratio QTL GWAS1155289 (human) | | 6e-11 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 2 | 99193592 | 99193593 | Human |
597272195 | GWAS1368269_H | high density lipoprotein cholesterol measurement QTL GWAS1368269 (human) | | 6e-10 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 2 | 100112831 | 100112832 | Human |
597284483 | GWAS1380557_H | BMI-adjusted hip circumference QTL GWAS1380557 (human) | | 1e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 2 | 100960284 | 100960285 | Human |
597284485 | GWAS1380559_H | BMI-adjusted hip circumference QTL GWAS1380559 (human) | | 3e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 2 | 105382552 | 105382553 | Human |
597284484 | GWAS1380558_H | BMI-adjusted hip circumference QTL GWAS1380558 (human) | | 3e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 2 | 100961996 | 100961997 | Human |
597284487 | GWAS1380561_H | BMI-adjusted hip circumference QTL GWAS1380561 (human) | | 8e-11 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 2 | 106146331 | 106146332 | Human |
597284486 | GWAS1380560_H | BMI-adjusted hip circumference QTL GWAS1380560 (human) | | 2e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 2 | 106073280 | 106073281 | Human |
406945121 | GWAS594097_H | hematocrit QTL GWAS594097 (human) | | 6e-10 | hematocrit | hematocrit (CMO:0000037) | 2 | 100026981 | 100026982 | Human |
597419711 | GWAS1515785_H | childhood onset asthma QTL GWAS1515785 (human) | | 2e-136 | childhood onset asthma | | 2 | 102319699 | 102319700 | Human |
407125357 | GWAS774333_H | serum IgG glycosylation measurement QTL GWAS774333 (human) | | 0.0000004 | serum IgG glycosylation measurement | | 2 | 99259781 | 99259782 | Human |
597247668 | GWAS1343742_H | complement factor H-related protein 3 measurement QTL GWAS1343742 (human) | | 0.000001 | complement factor H-related protein 3 measurement | | 2 | 100816076 | 100816077 | Human |
407305577 | GWAS954553_H | reticulocyte measurement QTL GWAS954553 (human) | | 7e-10 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 2 | 99248465 | 99248466 | Human |
597214892 | GWAS1310966_H | body mass index QTL GWAS1310966 (human) | | 2e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100299310 | 100299311 | Human |
597374636 | GWAS1470710_H | mean corpuscular hemoglobin QTL GWAS1470710 (human) | | 7e-12 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 2 | 100147663 | 100147664 | Human |
597055146 | GWAS1151220_H | eosinophil count QTL GWAS1151220 (human) | | 1e-26 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102349607 | 102349608 | Human |
597055145 | GWAS1151219_H | eosinophil count QTL GWAS1151219 (human) | | 7e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102324549 | 102324550 | Human |
597599962 | GWAS1656822_H | human papilloma virus infection QTL GWAS1656822 (human) | | 4e-08 | human papilloma virus infection | | 2 | 105690494 | 105690495 | Human |
597599963 | GWAS1656823_H | human papilloma virus infection QTL GWAS1656823 (human) | | 4e-08 | human papilloma virus infection | | 2 | 105670030 | 105670031 | Human |
597599961 | GWAS1656821_H | human papilloma virus infection QTL GWAS1656821 (human) | | 4e-08 | human papilloma virus infection | | 2 | 105685243 | 105685244 | Human |
597526231 | GWAS1622305_H | interleukin-1 receptor-like 1 measurement QTL GWAS1622305 (human) | | 5e-80 | interleukin-1 receptor-like 1 measurement | | 2 | 102349850 | 102349851 | Human |
597526230 | GWAS1622304_H | interleukin-1 receptor-like 1 measurement QTL GWAS1622304 (human) | | 5e-1125 | interleukin-1 receptor-like 1 measurement | | 2 | 102305323 | 102305324 | Human |
406908172 | GWAS557148_H | bipolar disorder QTL GWAS557148 (human) | | 0.000002 | bipolar disorder | | 2 | 97983036 | 97983037 | Human |
597296854 | GWAS1392928_H | interleukin 1 receptor-like 1 measurement QTL GWAS1392928 (human) | | 1e-11 | interleukin 1 receptor-like 1 measurement | | 2 | 102160058 | 102160059 | Human |
407145736 | GWAS794712_H | blood protein measurement QTL GWAS794712 (human) | | 9e-166 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 2 | 102324878 | 102324879 | Human |
597296855 | GWAS1392929_H | interleukin 1 receptor-like 1 measurement QTL GWAS1392929 (human) | | 1e-11 | interleukin 1 receptor-like 1 measurement | | 2 | 102369728 | 102369729 | Human |
407383320 | GWAS1032296_H | smoking status measurement QTL GWAS1032296 (human) | | 5e-11 | smoking status measurement | | 2 | 103651114 | 103651115 | Human |
597276360 | GWAS1372434_H | X-17357 measurement QTL GWAS1372434 (human) | | 9e-22 | X-17357 measurement | | 2 | 102750159 | 102750160 | Human |
597300936 | GWAS1397010_H | interleukin-1 receptor type 2 measurement QTL GWAS1397010 (human) | | 6e-62 | interleukin-1 receptor type 2 measurement | | 2 | 102000742 | 102000743 | Human |
597141186 | GWAS1237260_H | interleukin-1 receptor type 2 measurement QTL GWAS1237260 (human) | | 2e-09 | interleukin-1 receptor type 2 measurement | | 2 | 102000533 | 102000534 | Human |
596977344 | GWAS1096863_H | body height QTL GWAS1096863 (human) | | 6e-18 | body height | | 2 | 102487420 | 102487421 | Human |
406965527 | GWAS614503_H | HIV viral set point measurement QTL GWAS614503 (human) | | 0.000007 | HIV viral set point measurement | | 2 | 103682083 | 103682084 | Human |
597075663 | GWAS1171737_H | Parkinson disease QTL GWAS1171737 (human) | | 5e-11 | Parkinson disease | | 2 | 101796654 | 101796655 | Human |
597505728 | GWAS1601802_H | diastolic blood pressure, systolic blood pressure QTL GWAS1601802 (human) | | 8e-10 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 2 | 101001169 | 101001170 | Human |
597276356 | GWAS1372430_H | X-17340 measurement QTL GWAS1372430 (human) | | 8e-12 | X-17340 measurement | | 2 | 102722213 | 102722214 | Human |
597346047 | GWAS1442121_H | neutrophil measurement QTL GWAS1442121 (human) | | 2e-19 | neutrophil measurement | | 2 | 102382943 | 102382944 | Human |
597501691 | GWAS1597765_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1597765 (human) | | 2e-09 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 2 | 100144643 | 100144644 | Human |
406994231 | GWAS643207_H | energy intake QTL GWAS643207 (human) | | 0.000009 | energy intake | | 2 | 104192254 | 104192255 | Human |
407125308 | GWAS774284_H | pain QTL GWAS774284 (human) | | 0.000003 | pain | | 2 | 102090719 | 102090720 | Human |
597395172 | GWAS1491246_H | essential tremor QTL GWAS1491246 (human) | | 0.000002 | essential tremor | | 2 | 100982832 | 100982833 | Human |
597390879 | GWAS1486953_H | renal transplant outcome measurement, APOL1 risk genotype carrier status, donor genotype effect measurement QTL GWAS1486953 (human) | | 0.0000005 | renal transplant outcome measurement, APOL1 risk genotype carrier status, donor genotype effect measurement | | 2 | 103401605 | 103401606 | Human |
597104144 | GWAS1200218_H | platelet component distribution width QTL GWAS1200218 (human) | | 1e-10 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 2 | 100991684 | 100991685 | Human |
597440020 | GWAS1536094_H | intelligence QTL GWAS1536094 (human) | | 4e-09 | intelligence | | 2 | 100236272 | 100236273 | Human |
597181970 | GWAS1278044_H | Nasal Cavity Polyp QTL GWAS1278044 (human) | | 8e-16 | Nasal Cavity Polyp | | 2 | 102458191 | 102458192 | Human |
597087773 | GWAS1183847_H | allergic disease QTL GWAS1183847 (human) | | 3e-33 | allergic disease | | 2 | 102312157 | 102312158 | Human |
596956696 | GWAS1076215_H | neutrophil percentage of granulocytes QTL GWAS1076215 (human) | | 1e-26 | neutrophil percentage of granulocytes | | 2 | 102435014 | 102435015 | Human |
597440019 | GWAS1536093_H | intelligence QTL GWAS1536093 (human) | | 0.000007 | intelligence | | 2 | 100205083 | 100205084 | Human |
597071385 | GWAS1167459_H | ankylosing spondylitis QTL GWAS1167459 (human) | | 0.0000001 | ankylosing spondylitis | | 2 | 102030838 | 102030839 | Human |
597345802 | GWAS1441876_H | neutrophil measurement QTL GWAS1441876 (human) | | 2e-09 | neutrophil measurement | | 2 | 102374753 | 102374754 | Human |
597186056 | GWAS1282130_H | smoking cessation QTL GWAS1282130 (human) | | 3e-10 | smoking cessation | | 2 | 103830594 | 103830595 | Human |
597181961 | GWAS1278035_H | upper respiratory tract disorder QTL GWAS1278035 (human) | | 3e-08 | upper respiratory tract disorder | | 2 | 102316052 | 102316053 | Human |
597591564 | GWAS1648424_H | skin disease QTL GWAS1648424 (human) | | 6e-15 | skin disease | | 2 | 102477754 | 102477755 | Human |
597104133 | GWAS1200207_H | platelet component distribution width QTL GWAS1200207 (human) | | 4e-10 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 2 | 105717307 | 105717308 | Human |
597140994 | GWAS1237068_H | interleukin-1 receptor type 2 measurement QTL GWAS1237068 (human) | | 7e-16 | interleukin-1 receptor type 2 measurement | | 2 | 101850167 | 101850168 | Human |
597181965 | GWAS1278039_H | chronic rhinosinusitis QTL GWAS1278039 (human) | | 3e-08 | chronic rhinosinusitis | | 2 | 102380591 | 102380592 | Human |
596956674 | GWAS1076193_H | inflammatory bowel disease QTL GWAS1076193 (human) | | 2e-17 | inflammatory bowel disease | | 2 | 102435014 | 102435015 | Human |
597140992 | GWAS1237066_H | interleukin 1 receptor-like 2 measurement QTL GWAS1237066 (human) | | 2e-63 | interleukin 1 receptor-like 2 measurement | | 2 | 102212357 | 102212358 | Human |
597399043 | GWAS1495117_H | body mass index QTL GWAS1495117 (human) | | 4e-16 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100220664 | 100220665 | Human |
407305694 | GWAS954670_H | asthma QTL GWAS954670 (human) | | 4e-93 | asthma | | 2 | 102350089 | 102350090 | Human |
597284352 | GWAS1380426_H | interleukin-1 receptor type 2 measurement QTL GWAS1380426 (human) | | 9e-22 | interleukin-1 receptor type 2 measurement | | 2 | 101999692 | 101999693 | Human |
597059084 | GWAS1155158_H | central corneal thickness, intraocular pressure measurement QTL GWAS1155158 (human) | | 0.0000001 | central corneal thickness, intraocular pressure measurement | | 2 | 100980158 | 100980159 | Human |
407223771 | GWAS872747_H | diastolic blood pressure, systolic blood pressure QTL GWAS872747 (human) | | 4e-08 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 2 | 103419975 | 103419976 | Human |
597186055 | GWAS1282129_H | smoking cessation QTL GWAS1282129 (human) | | 5e-10 | smoking cessation | | 2 | 100568003 | 100568004 | Human |
407223770 | GWAS872746_H | systolic blood pressure, body mass index QTL GWAS872746 (human) | | 5e-08 | systolic blood pressure, body mass index | body mass index (BMI) (CMO:0000105) | 2 | 103419975 | 103419976 | Human |
597116468 | GWAS1212542_H | cardiac troponin T measurement QTL GWAS1212542 (human) | | 0.0000005 | cardiac troponin T measurement | blood troponin T level (CMO:0001284) | 2 | 97982529 | 97982530 | Human |
597415487 | GWAS1511561_H | smoking status measurement QTL GWAS1511561 (human) | | 3e-16 | smoking status measurement | | 2 | 104026208 | 104026209 | Human |
597349926 | GWAS1446000_H | body mass index QTL GWAS1446000 (human) | | 3e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 103646575 | 103646576 | Human |
407227899 | GWAS876875_H | self reported educational attainment QTL GWAS876875 (human) | | 0.000008 | self reported educational attainment | | 2 | 100705847 | 100705848 | Human |
597349924 | GWAS1445998_H | body mass index QTL GWAS1445998 (human) | | 3e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 103727023 | 103727026 | Human |
597530146 | GWAS1626220_H | vitamin D measurement QTL GWAS1626220 (human) | | 4e-09 | vitamin D measurement | | 2 | 100823689 | 100823690 | Human |
597464670 | GWAS1560744_H | body mass index QTL GWAS1560744 (human) | | 4e-20 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100185497 | 100185498 | Human |
597202524 | GWAS1298598_H | gestational age QTL GWAS1298598 (human) | | 0.000001 | gestational age | | 2 | 101775383 | 101775384 | Human |
597091933 | GWAS1188007_H | inflammatory bowel disease QTL GWAS1188007 (human) | | 2e-20 | inflammatory bowel disease | | 2 | 102367819 | 102367820 | Human |
597505616 | GWAS1601690_H | rheumatoid arthritis QTL GWAS1601690 (human) | | 1e-13 | rheumatoid arthritis | | 2 | 100144643 | 100144644 | Human |
597468748 | GWAS1564822_H | ST2 protein measurement QTL GWAS1564822 (human) | | 1e-60 | ST2 protein measurement | | 2 | 102599713 | 102599714 | Human |
597210696 | GWAS1306770_H | protein measurement QTL GWAS1306770 (human) | | 1e-11 | protein measurement | | 2 | 103423039 | 103423040 | Human |
597239370 | GWAS1335444_H | eosinophil count QTL GWAS1335444 (human) | | 7e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102482222 | 102482223 | Human |
597071425 | GWAS1167499_H | ankylosing spondylitis QTL GWAS1167499 (human) | | 0.000004 | ankylosing spondylitis | | 2 | 102152913 | 102152914 | Human |
597468747 | GWAS1564821_H | ST2 protein measurement QTL GWAS1564821 (human) | | 2e-196 | ST2 protein measurement | | 2 | 102354356 | 102354357 | Human |
407002524 | GWAS651500_H | age at menarche QTL GWAS651500 (human) | | 7e-13 | age at menarche | | 2 | 105248369 | 105248370 | Human |
597517948 | GWAS1614022_H | body mass index QTL GWAS1614022 (human) | | 6e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104863740 | 104863741 | Human |
597362288 | GWAS1458362_H | neutrophil percentage of granulocytes QTL GWAS1458362 (human) | | 1e-26 | neutrophil quantity (VT:0000222) | | 2 | 102435014 | 102435015 | Human |
597255796 | GWAS1351870_H | response to beta blocker QTL GWAS1351870 (human) | | 3e-08 | response to beta blocker | | 2 | 100298868 | 100298869 | Human |
597423732 | GWAS1519806_H | eosinophil count QTL GWAS1519806 (human) | | 3e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 97747944 | 97747945 | Human |
597177960 | GWAS1274034_H | body mass index QTL GWAS1274034 (human) | | 6e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 99364759 | 99364760 | Human |
597194346 | GWAS1290420_H | cortical thickness QTL GWAS1290420 (human) | | 7e-10 | cortical thickness | | 2 | 97658891 | 97658892 | Human |
597362287 | GWAS1458361_H | neutrophil percentage of granulocytes QTL GWAS1458361 (human) | | 5e-70 | neutrophil quantity (VT:0000222) | | 2 | 102352407 | 102352410 | Human |
597587556 | GWAS1644416_H | eosinophil count QTL GWAS1644416 (human) | | 8e-118 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102332010 | 102332011 | Human |
596956777 | GWAS1076296_H | basophil count, eosinophil count QTL GWAS1076296 (human) | | 8e-32 | basophil count, eosinophil count | | 2 | 102435014 | 102435015 | Human |
597177959 | GWAS1274033_H | body mass index QTL GWAS1274033 (human) | | 8e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 97658891 | 97658892 | Human |
596968852 | GWAS1088371_H | body mass index QTL GWAS1088371 (human) | | 7e-12 | body mass index | | 2 | 103804400 | 103804401 | Human |
597075358 | GWAS1171432_H | intelligence QTL GWAS1171432 (human) | | 9e-12 | intelligence | | 2 | 100069711 | 100069712 | Human |
597075359 | GWAS1171433_H | intelligence QTL GWAS1171433 (human) | | 3e-08 | intelligence | | 2 | 100530994 | 100530995 | Human |
597075356 | GWAS1171430_H | intelligence QTL GWAS1171430 (human) | | 7e-16 | intelligence | | 2 | 100322455 | 100322456 | Human |
597075357 | GWAS1171431_H | intelligence QTL GWAS1171431 (human) | | 1e-08 | intelligence | | 2 | 99062636 | 99062637 | Human |
597357974 | GWAS1454048_H | allergic sensitization measurement QTL GWAS1454048 (human) | | 5e-11 | allergic sensitization measurement | | 2 | 102343750 | 102343751 | Human |
597017988 | GWAS1114062_H | household income QTL GWAS1114062 (human) | | 4e-21 | household income | | 2 | 100241660 | 100241661 | Human |
597017990 | GWAS1114064_H | household income QTL GWAS1114064 (human) | | 5e-19 | household income | | 2 | 100187316 | 100187317 | Human |
597345676 | GWAS1441750_H | generalised epilepsy QTL GWAS1441750 (human) | | 5e-09 | generalised epilepsy | | 2 | 103653521 | 103653522 | Human |
597017986 | GWAS1114060_H | household income QTL GWAS1114060 (human) | | 6e-23 | household income | | 2 | 100208905 | 100208906 | Human |
597345677 | GWAS1441751_H | generalised epilepsy QTL GWAS1441751 (human) | | 1e-11 | generalised epilepsy | | 2 | 103816798 | 103816799 | Human |
597292417 | GWAS1388491_H | interleukin 18 receptor 1 measurement QTL GWAS1388491 (human) | | 1e-16 | interleukin 18 receptor 1 measurement | | 2 | 102490821 | 102490822 | Human |
597329282 | GWAS1425356_H | body mass index QTL GWAS1425356 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 105361319 | 105361320 | Human |
597095823 | GWAS1191897_H | testosterone measurement QTL GWAS1191897 (human) | | 2e-09 | testosterone measurement | serum testosterone level (CMO:0000568) | 2 | 102722213 | 102722214 | Human |
597292419 | GWAS1388493_H | interleukin 18 receptor accessory protein measurement QTL GWAS1388493 (human) | | 1e-24 | interleukin 18 receptor accessory protein measurement | | 2 | 102457814 | 102457815 | Human |
597329280 | GWAS1425354_H | body mass index QTL GWAS1425354 (human) | | 2e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 103542744 | 103542745 | Human |
597292418 | GWAS1388492_H | interleukin 18 receptor 1 measurement QTL GWAS1388492 (human) | | 9e-108 | interleukin 18 receptor 1 measurement | | 2 | 102368964 | 102368965 | Human |
597329281 | GWAS1425355_H | body mass index QTL GWAS1425355 (human) | | 1e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 103804400 | 103804401 | Human |
597517698 | GWAS1613772_H | asthma QTL GWAS1613772 (human) | | 5e-86 | asthma | | 2 | 102315152 | 102315153 | Human |
597083570 | GWAS1179644_H | protein measurement QTL GWAS1179644 (human) | | 7e-26 | protein measurement | | 2 | 102368964 | 102368965 | Human |
597046715 | GWAS1142789_H | C-reactive protein measurement QTL GWAS1142789 (human) | | 4e-18 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 2 | 102142833 | 102142834 | Human |
597206441 | GWAS1302515_H | colorectal cancer QTL GWAS1302515 (human) | | 1e-08 | colorectal cancer | | 2 | 97658891 | 97658892 | Human |
597194156 | GWAS1290230_H | cortical thickness QTL GWAS1290230 (human) | | 1e-11 | cortical thickness | | 2 | 97918271 | 97918272 | Human |
597591466 | GWAS1648326_H | actinic keratosis QTL GWAS1648326 (human) | | 1e-18 | actinic keratosis | | 2 | 102477754 | 102477755 | Human |
597075360 | GWAS1171434_H | intelligence QTL GWAS1171434 (human) | | 4e-10 | intelligence | | 2 | 99900176 | 99900177 | Human |
597194144 | GWAS1290218_H | cortical thickness QTL GWAS1290218 (human) | | 5e-15 | cortical thickness | | 2 | 97658891 | 97658892 | Human |
597194145 | GWAS1290219_H | cortical thickness QTL GWAS1290219 (human) | | 8e-14 | cortical thickness | | 2 | 97918271 | 97918272 | Human |
597378521 | GWAS1474595_H | lymphocyte percentage of leukocytes QTL GWAS1474595 (human) | | 4e-24 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 2 | 102433998 | 102433999 | Human |
596956630 | GWAS1076149_H | eosinophil percentage of granulocytes QTL GWAS1076149 (human) | | 6e-27 | eosinophil percentage of granulocytes | | 2 | 102435014 | 102435015 | Human |
597087701 | GWAS1183775_H | adult onset asthma QTL GWAS1183775 (human) | | 3e-33 | adult onset asthma | | 2 | 102332701 | 102332702 | Human |
597087697 | GWAS1183771_H | adult onset asthma QTL GWAS1183771 (human) | | 4e-14 | adult onset asthma | | 2 | 102236342 | 102236343 | Human |
597501399 | GWAS1597473_H | chronic obstructive pulmonary disease QTL GWAS1597473 (human) | | 2e-20 | lung integrity trait (VT:0010906) | | 2 | 102316102 | 102316103 | Human |
597087706 | GWAS1183780_H | adult onset asthma QTL GWAS1183780 (human) | | 1e-09 | adult onset asthma | | 2 | 102578099 | 102578100 | Human |
597444050 | GWAS1540124_H | interleukin-1 receptor-like 1 measurement QTL GWAS1540124 (human) | | 4e-213 | interleukin-1 receptor-like 1 measurement | | 2 | 102326460 | 102326461 | Human |
597087705 | GWAS1183779_H | adult onset asthma QTL GWAS1183779 (human) | | 4e-08 | adult onset asthma | | 2 | 101671373 | 101671374 | Human |
597444051 | GWAS1540125_H | interleukin-1 receptor-like 1 measurement QTL GWAS1540125 (human) | | 3e-391 | interleukin-1 receptor-like 1 measurement | | 2 | 102305323 | 102305324 | Human |
597300682 | GWAS1396756_H | interleukin-18 receptor 1 measurement QTL GWAS1396756 (human) | | 1e-273 | interleukin-18 receptor 1 measurement | | 2 | 102418584 | 102418585 | Human |
597300681 | GWAS1396755_H | interleukin-18 receptor 1 measurement QTL GWAS1396755 (human) | | 3e-129 | interleukin-18 receptor 1 measurement | | 2 | 102390760 | 102390761 | Human |
597411270 | GWAS1507344_H | interleukin 1 receptor-like 1 measurement QTL GWAS1507344 (human) | | 6e-254 | interleukin 1 receptor-like 1 measurement | | 2 | 102341256 | 102341257 | Human |
597030347 | GWAS1126421_H | waist-hip ratio QTL GWAS1126421 (human) | | 2e-11 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 2 | 99672016 | 99672017 | Human |
597018058 | GWAS1114132_H | eosinophil count QTL GWAS1114132 (human) | | 6e-305 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102354740 | 102354741 | Human |
597333499 | GWAS1429573_H | dyslexia QTL GWAS1429573 (human) | | 0.0000002 | dyslexia | | 2 | 97959068 | 97959069 | Human |
597439999 | GWAS1536073_H | intelligence, self reported educational attainment QTL GWAS1536073 (human) | | 2e-16 | intelligence, self reported educational attainment | | 2 | 100205083 | 100205084 | Human |
597140991 | GWAS1237065_H | interleukin 1 receptor-like 2 measurement QTL GWAS1237065 (human) | | 1e-12 | interleukin 1 receptor-like 2 measurement | | 2 | 102206236 | 102206237 | Human |
597140990 | GWAS1237064_H | interleukin 1 receptor-like 2 measurement QTL GWAS1237064 (human) | | 1e-18 | interleukin 1 receptor-like 2 measurement | | 2 | 101665356 | 101665357 | Human |
597018111 | GWAS1114185_H | intelligence QTL GWAS1114185 (human) | | 3e-11 | intelligence | | 2 | 100167191 | 100167192 | Human |
406969901 | GWAS618877_H | cannabis dependence measurement QTL GWAS618877 (human) | | 0.000002 | response to addictive substance trait (VT:0010488) | | 2 | 99835214 | 99835215 | Human |
597308916 | GWAS1404990_H | Thyroid preparation use measurement QTL GWAS1404990 (human) | | 3e-09 | Thyroid preparation use measurement | | 2 | 97756543 | 97756544 | Human |
597108196 | GWAS1204270_H | C-reactive protein measurement QTL GWAS1204270 (human) | | 7e-11 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 2 | 102128394 | 102128395 | Human |
597083621 | GWAS1179695_H | protein measurement QTL GWAS1179695 (human) | | 2e-31 | protein measurement | | 2 | 102346612 | 102346613 | Human |
596989414 | GWAS1108933_H | memory performance, sex interaction measurement QTL GWAS1108933 (human) | | 0.000005 | memory performance, sex interaction measurement | | 2 | 106015278 | 106015279 | Human |
597362150 | GWAS1458224_H | age at first birth measurement QTL GWAS1458224 (human) | | 5e-09 | age at first birth measurement | maternal age at birth of first offspring (CMO:0002510) | 2 | 100215756 | 100215757 | Human |
597366043 | GWAS1462117_H | eosinophil count QTL GWAS1462117 (human) | | 4e-17 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 97655112 | 97655113 | Human |
597218584 | GWAS1314658_H | serum gamma-glutamyl transferase measurement QTL GWAS1314658 (human) | | 1e-11 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 2 | 102622897 | 102622898 | Human |
597366047 | GWAS1462121_H | eosinophil count QTL GWAS1462121 (human) | | 8e-290 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102354740 | 102354741 | Human |
597366046 | GWAS1462120_H | eosinophil count QTL GWAS1462120 (human) | | 4e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 101969429 | 101969430 | Human |
597366045 | GWAS1462119_H | eosinophil count QTL GWAS1462119 (human) | | 5e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 101538302 | 101538303 | Human |
597366044 | GWAS1462118_H | eosinophil count QTL GWAS1462118 (human) | | 2e-08 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 98766429 | 98766430 | Human |
597288208 | GWAS1384282_H | body weight QTL GWAS1384282 (human) | | 8e-09 | body mass (VT:0001259) | body weight (CMO:0000012) | 2 | 103796466 | 103796467 | Human |
597423380 | GWAS1519454_H | eosinophil count QTL GWAS1519454 (human) | | 1e-96 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102349850 | 102349851 | Human |
597505291 | GWAS1601365_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1601365 (human) | | 5e-26 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 2 | 100144643 | 100144644 | Human |
597517575 | GWAS1613649_H | colorectal cancer QTL GWAS1613649 (human) | | 0.000002 | colorectal cancer | | 2 | 104558985 | 104558986 | Human |
597411130 | GWAS1507204_H | asthma QTL GWAS1507204 (human) | | 2e-20 | asthma | | 2 | 102337157 | 102337158 | Human |
597415226 | GWAS1511300_H | asthma QTL GWAS1511300 (human) | | 1e-52 | asthma | | 2 | 102350446 | 102350447 | Human |
597415225 | GWAS1511299_H | asthma QTL GWAS1511299 (human) | | 5e-76 | asthma | | 2 | 102319699 | 102319700 | Human |
597415224 | GWAS1511298_H | asthma QTL GWAS1511298 (human) | | 2e-56 | asthma | | 2 | 102309902 | 102309903 | Human |
597067061 | GWAS1163135_H | susceptibility to measles measurement QTL GWAS1163135 (human) | | 0.000004 | response to viral infection trait (VT:0010439) | | 2 | 105873995 | 105873996 | Human |
597411133 | GWAS1507207_H | asthma QTL GWAS1507207 (human) | | 9e-20 | asthma | | 2 | 102341256 | 102341257 | Human |
597292339 | GWAS1388413_H | interleukin 1 receptor-like 1 measurement QTL GWAS1388413 (human) | | 8e-18 | interleukin 1 receptor-like 1 measurement | | 2 | 102425941 | 102425942 | Human |
597292341 | GWAS1388415_H | interleukin 1 receptor-like 2 measurement QTL GWAS1388415 (human) | | 6e-12 | interleukin 1 receptor-like 2 measurement | | 2 | 102183770 | 102183771 | Human |
597415223 | GWAS1511297_H | asthma QTL GWAS1511297 (human) | | 5e-71 | asthma | | 2 | 102275879 | 102275880 | Human |
597415222 | GWAS1511296_H | asthma QTL GWAS1511296 (human) | | 2e-28 | asthma | | 2 | 102265892 | 102265893 | Human |
597292340 | GWAS1388414_H | interleukin 1 receptor-like 1 measurement QTL GWAS1388414 (human) | | 2e-11 | interleukin 1 receptor-like 1 measurement | | 2 | 102503941 | 102503942 | Human |
407052013 | GWAS700989_H | testosterone measurement QTL GWAS700989 (human) | | 9e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 2 | 101996551 | 101996552 | Human |
597415221 | GWAS1511295_H | asthma QTL GWAS1511295 (human) | | 1e-19 | asthma | | 2 | 102181785 | 102181786 | Human |
597247287 | GWAS1343361_H | bipolar disorder, sex interaction measurement QTL GWAS1343361 (human) | | 0.0000004 | bipolar disorder, sex interaction measurement | | 2 | 105439227 | 105439228 | Human |
597292342 | GWAS1388416_H | interleukin 1 receptor-like 2 measurement QTL GWAS1388416 (human) | | 1e-14 | interleukin 1 receptor-like 2 measurement | | 2 | 102212357 | 102212358 | Human |
597103910 | GWAS1199984_H | household income QTL GWAS1199984 (human) | | 2e-08 | household income | | 2 | 100590799 | 100590800 | Human |
597345580 | GWAS1441654_H | cannabis dependence QTL GWAS1441654 (human) | | 4e-13 | cannabis dependence | | 2 | 103618170 | 103618171 | Human |
406986369 | GWAS635345_H | intelligence QTL GWAS635345 (human) | | 3e-10 | intelligence | | 2 | 100259649 | 100259650 | Human |
597054805 | GWAS1150879_H | household income QTL GWAS1150879 (human) | | 2e-08 | household income | | 2 | 100712266 | 100712267 | Human |
597022033 | GWAS1118107_H | interleukin 7 measurement QTL GWAS1118107 (human) | | 0.000009 | blood interleukin-7 amount (VT:0008604) | | 2 | 100804390 | 100804391 | Human |
597239135 | GWAS1335209_H | eosinophil count QTL GWAS1335209 (human) | | 4e-15 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102451363 | 102451364 | Human |
597140831 | GWAS1236905_H | educational attainment QTL GWAS1236905 (human) | | 4e-08 | educational attainment | | 2 | 99603947 | 99603948 | Human |
597321042 | GWAS1417116_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1417116 (human) | | 2e-10 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 2 | 100342342 | 100342343 | Human |
597140830 | GWAS1236904_H | educational attainment QTL GWAS1236904 (human) | | 2e-20 | educational attainment | | 2 | 99492539 | 99492540 | Human |
597140829 | GWAS1236903_H | educational attainment QTL GWAS1236903 (human) | | 1e-13 | educational attainment | | 2 | 98259514 | 98259515 | Human |
597439830 | GWAS1535904_H | systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis QTL GWAS1535904 (human) | | 0.0000008 | systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis | | 2 | 100217755 | 100217756 | Human |
597140828 | GWAS1236902_H | educational attainment QTL GWAS1236902 (human) | | 2e-11 | educational attainment | | 2 | 97995161 | 97995162 | Human |
597321041 | GWAS1417115_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1417115 (human) | | 1e-11 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 2 | 100313064 | 100313065 | Human |
597140827 | GWAS1236901_H | educational attainment QTL GWAS1236901 (human) | | 8e-13 | educational attainment | | 2 | 97925411 | 97925412 | Human |
597054810 | GWAS1150884_H | household income QTL GWAS1150884 (human) | | 2e-08 | household income | | 2 | 100463752 | 100463753 | Human |
597140826 | GWAS1236900_H | educational attainment QTL GWAS1236900 (human) | | 8e-08 | educational attainment | | 2 | 97817228 | 97817229 | Human |
597054808 | GWAS1150882_H | household income QTL GWAS1150882 (human) | | 2e-08 | household income | | 2 | 99824056 | 99824057 | Human |
597239127 | GWAS1335201_H | eosinophil count QTL GWAS1335201 (human) | | 4e-16 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102168114 | 102168115 | Human |
597402964 | GWAS1499038_H | neuritic plaque measurement QTL GWAS1499038 (human) | | 0.000004 | neuritic plaque measurement | | 2 | 106026098 | 106026099 | Human |
597349706 | GWAS1445780_H | body mass index QTL GWAS1445780 (human) | | 5e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 103543327 | 103543328 | Human |
407178900 | GWAS827876_H | asthma, age at onset QTL GWAS827876 (human) | | 0.0000002 | asthma, age at onset | | 2 | 101809678 | 101809679 | Human |
597476686 | GWAS1572760_H | interleukin 18 receptor 1 measurement QTL GWAS1572760 (human) | | 1e-221 | interleukin 18 receptor 1 measurement | | 2 | 102350323 | 102350324 | Human |
597476687 | GWAS1572761_H | interleukin 18 receptor 1 measurement QTL GWAS1572761 (human) | | 4e-118 | interleukin 18 receptor 1 measurement | | 2 | 102350323 | 102350324 | Human |
597017921 | GWAS1113995_H | eosinophil count QTL GWAS1113995 (human) | | 9e-297 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102354740 | 102354741 | Human |
597521733 | GWAS1617807_H | diastolic blood pressure QTL GWAS1617807 (human) | | 0.000007 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 2 | 104589093 | 104589094 | Human |
597521732 | GWAS1617806_H | diastolic blood pressure QTL GWAS1617806 (human) | | 3e-13 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 2 | 97740700 | 97740701 | Human |
597284167 | GWAS1380241_H | interleukin-1 receptor-like 2 measurement QTL GWAS1380241 (human) | | 3e-16 | interleukin-1 receptor-like 2 measurement | | 2 | 102200235 | 102200236 | Human |
597091703 | GWAS1187777_H | leprosy QTL GWAS1187777 (human) | | 2e-23 | leprosy | | 2 | 102328956 | 102328957 | Human |
597177724 | GWAS1273798_H | body mass index QTL GWAS1273798 (human) | | 7e-14 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100130111 | 100130112 | Human |
597329279 | GWAS1425353_H | body mass index QTL GWAS1425353 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 99506568 | 99506569 | Human |
597177725 | GWAS1273799_H | body mass index QTL GWAS1273799 (human) | | 3e-22 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100299310 | 100299311 | Human |
597177726 | GWAS1273800_H | body mass index QTL GWAS1273800 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 101820276 | 101820277 | Human |
597177727 | GWAS1273801_H | body mass index QTL GWAS1273801 (human) | | 8e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 103543327 | 103543328 | Human |
597538162 | GWAS1634236_H | creativity measurement QTL GWAS1634236 (human) | | 9e-11 | behavior trait (VT:0010442) | | 2 | 100189534 | 100189535 | Human |
597448044 | GWAS1544118_H | body mass index QTL GWAS1544118 (human) | | 1e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 103809919 | 103809920 | Human |
597140834 | GWAS1236908_H | educational attainment QTL GWAS1236908 (human) | | 2e-17 | educational attainment | | 2 | 99909976 | 99909977 | Human |
597140833 | GWAS1236907_H | educational attainment QTL GWAS1236907 (human) | | 2e-12 | educational attainment | | 2 | 99806696 | 99806697 | Human |
597140832 | GWAS1236906_H | educational attainment QTL GWAS1236906 (human) | | 8e-27 | educational attainment | | 2 | 99730502 | 99730503 | Human |
597365912 | GWAS1461986_H | balding measurement QTL GWAS1461986 (human) | | 4e-12 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 2 | 100178867 | 100178868 | Human |
597243037 | GWAS1339111_H | BMI-adjusted waist-hip ratio QTL GWAS1339111 (human) | | 9e-13 | body size trait (VT:0100005) | | 2 | 99672016 | 99672017 | Human |
597283997 | GWAS1380071_H | serum gamma-glutamyl transferase measurement QTL GWAS1380071 (human) | | 8e-12 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 2 | 102553355 | 102553356 | Human |
597283996 | GWAS1380070_H | serum gamma-glutamyl transferase measurement QTL GWAS1380070 (human) | | 2e-11 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 2 | 101018368 | 101018369 | Human |
597480601 | GWAS1576675_H | lymphocyte count QTL GWAS1576675 (human) | | 2e-08 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 2 | 104971345 | 104971346 | Human |
597243038 | GWAS1339112_H | BMI-adjusted waist-hip ratio QTL GWAS1339112 (human) | | 5e-10 | body size trait (VT:0100005) | | 2 | 99771097 | 99771098 | Human |
597484694 | GWAS1580768_H | monocyte count QTL GWAS1580768 (human) | | 3e-12 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 2 | 101515720 | 101515721 | Human |
597279890 | GWAS1375964_H | hypothyroidism QTL GWAS1375964 (human) | | 1e-10 | hypothyroidism | | 2 | 97890066 | 97890067 | Human |
406916941 | GWAS565917_H | bipolar disorder QTL GWAS565917 (human) | | 0.000003 | bipolar disorder | | 2 | 104366809 | 104366810 | Human |
597038215 | GWAS1134289_H | gut microbiome measurement QTL GWAS1134289 (human) | | 0.000003 | gut microbiome measurement | | 2 | 104231350 | 104231351 | Human |
597222540 | GWAS1318614_H | activities of daily living score measurement QTL GWAS1318614 (human) | | 0.000009 | activities of daily living score measurement | | 2 | 105429876 | 105429877 | Human |
597283971 | GWAS1380045_H | interleukin-1 receptor-like 1 measurement QTL GWAS1380045 (human) | | 1e-24 | interleukin-1 receptor-like 1 measurement | | 2 | 102315366 | 102315367 | Human |
597468295 | GWAS1564369_H | balding measurement QTL GWAS1564369 (human) | | 3e-11 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 2 | 100178867 | 100178868 | Human |
597283970 | GWAS1380044_H | interleukin-1 receptor-like 1 measurement QTL GWAS1380044 (human) | | 4e-13 | interleukin-1 receptor-like 1 measurement | | 2 | 102340831 | 102340832 | Human |
597144714 | GWAS1240788_H | age of onset of childhood onset asthma QTL GWAS1240788 (human) | | 1e-61 | age of onset of childhood onset asthma | | 2 | 102350089 | 102350090 | Human |
597587134 | GWAS1643994_H | type 2 diabetes mellitus QTL GWAS1643994 (human) | | 2e-10 | type 2 diabetes mellitus | | 2 | 104849547 | 104849548 | Human |
597587133 | GWAS1643993_H | type 2 diabetes mellitus QTL GWAS1643993 (human) | | 3e-08 | type 2 diabetes mellitus | | 2 | 104573962 | 104573963 | Human |
597271729 | GWAS1367803_H | interleukin 1 receptor-like 1 measurement QTL GWAS1367803 (human) | | 3e-11 | interleukin 1 receptor-like 1 measurement | | 2 | 102474116 | 102474117 | Human |
597271728 | GWAS1367802_H | interleukin 1 receptor-like 1 measurement QTL GWAS1367802 (human) | | 1e-11 | interleukin 1 receptor-like 1 measurement | | 2 | 100839497 | 100839498 | Human |
597365936 | GWAS1462010_H | blood protein measurement QTL GWAS1462010 (human) | | 9e-75 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 2 | 102350323 | 102350324 | Human |
407060328 | GWAS709304_H | Nasal Cavity Polyp QTL GWAS709304 (human) | | 7e-10 | Nasal Cavity Polyp | | 2 | 102370999 | 102371000 | Human |
597386411 | GWAS1482485_H | type 1 diabetes mellitus QTL GWAS1482485 (human) | | 0.0000001 | type 1 diabetes mellitus | | 2 | 100147625 | 100147626 | Human |
407002999 | GWAS651975_H | body mass index QTL GWAS651975 (human) | | 3e-09 | body mass index | | 2 | 99506568 | 99506569 | Human |
597271727 | GWAS1367801_H | interleukin 1 receptor-like 1 measurement QTL GWAS1367801 (human) | | 5e-12 | interleukin 1 receptor-like 1 measurement | | 2 | 102085948 | 102085949 | Human |
597460138 | GWAS1556212_H | respiratory system disease QTL GWAS1556212 (human) | | 4e-101 | respiratory system disease | | 2 | 102319699 | 102319700 | Human |
407003003 | GWAS651979_H | body mass index QTL GWAS651979 (human) | | 2e-17 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100278425 | 100278426 | Human |
407003000 | GWAS651976_H | body mass index QTL GWAS651976 (human) | | 5e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 105361319 | 105361320 | Human |
407003001 | GWAS651977_H | body mass index QTL GWAS651977 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 105312447 | 105312448 | Human |
597619935 | GWAS1676795_H | Aphasia QTL GWAS1676795 (human) | | 2e-11 | Aphasia | | 2 | 102936674 | 102936675 | Human |
597066965 | GWAS1163039_H | age at menarche QTL GWAS1163039 (human) | | 0.0000004 | age at menarche | | 2 | 105248369 | 105248370 | Human |
597017822 | GWAS1113896_H | household income QTL GWAS1113896 (human) | | 2e-08 | household income | | 2 | 100236725 | 100236726 | Human |
597378256 | GWAS1474330_H | celiac disease QTL GWAS1474330 (human) | | 4e-09 | celiac disease | | 2 | 102355405 | 102355406 | Human |
597357782 | GWAS1453856_H | rheumatoid arthritis QTL GWAS1453856 (human) | | 2e-18 | rheumatoid arthritis | | 2 | 100208905 | 100208906 | Human |
597357783 | GWAS1453857_H | rheumatoid arthritis QTL GWAS1453857 (human) | | 1e-14 | rheumatoid arthritis | | 2 | 100208905 | 100208906 | Human |
597193928 | GWAS1290002_H | cortical thickness QTL GWAS1290002 (human) | | 7e-12 | cortical thickness | | 2 | 97918271 | 97918272 | Human |
597206216 | GWAS1302290_H | protein measurement QTL GWAS1302290 (human) | | 5e-09 | protein measurement | | 2 | 105356819 | 105356820 | Human |
597066946 | GWAS1163020_H | susceptibility to chronic sinus infection measurement QTL GWAS1163020 (human) | | 0.000004 | response to infection trait (VT:0010434) | | 2 | 99549992 | 99549993 | Human |
597066944 | GWAS1163018_H | susceptibility to chronic sinus infection measurement QTL GWAS1163018 (human) | | 0.0000002 | response to infection trait (VT:0010434) | | 2 | 99224622 | 99224623 | Human |
597193927 | GWAS1290001_H | cortical thickness QTL GWAS1290001 (human) | | 3e-14 | cortical thickness | | 2 | 97658891 | 97658892 | Human |
597419257 | GWAS1515331_H | asthma QTL GWAS1515331 (human) | | 8e-43 | asthma | | 2 | 102309902 | 102309903 | Human |
597083378 | GWAS1179452_H | lymphocyte count QTL GWAS1179452 (human) | | 8e-25 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 2 | 102431643 | 102431644 | Human |
406990629 | GWAS639605_H | intelligence QTL GWAS639605 (human) | | 2e-08 | intelligence | | 2 | 100342342 | 100342343 | Human |
597071079 | GWAS1167153_H | ankylosing spondylitis QTL GWAS1167153 (human) | | 0.000001 | ankylosing spondylitis | | 2 | 102030838 | 102030839 | Human |
597087463 | GWAS1183537_H | adult onset asthma QTL GWAS1183537 (human) | | 5e-27 | adult onset asthma | | 2 | 102327786 | 102327787 | Human |
597480680 | GWAS1576754_H | intraocular pressure measurement QTL GWAS1576754 (human) | | 2e-08 | intraocular pressure measurement | | 2 | 100987350 | 100987351 | Human |
597529834 | GWAS1625908_H | vitamin D measurement QTL GWAS1625908 (human) | | 1e-10 | vitamin D measurement | | 2 | 100826935 | 100826936 | Human |
597538022 | GWAS1634096_H | body mass index QTL GWAS1634096 (human) | | 4e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100189534 | 100189535 | Human |
597374176 | GWAS1470250_H | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder QTL GWAS1470250 (human) | | 0.000003 | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | | 2 | 102047167 | 102047168 | Human |
597439713 | GWAS1535787_H | Crohn's disease QTL GWAS1535787 (human) | | 6e-11 | intestine integrity trait (VT:0010554) | | 2 | 102322576 | 102322577 | Human |
597087464 | GWAS1183538_H | adult onset asthma QTL GWAS1183538 (human) | | 1e-14 | adult onset asthma | | 2 | 102475982 | 102475983 | Human |
597431522 | GWAS1527596_H | platelet count QTL GWAS1527596 (human) | | 1e-10 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 2 | 105577095 | 105577096 | Human |
597050388 | GWAS1146462_H | Eczematoid dermatitis QTL GWAS1146462 (human) | | 4e-79 | Eczematoid dermatitis | | 2 | 102327786 | 102327787 | Human |
597124117 | GWAS1220191_H | interleukin 18 receptor 1 measurement QTL GWAS1220191 (human) | | 2e-69 | interleukin 18 receptor 1 measurement | | 2 | 102489152 | 102489153 | Human |
597271578 | GWAS1367652_H | interleukin-1 receptor type 1 measurement QTL GWAS1367652 (human) | | 2e-18 | interleukin-1 receptor type 1 measurement | | 2 | 102115909 | 102115910 | Human |
597402643 | GWAS1498717_H | ulcerative colitis QTL GWAS1498717 (human) | | 1e-14 | ulcerative colitis | | 2 | 102046427 | 102046428 | Human |
597378065 | GWAS1474139_H | neutrophil count QTL GWAS1474139 (human) | | 3e-11 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 2 | 101987463 | 101987464 | Human |
407003081 | GWAS652057_H | body mass index QTL GWAS652057 (human) | | 6e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 97716827 | 97716828 | Human |
597115911 | GWAS1211985_H | cognitive function measurement QTL GWAS1211985 (human) | | 1e-08 | cognitive behavior trait (VT:0010450) | | 2 | 99443979 | 99443980 | Human |
597509131 | GWAS1605205_H | testosterone measurement QTL GWAS1605205 (human) | | 8e-11 | testosterone measurement | serum testosterone level (CMO:0000568) | 2 | 101019918 | 101019919 | Human |
597054479 | GWAS1150553_H | eosinophil percentage of leukocytes QTL GWAS1150553 (human) | | 2e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 2 | 97949280 | 97949281 | Human |
597414914 | GWAS1510988_H | gut microbiome measurement QTL GWAS1510988 (human) | | 0.0000006 | gut microbiome measurement | | 2 | 105933013 | 105933014 | Human |
597308422 | GWAS1404496_H | total blood protein measurement QTL GWAS1404496 (human) | | 7e-14 | total blood protein measurement | blood protein measurement (CMO:0000028) | 2 | 97855699 | 97855700 | Human |
597476352 | GWAS1572426_H | interleukin 18 receptor 1 measurement QTL GWAS1572426 (human) | | 1e-48 | interleukin 18 receptor 1 measurement | | 2 | 102354903 | 102354904 | Human |
597115914 | GWAS1211988_H | cognitive function measurement QTL GWAS1211988 (human) | | 3e-11 | cognitive behavior trait (VT:0010450) | | 2 | 100705731 | 100705732 | Human |
597115913 | GWAS1211987_H | cognitive function measurement QTL GWAS1211987 (human) | | 1e-32 | cognitive behavior trait (VT:0010450) | | 2 | 100254724 | 100254725 | Human |
597115912 | GWAS1211986_H | cognitive function measurement QTL GWAS1211986 (human) | | 3e-15 | cognitive behavior trait (VT:0010450) | | 2 | 99992378 | 99992379 | Human |
597468221 | GWAS1564295_H | systolic blood pressure, trait in response to thiazide, response to beta blocker QTL GWAS1564295 (human) | | 0.000008 | systolic blood pressure, trait in response to thiazide, response to beta blocker | systolic blood pressure (CMO:0000004) | 2 | 104434714 | 104434715 | Human |
597054525 | GWAS1150599_H | eosinophil percentage of leukocytes QTL GWAS1150599 (human) | | 4e-60 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 2 | 102324549 | 102324550 | Human |
597419061 | GWAS1515135_H | childhood onset asthma QTL GWAS1515135 (human) | | 2e-69 | childhood onset asthma | | 2 | 102350446 | 102350447 | Human |
597144615 | GWAS1240689_H | self reported educational attainment QTL GWAS1240689 (human) | | 4e-08 | self reported educational attainment | | 2 | 99672640 | 99672641 | Human |
597099558 | GWAS1195632_H | monocyte count QTL GWAS1195632 (human) | | 8e-11 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 2 | 102533847 | 102533848 | Human |
407027697 | GWAS676673_H | eosinophil count QTL GWAS676673 (human) | | 0.000007 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102475081 | 102475082 | Human |
597029923 | GWAS1125997_H | BMI-adjusted waist-hip ratio QTL GWAS1125997 (human) | | 8e-16 | body size trait (VT:0100005) | | 2 | 99672016 | 99672017 | Human |
597124128 | GWAS1220202_H | blood protein measurement QTL GWAS1220202 (human) | | 2e-26 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 2 | 98540484 | 98540485 | Human |
597271585 | GWAS1367659_H | interleukin 18 receptor accessory protein measurement QTL GWAS1367659 (human) | | 5e-22 | interleukin 18 receptor accessory protein measurement | | 2 | 102412491 | 102412492 | Human |
597431334 | GWAS1527408_H | protein measurement QTL GWAS1527408 (human) | | 7e-784 | protein measurement | | 2 | 102310051 | 102310052 | Human |
597238821 | GWAS1334895_H | electrocardiography QTL GWAS1334895 (human) | | 7e-10 | electrocardiography | | 2 | 102782676 | 102782677 | Human |
597144617 | GWAS1240691_H | self reported educational attainment QTL GWAS1240691 (human) | | 3e-08 | self reported educational attainment | | 2 | 103191486 | 103191487 | Human |
597312549 | GWAS1408623_H | uric acid measurement QTL GWAS1408623 (human) | | 6e-09 | uric acid measurement | blood uric acid level (CMO:0000501) | 2 | 100961560 | 100961561 | Human |
597439523 | GWAS1535597_H | atopic eczema QTL GWAS1535597 (human) | | 2e-12 | atopic eczema | | 2 | 102355405 | 102355406 | Human |
597238822 | GWAS1334896_H | electrocardiography QTL GWAS1334896 (human) | | 3e-11 | electrocardiography | | 2 | 102782676 | 102782677 | Human |
597054545 | GWAS1150619_H | household income QTL GWAS1150619 (human) | | 5e-12 | household income | | 2 | 100342342 | 100342343 | Human |
597316693 | GWAS1412767_H | X-17357 measurement QTL GWAS1412767 (human) | | 3e-15 | X-17357 measurement | | 2 | 102723774 | 102723775 | Human |
597488718 | GWAS1584792_H | BMI-adjusted hip circumference QTL GWAS1584792 (human) | | 3e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 2 | 100997385 | 100997386 | Human |
597529673 | GWAS1625747_H | asthma QTL GWAS1625747 (human) | | 2e-10 | asthma | | 2 | 102275879 | 102275880 | Human |
596952129 | GWAS1071648_H | educational attainment QTL GWAS1071648 (human) | | 1e-12 | educational attainment | | 2 | 100226176 | 100226177 | Human |
596960321 | GWAS1079840_H | glomerular filtration rate QTL GWAS1079840 (human) | | 6e-18 | glomerular filtration rate | | 2 | 101045434 | 101045435 | Human |
597464137 | GWAS1560211_H | squamous cell lung carcinoma, family history of lung cancer QTL GWAS1560211 (human) | | 0.000001 | squamous cell lung carcinoma, family history of lung cancer | | 2 | 102241279 | 102241280 | Human |
597066819 | GWAS1162893_H | Hepatic fibrosis QTL GWAS1162893 (human) | | 0.000008 | Hepatic fibrosis | | 2 | 102417980 | 102417981 | Human |
596960322 | GWAS1079841_H | glomerular filtration rate QTL GWAS1079841 (human) | | 2e-13 | glomerular filtration rate | | 2 | 102538616 | 102538617 | Human |
597529674 | GWAS1625748_H | asthma QTL GWAS1625748 (human) | | 2e-08 | asthma | | 2 | 102309902 | 102309903 | Human |
597419074 | GWAS1515148_H | childhood onset asthma QTL GWAS1515148 (human) | | 5e-37 | childhood onset asthma | | 2 | 102181785 | 102181786 | Human |
597365830 | GWAS1461904_H | hemoglobin measurement QTL GWAS1461904 (human) | | 1e-12 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 2 | 100179464 | 100179465 | Human |
597476418 | GWAS1572492_H | asthma exacerbation measurement QTL GWAS1572492 (human) | | 8e-12 | asthma exacerbation measurement | | 2 | 102263004 | 102263005 | Human |
597468286 | GWAS1564360_H | self reported educational attainment QTL GWAS1564360 (human) | | 9e-21 | self reported educational attainment | | 2 | 100253240 | 100253241 | Human |
597189759 | GWAS1285833_H | systemic lupus erythematosus QTL GWAS1285833 (human) | | 3e-12 | systemic lupus erythematosus | | 2 | 102473668 | 102473669 | Human |
597619830 | GWAS1676690_H | mental or behavioural disorder QTL GWAS1676690 (human) | | 3e-11 | mental or behavioural disorder | | 2 | 101330038 | 101330039 | Human |
597017725 | GWAS1113799_H | eosinophil count QTL GWAS1113799 (human) | | 1e-26 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102354705 | 102354706 | Human |
597492849 | GWAS1588923_H | educational attainment QTL GWAS1588923 (human) | | 5e-09 | educational attainment | | 2 | 105396791 | 105396792 | Human |
597492848 | GWAS1588922_H | educational attainment QTL GWAS1588922 (human) | | 6e-09 | educational attainment | | 2 | 105253167 | 105253168 | Human |
597070950 | GWAS1167024_H | rheumatoid arthritis QTL GWAS1167024 (human) | | 1e-08 | rheumatoid arthritis | | 2 | 100056230 | 100056231 | Human |
597492845 | GWAS1588919_H | educational attainment QTL GWAS1588919 (human) | | 3e-15 | educational attainment | | 2 | 103894919 | 103894920 | Human |
597292136 | GWAS1388210_H | lymphocyte measurement, neutrophil measurement QTL GWAS1388210 (human) | | 8e-17 | lymphocyte measurement, neutrophil measurement | | 2 | 102431643 | 102431644 | Human |
597492844 | GWAS1588918_H | educational attainment QTL GWAS1588918 (human) | | 4e-09 | educational attainment | | 2 | 103882304 | 103882305 | Human |
597492847 | GWAS1588921_H | educational attainment QTL GWAS1588921 (human) | | 4e-12 | educational attainment | | 2 | 104091597 | 104091598 | Human |
597329001 | GWAS1425075_H | post-traumatic stress disorder QTL GWAS1425075 (human) | | 3e-08 | post-traumatic stress disorder | | 2 | 99863501 | 99863502 | Human |
597492846 | GWAS1588920_H | educational attainment QTL GWAS1588920 (human) | | 5e-13 | educational attainment | | 2 | 103962465 | 103962466 | Human |
597320814 | GWAS1416888_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1416888 (human) | | 4e-09 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 2 | 100051367 | 100051368 | Human |
597378159 | GWAS1474233_H | monocyte count QTL GWAS1474233 (human) | | 4e-24 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 2 | 101509468 | 101509469 | Human |
597320813 | GWAS1416887_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1416887 (human) | | 1e-08 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 2 | 99992378 | 99992379 | Human |
597054573 | GWAS1150647_H | household income QTL GWAS1150647 (human) | | 2e-11 | household income | | 2 | 100003323 | 100003324 | Human |
597509216 | GWAS1605290_H | adult onset asthma QTL GWAS1605290 (human) | | 4e-12 | adult onset asthma | | 2 | 102319699 | 102319700 | Human |
597034091 | GWAS1130165_H | blood protein measurement QTL GWAS1130165 (human) | | 0.0000002 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 2 | 102460685 | 102460686 | Human |
597052308 | GWAS1148382_H | childhood onset asthma QTL GWAS1148382 (human) | | 8e-10 | childhood onset asthma | | 2 | 102470626 | 102470627 | Human |
597052309 | GWAS1148383_H | childhood onset asthma QTL GWAS1148383 (human) | | 3e-16 | childhood onset asthma | | 2 | 102562489 | 102562490 | Human |
407113792 | GWAS762768_H | waist-hip ratio QTL GWAS762768 (human) | | 2e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 2 | 100961996 | 100961997 | Human |
597482392 | GWAS1578466_H | serum ST2 amount QTL GWAS1578466 (human) | | 3e-13 | serum ST2 amount | | 2 | 102310051 | 102310052 | Human |
597052307 | GWAS1148381_H | childhood onset asthma QTL GWAS1148381 (human) | | 1e-13 | childhood onset asthma | | 2 | 102635468 | 102635469 | Human |
597166993 | GWAS1263067_H | uterine fibroid QTL GWAS1263067 (human) | | 4e-10 | uterine fibroid | | 2 | 99428722 | 99428723 | Human |
597265298 | GWAS1361372_H | low density lipoprotein cholesterol measurement QTL GWAS1361372 (human) | | 1e-16 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 2 | 101015426 | 101015427 | Human |
597416852 | GWAS1512926_H | major depressive disorder QTL GWAS1512926 (human) | | 0.000002 | major depressive disorder | | 2 | 105194762 | 105194763 | Human |
597044108 | GWAS1140182_H | Astigmatism QTL GWAS1140182 (human) | | 0.000003 | Astigmatism | | 2 | 99939404 | 99939405 | Human |
597326778 | GWAS1422852_H | sex interaction measurement, inflammatory bowel disease QTL GWAS1422852 (human) | | 0.0000002 | sex interaction measurement, inflammatory bowel disease | | 2 | 101904152 | 101904153 | Human |
597044147 | GWAS1140221_H | smoking initiation QTL GWAS1140221 (human) | | 1e-15 | smoking initiation | | 2 | 103510525 | 103510526 | Human |
597478324 | GWAS1574398_H | asthma, age at onset QTL GWAS1574398 (human) | | 1e-12 | asthma, age at onset | | 2 | 102265892 | 102265893 | Human |
597478322 | GWAS1574396_H | asthma, age at onset QTL GWAS1574396 (human) | | 9e-30 | asthma, age at onset | | 2 | 102319699 | 102319700 | Human |
596974503 | GWAS1094022_H | major depressive disorder QTL GWAS1094022 (human) | | 4e-08 | major depressive disorder | | 2 | 105482561 | 105482562 | Human |
597396387 | GWAS1492461_H | asthma exacerbation measurement, response to corticosteroid QTL GWAS1492461 (human) | | 0.0000006 | asthma exacerbation measurement, response to corticosteroid | | 2 | 105176393 | 105176394 | Human |
597457829 | GWAS1553903_H | interleukin-18 receptor 1 measurement QTL GWAS1553903 (human) | | 3e-17 | interleukin-18 receptor 1 measurement | | 2 | 102294597 | 102294598 | Human |
597478306 | GWAS1574380_H | testosterone measurement QTL GWAS1574380 (human) | | 7e-13 | testosterone measurement | serum testosterone level (CMO:0000568) | 2 | 105254672 | 105254673 | Human |
597502933 | GWAS1599007_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1599007 (human) | | 5e-09 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 2 | 100219272 | 100219273 | Human |
597502932 | GWAS1599006_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1599006 (human) | | 5e-10 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 2 | 100167191 | 100167192 | Human |
597502935 | GWAS1599009_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1599009 (human) | | 1e-16 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 2 | 100260908 | 100260909 | Human |
597502934 | GWAS1599008_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1599008 (human) | | 3e-16 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 2 | 100253240 | 100253241 | Human |
597060570 | GWAS1156644_H | adolescent idiopathic scoliosis QTL GWAS1156644 (human) | | 3e-09 | adolescent idiopathic scoliosis | | 2 | 102816833 | 102816834 | Human |
407076878 | GWAS725854_H | smoking behavior QTL GWAS725854 (human) | | 2e-10 | smoking behavior | | 2 | 103240616 | 103240617 | Human |
597384143 | GWAS1480217_H | allergic disease, age at onset QTL GWAS1480217 (human) | | 4e-33 | allergic disease, age at onset | | 2 | 102324851 | 102324852 | Human |
597453768 | GWAS1549842_H | COVID-19 QTL GWAS1549842 (human) | | 0.000002 | COVID-19 | | 2 | 106283266 | 106283267 | Human |
407224344 | GWAS873320_H | lymphocyte count QTL GWAS873320 (human) | | 6e-16 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 2 | 102470310 | 102470311 | Human |
407167008 | GWAS815984_H | allergic disease QTL GWAS815984 (human) | | 6e-27 | allergic disease | | 2 | 102316052 | 102316053 | Human |
597478393 | GWAS1574467_H | pseudotumor cerebri QTL GWAS1574467 (human) | | 0.000002 | pseudotumor cerebri | | 2 | 105933971 | 105933972 | Human |
597367793 | GWAS1463867_H | asthma QTL GWAS1463867 (human) | | 8e-09 | asthma | | 2 | 102298194 | 102298195 | Human |
597060576 | GWAS1156650_H | adolescent idiopathic scoliosis QTL GWAS1156650 (human) | | 3e-08 | adolescent idiopathic scoliosis | | 2 | 97921970 | 97921971 | Human |
597470180 | GWAS1566254_H | mathematical ability QTL GWAS1566254 (human) | | 2e-40 | mathematical ability | | 2 | 100191263 | 100191264 | Human |
597322722 | GWAS1418796_H | ST2 protein measurement QTL GWAS1418796 (human) | | 3e-33 | ST2 protein measurement | | 2 | 102371859 | 102371860 | Human |
597040110 | GWAS1136184_H | diet measurement QTL GWAS1136184 (human) | | 2e-09 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 2 | 103522964 | 103522967 | Human |
597470181 | GWAS1566255_H | mathematical ability QTL GWAS1566255 (human) | | 3e-10 | mathematical ability | | 2 | 100707116 | 100707117 | Human |
597322723 | GWAS1418797_H | ST2 protein measurement QTL GWAS1418797 (human) | | 6e-21 | ST2 protein measurement | | 2 | 102409510 | 102409511 | Human |
597470182 | GWAS1566256_H | mathematical ability QTL GWAS1566256 (human) | | 4e-08 | mathematical ability | | 2 | 103962465 | 103962466 | Human |
407113791 | GWAS762767_H | waist-hip ratio QTL GWAS762767 (human) | | 2e-13 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 2 | 99663560 | 99663561 | Human |
597273574 | GWAS1369648_H | low density lipoprotein cholesterol measurement QTL GWAS1369648 (human) | | 5e-15 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 2 | 101025798 | 101025799 | Human |
407044291 | GWAS693267_H | IGFBP-1 measurement QTL GWAS693267 (human) | | 0.000006 | IGFBP-1 measurement | | 2 | 105294056 | 105294057 | Human |
596966172 | GWAS1085691_H | lichen planus QTL GWAS1085691 (human) | | 8e-11 | lichen planus | | 2 | 102456671 | 102456676 | Human |
597482259 | GWAS1578333_H | reticulocyte measurement QTL GWAS1578333 (human) | | 5e-11 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 2 | 101160919 | 101160920 | Human |
597420811 | GWAS1516885_H | asthma QTL GWAS1516885 (human) | | 3e-53 | asthma | | 2 | 102319699 | 102319700 | Human |
596978435 | GWAS1097954_H | Crohn's disease QTL GWAS1097954 (human) | | 6e-18 | Crohn's disease | | 2 | 102368211 | 102368212 | Human |
597170946 | GWAS1267020_H | cigarettes per day measurement QTL GWAS1267020 (human) | | 5e-08 | cigarettes per day measurement | | 2 | 105361319 | 105361320 | Human |
597371654 | GWAS1467728_H | body mass index QTL GWAS1467728 (human) | | 1e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104974455 | 104974456 | Human |
597035784 | GWAS1131858_H | intraocular pressure measurement QTL GWAS1131858 (human) | | 6e-08 | intraocular pressure measurement | | 2 | 100991684 | 100991685 | Human |
597359365 | GWAS1455439_H | platelet crit QTL GWAS1455439 (human) | | 6e-10 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 2 | 100145753 | 100145754 | Human |
597166904 | GWAS1262978_H | serum alanine aminotransferase measurement QTL GWAS1262978 (human) | | 6e-09 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 2 | 102112256 | 102112257 | Human |
597453629 | GWAS1549703_H | cystatin C measurement QTL GWAS1549703 (human) | | 9e-123 | cystatin C measurement | blood cystatin C level (CMO:0002777) | 2 | 104650006 | 104650007 | Human |
596974385 | GWAS1093904_H | vitamin D measurement QTL GWAS1093904 (human) | | 4e-09 | vitamin D measurement | | 2 | 100823689 | 100823690 | Human |
597084978 | GWAS1181052_H | mean corpuscular hemoglobin concentration QTL GWAS1181052 (human) | | 5e-13 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 2 | 102538616 | 102538617 | Human |
597510968 | GWAS1607042_H | interleukin 1 receptor-like 2 measurement QTL GWAS1607042 (human) | | 3e-15 | interleukin 1 receptor-like 2 measurement | | 2 | 101921974 | 101921975 | Human |
407298275 | GWAS947251_H | BMI-adjusted waist circumference QTL GWAS947251 (human) | | 4e-08 | body size trait (VT:0100005) | | 2 | 104857240 | 104857241 | Human |
597056304 | GWAS1152378_H | adolescent idiopathic scoliosis QTL GWAS1152378 (human) | | 0.000002 | adolescent idiopathic scoliosis | | 2 | 106602375 | 106602376 | Human |
597072689 | GWAS1168763_H | schizophrenia QTL GWAS1168763 (human) | | 6e-09 | schizophrenia | | 2 | 104367929 | 104367930 | Human |
597596982 | GWAS1653842_H | eosinophil count QTL GWAS1653842 (human) | | 6e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102334362 | 102334363 | Human |
597056319 | GWAS1152393_H | basophil percentage of leukocytes QTL GWAS1152393 (human) | | 7e-11 | basophil quantity (VT:0002607) | blood basophil count to total leukocyte count ratio (CMO:0000368) | 2 | 102426252 | 102426253 | Human |
597203763 | GWAS1299837_H | asthma QTL GWAS1299837 (human) | | 2e-29 | asthma | | 2 | 102332701 | 102332702 | Human |
407126249 | GWAS775225_H | chronic kidney disease, diabetic nephropathy QTL GWAS775225 (human) | | 0.0000004 | kidney integrity trait (VT:0010580) | | 2 | 99767892 | 99767893 | Human |
407302379 | GWAS951355_H | unipolar depression QTL GWAS951355 (human) | | 0.000002 | unipolar depression | | 2 | 105194762 | 105194763 | Human |
597101349 | GWAS1197423_H | Chlamydia trachomatis seropositivity QTL GWAS1197423 (human) | | 5e-09 | Chlamydia trachomatis seropositivity | | 2 | 105679190 | 105679191 | Human |
597056296 | GWAS1152370_H | adolescent idiopathic scoliosis QTL GWAS1152370 (human) | | 0.0000002 | adolescent idiopathic scoliosis | | 2 | 100122979 | 100122980 | Human |
597052246 | GWAS1148320_H | opioid use disorder QTL GWAS1148320 (human) | | 0.0000002 | conditioned place preference behavior trait (VT:0010723) | | 2 | 98848955 | 98848956 | Human |
597179224 | GWAS1275298_H | smoking initiation QTL GWAS1275298 (human) | | 2e-50 | smoking initiation | | 2 | 103831447 | 103831448 | Human |
597179225 | GWAS1275299_H | smoking initiation QTL GWAS1275299 (human) | | 4e-21 | smoking initiation | | 2 | 105352905 | 105352906 | Human |
597150546 | GWAS1246620_H | reaction time measurement QTL GWAS1246620 (human) | | 4e-08 | cognitive behavior trait (VT:0010450) | | 2 | 103456576 | 103456577 | Human |
597330783 | GWAS1426857_H | colorectal cancer QTL GWAS1426857 (human) | | 0.000002 | colorectal cancer | | 2 | 104300113 | 104300114 | Human |
597506907 | GWAS1602981_H | physical activity measurement QTL GWAS1602981 (human) | | 1e-13 | wellness/fitness trait (VT:1000152) | voluntary body mobility/immobility measurement (CMO:0000954) | 2 | 100215807 | 100215808 | Human |
597506906 | GWAS1602980_H | physical activity measurement QTL GWAS1602980 (human) | | 5e-14 | wellness/fitness trait (VT:1000152) | voluntary body mobility/immobility measurement (CMO:0000954) | 2 | 100213578 | 100213579 | Human |
597179216 | GWAS1275290_H | smoking initiation QTL GWAS1275290 (human) | | 4e-27 | smoking initiation | | 2 | 100067088 | 100067089 | Human |
597179217 | GWAS1275291_H | smoking initiation QTL GWAS1275291 (human) | | 7e-27 | smoking initiation | | 2 | 100083468 | 100083469 | Human |
597506900 | GWAS1602974_H | physical activity measurement QTL GWAS1602974 (human) | | 2e-09 | wellness/fitness trait (VT:1000152) | voluntary body mobility/immobility measurement (CMO:0000954) | 2 | 100215807 | 100215808 | Human |
597334867 | GWAS1430941_H | asthma QTL GWAS1430941 (human) | | 4e-13 | asthma | | 2 | 102115136 | 102115137 | Human |
597179218 | GWAS1275292_H | smoking initiation QTL GWAS1275292 (human) | | 8e-16 | smoking initiation | | 2 | 100341779 | 100341780 | Human |
597052252 | GWAS1148326_H | childhood onset asthma QTL GWAS1148326 (human) | | 1e-19 | childhood onset asthma | | 2 | 102225664 | 102225665 | Human |
597109597 | GWAS1205671_H | Glucocorticoid use measurement QTL GWAS1205671 (human) | | 4e-17 | Glucocorticoid use measurement | | 2 | 102362568 | 102362569 | Human |
597326672 | GWAS1422746_H | coronary artery disease QTL GWAS1422746 (human) | | 0.000006 | coronary artery disease | | 2 | 103589213 | 103589214 | Human |
597052253 | GWAS1148327_H | childhood onset asthma QTL GWAS1148327 (human) | | 1e-10 | childhood onset asthma | | 2 | 101671373 | 101671374 | Human |
597179219 | GWAS1275293_H | smoking initiation QTL GWAS1275293 (human) | | 1e-81 | smoking initiation | | 2 | 103473485 | 103473486 | Human |
597052250 | GWAS1148324_H | childhood onset asthma QTL GWAS1148324 (human) | | 7e-10 | childhood onset asthma | | 2 | 102113414 | 102113415 | Human |
597179220 | GWAS1275294_H | smoking initiation QTL GWAS1275294 (human) | | 2e-77 | smoking initiation | | 2 | 103524835 | 103524836 | Human |
597052251 | GWAS1148325_H | childhood onset asthma QTL GWAS1148325 (human) | | 3e-09 | childhood onset asthma | | 2 | 102165764 | 102165765 | Human |
597179221 | GWAS1275295_H | smoking initiation QTL GWAS1275295 (human) | | 9e-16 | smoking initiation | | 2 | 103616464 | 103616465 | Human |
597506899 | GWAS1602973_H | physical activity measurement QTL GWAS1602973 (human) | | 0.0000007 | wellness/fitness trait (VT:1000152) | voluntary body mobility/immobility measurement (CMO:0000954) | 2 | 100213578 | 100213579 | Human |
597179222 | GWAS1275296_H | smoking initiation QTL GWAS1275296 (human) | | 3e-15 | smoking initiation | | 2 | 103683312 | 103683315 | Human |
597052249 | GWAS1148323_H | childhood onset asthma QTL GWAS1148323 (human) | | 6e-14 | childhood onset asthma | | 2 | 102115136 | 102115137 | Human |
597179223 | GWAS1275297_H | smoking initiation QTL GWAS1275297 (human) | | 6e-14 | smoking initiation | | 2 | 103713641 | 103713643 | Human |
597179214 | GWAS1275288_H | smoking initiation QTL GWAS1275288 (human) | | 2e-11 | smoking initiation | | 2 | 99947641 | 99947642 | Human |
597597000 | GWAS1653860_H | eosinophil count QTL GWAS1653860 (human) | | 5e-34 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102332010 | 102332011 | Human |
597179215 | GWAS1275289_H | smoking initiation QTL GWAS1275289 (human) | | 2e-27 | smoking initiation | | 2 | 100060124 | 100060125 | Human |
597433154 | GWAS1529228_H | reticulocyte count QTL GWAS1529228 (human) | | 8e-12 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 2 | 101153455 | 101153456 | Human |
597396347 | GWAS1492421_H | interleukin 1 receptor-like 1 measurement QTL GWAS1492421 (human) | | 2e-201 | interleukin 1 receptor-like 1 measurement | | 2 | 102303577 | 102303578 | Human |
407027875 | GWAS676851_H | estradiol measurement QTL GWAS676851 (human) | | 0.000001 | estradiol measurement | blood estradiol level (CMO:0000513) | 2 | 101413184 | 101413185 | Human |
597195643 | GWAS1291717_H | systolic blood pressure QTL GWAS1291717 (human) | | 0.0000003 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 2 | 100962027 | 100962028 | Human |
597461880 | GWAS1557954_H | rheumatoid arthritis QTL GWAS1557954 (human) | | 2e-15 | rheumatoid arthritis | | 2 | 100208905 | 100208906 | Human |
597195644 | GWAS1291718_H | systolic blood pressure QTL GWAS1291718 (human) | | 5e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 2 | 105511000 | 105511001 | Human |
597396348 | GWAS1492422_H | interleukin 1 receptor-like 1 measurement QTL GWAS1492422 (human) | | 8e-34 | interleukin 1 receptor-like 1 measurement | | 2 | 102311189 | 102311190 | Human |
597195634 | GWAS1291708_H | intelligence QTL GWAS1291708 (human) | | 1e-11 | intelligence | | 2 | 100003511 | 100003512 | Human |
597298038 | GWAS1394112_H | sphingomyelin measurement QTL GWAS1394112 (human) | | 0.000003 | sphingomyelin measurement | | 2 | 98930629 | 98930630 | Human |
597465969 | GWAS1562043_H | triglyceride measurement QTL GWAS1562043 (human) | | 2e-08 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 2 | 98084782 | 98084783 | Human |
597367670 | GWAS1463744_H | hemoglobin measurement QTL GWAS1463744 (human) | | 2e-09 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 2 | 100159458 | 100159459 | Human |
597371766 | GWAS1467840_H | asthma QTL GWAS1467840 (human) | | 1e-09 | asthma | | 2 | 102338622 | 102338623 | Human |
597244791 | GWAS1340865_H | trait in response to lamotrigine QTL GWAS1340865 (human) | | 0.000003 | trait in response to lamotrigine | | 2 | 105500197 | 105500198 | Human |
597494637 | GWAS1590711_H | educational attainment QTL GWAS1590711 (human) | | 5e-10 | educational attainment | | 2 | 99338004 | 99338005 | Human |
597216108 | GWAS1312182_H | protein measurement QTL GWAS1312182 (human) | | 6e-09 | protein measurement | | 2 | 106165515 | 106165516 | Human |
406986932 | GWAS635908_H | intelligence QTL GWAS635908 (human) | | 3e-08 | intelligence | | 2 | 99959842 | 99959843 | Human |
597265263 | GWAS1361337_H | total cholesterol measurement QTL GWAS1361337 (human) | | 2e-11 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 2 | 101015426 | 101015427 | Human |
406986942 | GWAS635918_H | intelligence QTL GWAS635918 (human) | | 3e-08 | intelligence | | 2 | 99692662 | 99692663 | Human |
597027691 | GWAS1123765_H | gastroesophageal reflux disease QTL GWAS1123765 (human) | | 9e-10 | gastroesophageal reflux disease | | 2 | 99873901 | 99873902 | Human |
597584543 | GWAS1641403_H | mean corpuscular hemoglobin concentration QTL GWAS1641403 (human) | | 8e-13 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 2 | 100138535 | 100138536 | Human |
597219997 | GWAS1316071_H | behavioural disinhibition measurement QTL GWAS1316071 (human) | | 0.0000009 | behavioural disinhibition measurement | | 2 | 101037928 | 101037929 | Human |
597379740 | GWAS1475814_H | plasma betaine measurement QTL GWAS1475814 (human) | | 0.000007 | plasma betaine measurement | | 2 | 104015636 | 104015637 | Human |
597318290 | GWAS1414364_H | diastolic blood pressure, systolic blood pressure QTL GWAS1414364 (human) | | 0.0000003 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 2 | 98133007 | 98133008 | Human |
597318291 | GWAS1414365_H | diastolic blood pressure, systolic blood pressure QTL GWAS1414365 (human) | | 0.000004 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 2 | 105377402 | 105377403 | Human |
597207701 | GWAS1303775_H | mathematical ability QTL GWAS1303775 (human) | | 6e-18 | mathematical ability | | 2 | 97716827 | 97716828 | Human |
597207702 | GWAS1303776_H | mathematical ability QTL GWAS1303776 (human) | | 6e-11 | mathematical ability | | 2 | 99440746 | 99440747 | Human |
597371540 | GWAS1467614_H | chronotype measurement QTL GWAS1467614 (human) | | 3e-08 | sleep behavior trait (VT:0001501) | | 2 | 104696517 | 104696518 | Human |
597072518 | GWAS1168592_H | feeling nervous measurement QTL GWAS1168592 (human) | | 6e-09 | feeling nervous measurement | | 2 | 103659518 | 103659519 | Human |
597072516 | GWAS1168590_H | feeling nervous measurement QTL GWAS1168590 (human) | | 1e-13 | feeling nervous measurement | | 2 | 103448268 | 103448269 | Human |
597072517 | GWAS1168591_H | feeling nervous measurement QTL GWAS1168591 (human) | | 2e-09 | feeling nervous measurement | | 2 | 103548492 | 103548493 | Human |
597609149 | GWAS1666009_H | Benign Thyroid Gland Neoplasm QTL GWAS1666009 (human) | | 6e-12 | Benign Thyroid Gland Neoplasm | | 2 | 100821896 | 100821897 | Human |
407040359 | GWAS689335_H | mammographic density measurement QTL GWAS689335 (human) | | 0.000009 | mammographic density measurement | | 2 | 99743888 | 99743889 | Human |
597043891 | GWAS1139965_H | erythrocyte count QTL GWAS1139965 (human) | | 5e-08 | erythrocyte count | red blood cell count (CMO:0000025) | 2 | 101430369 | 101430370 | Human |
597412542 | GWAS1508616_H | childhood onset asthma QTL GWAS1508616 (human) | | 3e-28 | childhood onset asthma | | 2 | 102309902 | 102309903 | Human |
597412541 | GWAS1508615_H | childhood onset asthma QTL GWAS1508615 (human) | | 7e-60 | childhood onset asthma | | 2 | 102319699 | 102319700 | Human |
597318333 | GWAS1414407_H | diet measurement QTL GWAS1414407 (human) | | 5e-08 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 2 | 102150174 | 102150175 | Human |
597502645 | GWAS1598719_H | high density lipoprotein cholesterol measurement QTL GWAS1598719 (human) | | 3e-09 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 2 | 100178867 | 100178868 | Human |
597342896 | GWAS1438970_H | Alzheimer disease QTL GWAS1438970 (human) | | 1e-10 | Alzheimer disease | | 2 | 105749599 | 105749600 | Human |
597056187 | GWAS1152261_H | intelligence QTL GWAS1152261 (human) | | 3e-10 | intelligence | | 2 | 100308360 | 100308361 | Human |
597482156 | GWAS1578230_H | mathematical ability QTL GWAS1578230 (human) | | 2e-19 | mathematical ability | | 2 | 100191263 | 100191264 | Human |
597240489 | GWAS1336563_H | Eczematoid dermatitis QTL GWAS1336563 (human) | | 2e-24 | Eczematoid dermatitis | | 2 | 102385935 | 102385936 | Human |
597482157 | GWAS1578231_H | mathematical ability QTL GWAS1578231 (human) | | 2e-08 | mathematical ability | | 2 | 102962092 | 102962093 | Human |
597289645 | GWAS1385719_H | inflammatory bowel disease QTL GWAS1385719 (human) | | 2e-26 | inflammatory bowel disease | | 2 | 102368211 | 102368212 | Human |
597584553 | GWAS1641413_H | drug use measurement, asthma QTL GWAS1641413 (human) | | 6e-23 | drug use measurement, asthma | | 2 | 102341256 | 102341257 | Human |
597375655 | GWAS1471729_H | ulcerative colitis QTL GWAS1471729 (human) | | 3e-12 | ulcerative colitis | | 2 | 102047167 | 102047168 | Human |
597326500 | GWAS1422574_H | pain QTL GWAS1422574 (human) | | 3e-12 | pain | | 2 | 99876977 | 99876978 | Human |
597359322 | GWAS1455396_H | acute myeloid leukemia QTL GWAS1455396 (human) | | 6e-11 | leukocyte integrity trait (VT:0010898) | | 2 | 103150997 | 103150998 | Human |
597359323 | GWAS1455397_H | acute myeloid leukemia QTL GWAS1455397 (human) | | 4e-11 | leukocyte integrity trait (VT:0010898) | | 2 | 105475760 | 105475761 | Human |
597494491 | GWAS1590565_H | neuroimaging measurement QTL GWAS1590565 (human) | | 2e-09 | neuroimaging measurement | | 2 | 103889320 | 103889321 | Human |
407408897 | GWAS1057873_H | unipolar depression QTL GWAS1057873 (human) | | 4e-08 | unipolar depression | | 2 | 105482561 | 105482562 | Human |
597084868 | GWAS1180942_H | response to ketamine QTL GWAS1180942 (human) | | 0.000005 | response to ketamine | | 2 | 106292093 | 106292094 | Human |
597215951 | GWAS1312025_H | verbal-numerical reasoning measurement QTL GWAS1312025 (human) | | 3e-11 | cognitive behavior trait (VT:0010450) | | 2 | 100254724 | 100254725 | Human |
597240513 | GWAS1336587_H | corneal resistance factor QTL GWAS1336587 (human) | | 1e-11 | corneal resistance factor | | 2 | 99725106 | 99725107 | Human |
597453508 | GWAS1549582_H | serum gamma-glutamyl transferase measurement QTL GWAS1549582 (human) | | 3e-13 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 2 | 101008427 | 101008428 | Human |
597240512 | GWAS1336586_H | corneal resistance factor QTL GWAS1336586 (human) | | 6e-09 | corneal resistance factor | | 2 | 99654956 | 99654957 | Human |
597240514 | GWAS1336588_H | corneal resistance factor QTL GWAS1336588 (human) | | 7e-10 | corneal resistance factor | | 2 | 100092890 | 100092891 | Human |
597412544 | GWAS1508618_H | childhood onset asthma QTL GWAS1508618 (human) | | 3e-12 | childhood onset asthma | | 2 | 102593137 | 102593138 | Human |
597138122 | GWAS1234196_H | interleukin-18 receptor 1 measurement QTL GWAS1234196 (human) | | 6e-996 | interleukin-18 receptor 1 measurement | | 2 | 102376215 | 102376216 | Human |
597039859 | GWAS1135933_H | diet measurement QTL GWAS1135933 (human) | | 8e-09 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 2 | 103477550 | 103477551 | Human |
597404413 | GWAS1500487_H | Alzheimer disease, age at onset QTL GWAS1500487 (human) | | 0.0000001 | Alzheimer disease, age at onset | | 2 | 104003000 | 104003001 | Human |
597617398 | GWAS1674258_H | Splenomegaly QTL GWAS1674258 (human) | | 1e-11 | Splenomegaly | | 2 | 99677975 | 99677976 | Human |
407302445 | GWAS951421_H | intelligence QTL GWAS951421 (human) | | 0.0000002 | intelligence | | 2 | 99242816 | 99242817 | Human |
597342961 | GWAS1439035_H | aging QTL GWAS1439035 (human) | | 1e-08 | aging | | 2 | 100013653 | 100013654 | Human |
596986597 | GWAS1106116_H | body mass index QTL GWAS1106116 (human) | | 2e-09 | body mass index | | 2 | 100130111 | 100130112 | Human |
596986599 | GWAS1106118_H | body mass index QTL GWAS1106118 (human) | | 7e-09 | body mass index | | 2 | 101820276 | 101820277 | Human |
596986598 | GWAS1106117_H | body mass index QTL GWAS1106117 (human) | | 3e-10 | body mass index | | 2 | 100198396 | 100198397 | Human |
597326572 | GWAS1422646_H | inflammatory bowel disease QTL GWAS1422646 (human) | | 4e-08 | inflammatory bowel disease | | 2 | 101904152 | 101904153 | Human |
596986600 | GWAS1106119_H | body mass index QTL GWAS1106119 (human) | | 1e-09 | body mass index | | 2 | 103809919 | 103809920 | Human |
597584608 | GWAS1641468_H | asthma QTL GWAS1641468 (human) | | 2e-29 | asthma | | 2 | 102344025 | 102344026 | Human |
407073218 | GWAS722194_H | total cholesterol measurement QTL GWAS722194 (human) | | 7e-08 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 2 | 101011463 | 101011464 | Human |
597449240 | GWAS1545314_H | Alzheimer disease, educational attainment QTL GWAS1545314 (human) | | 2e-17 | Alzheimer disease, educational attainment | | 2 | 100205086 | 100205087 | Human |
597383710 | GWAS1479784_H | type 2 diabetes mellitus QTL GWAS1479784 (human) | | 4e-08 | type 2 diabetes mellitus | | 2 | 104549216 | 104549217 | Human |
596974099 | GWAS1093618_H | creativity measurement QTL GWAS1093618 (human) | | 7e-12 | creativity measurement | | 2 | 100186429 | 100186430 | Human |
597146129 | GWAS1242203_H | age of onset of asthma QTL GWAS1242203 (human) | | 5e-08 | age of onset of asthma | | 2 | 100800585 | 100800586 | Human |
597371421 | GWAS1467495_H | atopic eczema QTL GWAS1467495 (human) | | 8e-18 | atopic eczema | | 2 | 102355405 | 102355406 | Human |
596974098 | GWAS1093617_H | creativity measurement QTL GWAS1093617 (human) | | 9e-11 | creativity measurement | | 2 | 100189534 | 100189535 | Human |
597461526 | GWAS1557600_H | serum alanine aminotransferase measurement, response to combination chemotherapy QTL GWAS1557600 (human) | | 0.000007 | serum alanine aminotransferase measurement, response to combination chemotherapy | serum alanine aminotransferase activity level (CMO:0000575) | 2 | 104651032 | 104651033 | Human |
597113371 | GWAS1209445_H | Alzheimer disease, family history of Alzheimer’s disease QTL GWAS1209445 (human) | | 0.000003 | Alzheimer disease, family history of Alzheimer’s disease | | 2 | 105805908 | 105805909 | Human |
407130580 | GWAS779556_H | eosinophil percentage of leukocytes QTL GWAS779556 (human) | | 1e-27 | eosinophil percentage of leukocytes | | 2 | 102435014 | 102435015 | Human |
597248525 | GWAS1344599_H | serum copper measurement QTL GWAS1344599 (human) | | 0.000004 | serum copper measurement | serum copper level (CMO:0003465) | 2 | 98250312 | 98250313 | Human |
597596683 | GWAS1653543_H | eosinophil count QTL GWAS1653543 (human) | | 5e-42 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102341256 | 102341257 | Human |
597334540 | GWAS1430614_H | C-reactive protein measurement QTL GWAS1430614 (human) | | 2e-11 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 2 | 101686516 | 101686517 | Human |
597264910 | GWAS1360984_H | cortical thickness QTL GWAS1360984 (human) | | 2e-09 | cortical thickness | | 2 | 97658891 | 97658892 | Human |
597334541 | GWAS1430615_H | C-reactive protein measurement QTL GWAS1430615 (human) | | 3e-09 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 2 | 102106634 | 102106635 | Human |
597051916 | GWAS1147990_H | household income QTL GWAS1147990 (human) | | 7e-13 | household income | | 2 | 99716915 | 99716916 | Human |
597051915 | GWAS1147989_H | household income QTL GWAS1147989 (human) | | 7e-13 | household income | | 2 | 100308360 | 100308361 | Human |
597596672 | GWAS1653532_H | eosinophil count QTL GWAS1653532 (human) | | 8e-257 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102341256 | 102341257 | Human |
597461507 | GWAS1557581_H | educational attainment QTL GWAS1557581 (human) | | 1e-21 | educational attainment | | 2 | 100248944 | 100248945 | Human |
597514815 | GWAS1610889_H | creativity measurement QTL GWAS1610889 (human) | | 4e-11 | behavior trait (VT:0010442) | | 2 | 100189534 | 100189535 | Human |
597039666 | GWAS1135740_H | pulse pressure measurement QTL GWAS1135740 (human) | | 2e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 2 | 105511000 | 105511001 | Human |
597252671 | GWAS1348745_H | Cleft palate, cleft lip QTL GWAS1348745 (human) | | 0.000008 | Cleft palate, cleft lip | | 2 | 98713986 | 98713987 | Human |
597240372 | GWAS1336446_H | smoking status measurement QTL GWAS1336446 (human) | | 1e-12 | smoking status measurement | | 2 | 103657096 | 103657097 | Human |
597326376 | GWAS1422450_H | pain QTL GWAS1422450 (human) | | 0.0000007 | pain | | 2 | 99863819 | 99863820 | Human |
407069175 | GWAS718151_H | total cholesterol measurement QTL GWAS718151 (human) | | 0.000004 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 2 | 101011463 | 101011464 | Human |
597318190 | GWAS1414264_H | smoking initiation QTL GWAS1414264 (human) | | 9e-61 | smoking initiation | | 2 | 103737774 | 103737775 | Human |
597318191 | GWAS1414265_H | smoking initiation QTL GWAS1414265 (human) | | 2e-19 | smoking initiation | | 2 | 105356637 | 105356638 | Human |
597318189 | GWAS1414263_H | smoking initiation QTL GWAS1414263 (human) | | 2e-73 | smoking initiation | | 2 | 103701481 | 103701482 | Human |
597596766 | GWAS1653626_H | eosinophil count QTL GWAS1653626 (human) | | 5e-53 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102341256 | 102341257 | Human |
597477982 | GWAS1574056_H | asthma, age at onset QTL GWAS1574056 (human) | | 7e-27 | asthma, age at onset | | 2 | 102275879 | 102275880 | Human |
597400152 | GWAS1496226_H | vital capacity QTL GWAS1496226 (human) | | 0.0000001 | vital capacity | | 2 | 104896266 | 104896267 | Human |
597314142 | GWAS1410216_H | age at menarche QTL GWAS1410216 (human) | | 4e-11 | age at menarche | | 2 | 105248369 | 105248370 | Human |
597273183 | GWAS1369257_H | interleukin 1 receptor-like 2 measurement QTL GWAS1369257 (human) | | 2e-31 | interleukin 1 receptor-like 2 measurement | | 2 | 102215251 | 102215252 | Human |
597338704 | GWAS1434778_H | neuroticism measurement, cognitive function measurement QTL GWAS1434778 (human) | | 4e-17 | cognitive behavior trait (VT:0010450) | | 2 | 103502147 | 103502148 | Human |
597346900 | GWAS1442974_H | atopic eczema QTL GWAS1442974 (human) | | 2e-100 | atopic eczema | | 2 | 102423469 | 102423470 | Human |
407019920 | GWAS668896_H | Crohn's disease QTL GWAS668896 (human) | | 2e-12 | intestine integrity trait (VT:0010554) | | 2 | 102437989 | 102437990 | Human |
597154372 | GWAS1250446_H | colorectal cancer QTL GWAS1250446 (human) | | 2e-08 | colorectal cancer | | 2 | 97738048 | 97738049 | Human |
597346889 | GWAS1442963_H | eosinophil measurement QTL GWAS1442963 (human) | | 8e-10 | eosinophil measurement | | 2 | 102361051 | 102361052 | Human |
407073174 | GWAS722150_H | BMI-adjusted waist-hip ratio QTL GWAS722150 (human) | | 9e-16 | body size trait (VT:0100005) | | 2 | 99663560 | 99663561 | Human |
597154380 | GWAS1250454_H | colorectal cancer QTL GWAS1250454 (human) | | 3e-08 | colorectal cancer | | 2 | 98006764 | 98006765 | Human |
597080653 | GWAS1176727_H | alcohol use disorder measurement QTL GWAS1176727 (human) | | 2e-09 | alcohol use disorder measurement | | 2 | 103517974 | 103517975 | Human |
407060892 | GWAS709868_H | body mass index QTL GWAS709868 (human) | | 2e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 103720295 | 103720296 | Human |
597441148 | GWAS1537222_H | interleukin-18 receptor 1 measurement QTL GWAS1537222 (human) | | 1e-34 | interleukin-18 receptor 1 measurement | | 2 | 102354903 | 102354904 | Human |
597359226 | GWAS1455300_H | acute myeloid leukemia QTL GWAS1455300 (human) | | 2e-20 | leukocyte integrity trait (VT:0010898) | | 2 | 103150997 | 103150998 | Human |
596961909 | GWAS1081428_H | Eczematoid dermatitis, allergic rhinitis QTL GWAS1081428 (human) | | 2e-33 | Eczematoid dermatitis, allergic rhinitis | | 2 | 102315366 | 102315367 | Human |
597441149 | GWAS1537223_H | interleukin-18 receptor 1 measurement QTL GWAS1537223 (human) | | 3e-46 | interleukin-18 receptor 1 measurement | | 2 | 102354903 | 102354904 | Human |
597113460 | GWAS1209534_H | intraocular pressure measurement QTL GWAS1209534 (human) | | 1e-09 | intraocular pressure measurement | | 2 | 99725106 | 99725107 | Human |
597359225 | GWAS1455299_H | acute myeloid leukemia QTL GWAS1455299 (human) | | 0.000001 | leukocyte integrity trait (VT:0010898) | | 2 | 100657433 | 100657434 | Human |
597301886 | GWAS1397960_H | sphingomyelin measurement QTL GWAS1397960 (human) | | 3e-08 | sphingomyelin measurement | | 2 | 98930629 | 98930630 | Human |
597518961 | GWAS1615035_H | body mass index QTL GWAS1615035 (human) | | 3e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104751861 | 104751862 | Human |
597518960 | GWAS1615034_H | body mass index QTL GWAS1615034 (human) | | 3e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100146475 | 100146476 | Human |
597367403 | GWAS1463477_H | sodium measurement QTL GWAS1463477 (human) | | 1e-10 | sodium measurement | blood sodium level (CMO:0000499) | 2 | 100370502 | 100370503 | Human |
597412456 | GWAS1508530_H | metabolic syndrome QTL GWAS1508530 (human) | | 3e-11 | metabolic syndrome | | 2 | 104974032 | 104974033 | Human |
597477992 | GWAS1574066_H | self reported educational attainment QTL GWAS1574066 (human) | | 1e-50 | self reported educational attainment | | 2 | 100205083 | 100205084 | Human |
597477993 | GWAS1574067_H | self reported educational attainment QTL GWAS1574067 (human) | | 2e-10 | self reported educational attainment | | 2 | 100707116 | 100707117 | Human |
597477994 | GWAS1574068_H | self reported educational attainment QTL GWAS1574068 (human) | | 2e-12 | self reported educational attainment | | 2 | 103158977 | 103158978 | Human |
597346925 | GWAS1442999_H | forced expiratory volume QTL GWAS1442999 (human) | | 6e-15 | forced expiratory volume | forced expiratory volume (CMO:0000254) | 2 | 99956893 | 99956894 | Human |
597273185 | GWAS1369259_H | interleukin 1 receptor-like 2 measurement QTL GWAS1369259 (human) | | 4e-13 | interleukin 1 receptor-like 2 measurement | | 2 | 102225970 | 102225971 | Human |
597477989 | GWAS1574063_H | self reported educational attainment QTL GWAS1574063 (human) | | 8e-10 | self reported educational attainment | | 2 | 97626092 | 97626093 | Human |
597273184 | GWAS1369258_H | interleukin 1 receptor-like 2 measurement QTL GWAS1369258 (human) | | 7e-14 | interleukin 1 receptor-like 2 measurement | | 2 | 102159742 | 102159743 | Human |
597477990 | GWAS1574064_H | self reported educational attainment QTL GWAS1574064 (human) | | 9e-09 | self reported educational attainment | | 2 | 97712734 | 97712735 | Human |
597477991 | GWAS1574065_H | self reported educational attainment QTL GWAS1574065 (human) | | 8e-11 | self reported educational attainment | | 2 | 100185405 | 100185406 | Human |
597305958 | GWAS1402032_H | bilirubin measurement QTL GWAS1402032 (human) | | 2e-08 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 2 | 100996122 | 100996123 | Human |
597412455 | GWAS1508529_H | metabolic syndrome QTL GWAS1508529 (human) | | 3e-15 | metabolic syndrome | | 2 | 104838132 | 104838133 | Human |
597215640 | GWAS1311714_H | smoking status measurement QTL GWAS1311714 (human) | | 4e-09 | smoking status measurement | | 2 | 105354559 | 105354560 | Human |
597612950 | GWAS1669810_H | erythrocyte count QTL GWAS1669810 (human) | | 8e-15 | erythrocyte count | red blood cell count (CMO:0000025) | 2 | 100129745 | 100129746 | Human |
597215637 | GWAS1311711_H | smoking status measurement QTL GWAS1311711 (human) | | 2e-12 | smoking status measurement | | 2 | 97658891 | 97658892 | Human |
597215638 | GWAS1311712_H | smoking status measurement QTL GWAS1311712 (human) | | 2e-14 | smoking status measurement | | 2 | 100055946 | 100055947 | Human |
407003725 | GWAS652701_H | mean corpuscular hemoglobin concentration QTL GWAS652701 (human) | | 3e-16 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 2 | 102538616 | 102538617 | Human |
597215639 | GWAS1311713_H | smoking status measurement QTL GWAS1311713 (human) | | 4e-41 | smoking status measurement | | 2 | 103459962 | 103459963 | Human |
597154181 | GWAS1250255_H | colorectal cancer QTL GWAS1250255 (human) | | 4e-08 | colorectal cancer | | 2 | 97737676 | 97737677 | Human |
597526920 | GWAS1622994_H | nasal disorder QTL GWAS1622994 (human) | | 4e-15 | nasal disorder | | 2 | 102349850 | 102349851 | Human |
596965768 | GWAS1085287_H | colorectal cancer QTL GWAS1085287 (human) | | 3e-08 | colorectal cancer | | 2 | 98006764 | 98006765 | Human |
597420421 | GWAS1516495_H | complement factor H-related protein 3 measurement QTL GWAS1516495 (human) | | 0.000009 | complement factor H-related protein 3 measurement | | 2 | 101678967 | 101678968 | Human |
407069276 | GWAS718252_H | gut microbiome measurement QTL GWAS718252 (human) | | 0.000005 | gut microbiome measurement | | 2 | 105445058 | 105445059 | Human |
597387707 | GWAS1483781_H | intelligence QTL GWAS1483781 (human) | | 6e-20 | intelligence | | 2 | 100236272 | 100236273 | Human |
597244344 | GWAS1340418_H | blood phosphate measurement QTL GWAS1340418 (human) | | 2e-09 | blood phosphate amount (VT:0001565) | blood phosphate level (CMO:0000504) | 2 | 97925411 | 97925412 | Human |
597387706 | GWAS1483780_H | intelligence QTL GWAS1483780 (human) | | 5e-09 | intelligence | | 2 | 100188666 | 100188667 | Human |
597510591 | GWAS1606665_H | interleukin 1 receptor-like 1 measurement QTL GWAS1606665 (human) | | 3e-72 | interleukin 1 receptor-like 1 measurement | | 2 | 102315342 | 102315343 | Human |
597436863 | GWAS1532937_H | asthma QTL GWAS1532937 (human) | | 2e-37 | asthma | | 2 | 102343750 | 102343751 | Human |
597584312 | GWAS1641172_H | mean corpuscular hemoglobin concentration QTL GWAS1641172 (human) | | 2e-12 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 2 | 100138535 | 100138536 | Human |
597191088 | GWAS1287162_H | testosterone measurement QTL GWAS1287162 (human) | | 2e-11 | testosterone measurement | serum testosterone level (CMO:0000568) | 2 | 105251362 | 105251363 | Human |
597084580 | GWAS1180654_H | type 2 diabetes mellitus QTL GWAS1180654 (human) | | 1e-08 | type 2 diabetes mellitus | | 2 | 99982264 | 99982265 | Human |
597170602 | GWAS1266676_H | osteoarthritis, hip QTL GWAS1266676 (human) | | 2e-10 | osteoarthritis, hip | | 2 | 106073280 | 106073281 | Human |
597076388 | GWAS1172462_H | lobe attachment QTL GWAS1172462 (human) | | 0.000007 | lobe attachment | ear measurement (CMO:0002667) | 2 | 106173309 | 106173310 | Human |
597531044 | GWAS1627118_H | Ischemic stroke QTL GWAS1627118 (human) | | 0.000002 | Ischemic stroke | | 2 | 104647152 | 104647153 | Human |
597375399 | GWAS1471473_H | bipolar disorder QTL GWAS1471473 (human) | | 0.000003 | bipolar disorder | | 2 | 98766429 | 98766430 | Human |
407040636 | GWAS689612_H | very long-chain saturated fatty acid measurement QTL GWAS689612 (human) | | 0.000008 | very long-chain saturated fatty acid measurement | | 2 | 102135190 | 102135191 | Human |
597313957 | GWAS1410031_H | total blood protein measurement QTL GWAS1410031 (human) | | 1e-26 | total blood protein measurement | blood protein measurement (CMO:0000028) | 2 | 101466721 | 101466722 | Human |
597375451 | GWAS1471525_H | cholesteryl ester 18:0 measurement QTL GWAS1471525 (human) | | 0.000001 | blood lipid amount (VT:0003949) | | 2 | 100182541 | 100182542 | Human |
597498332 | GWAS1594406_H | sex interaction measurement, ascorbic acid 2-sulfate measurement QTL GWAS1594406 (human) | | 0.000006 | vitamin metabolism trait (VT:0015087) | | 2 | 101241563 | 101241564 | Human |
596953553 | GWAS1073072_H | respiratory system disease QTL GWAS1073072 (human) | | 4e-101 | respiratory system disease | | 2 | 102319699 | 102319700 | Human |
597445076 | GWAS1541150_H | puberty onset measurement QTL GWAS1541150 (human) | | 4e-08 | puberty onset measurement | | 2 | 102829501 | 102829502 | Human |
597613012 | GWAS1669872_H | erythrocyte count QTL GWAS1669872 (human) | | 3e-12 | erythrocyte count | red blood cell count (CMO:0000025) | 2 | 100138535 | 100138536 | Human |
597121499 | GWAS1217573_H | self reported educational attainment QTL GWAS1217573 (human) | | 2e-08 | self reported educational attainment | | 2 | 103744962 | 103744963 | Human |
597121498 | GWAS1217572_H | self reported educational attainment QTL GWAS1217572 (human) | | 4e-09 | self reported educational attainment | | 2 | 99834895 | 99834896 | Human |
597428689 | GWAS1524763_H | depressive symptom measurement QTL GWAS1524763 (human) | | 4e-08 | depressive symptom measurement | | 2 | 103863404 | 103863405 | Human |
597023192 | GWAS1119266_H | pursuit maintenance gain measurement QTL GWAS1119266 (human) | | 0.0000003 | eye physiology trait (VT:0005253) | | 2 | 106193504 | 106193505 | Human |
597391818 | GWAS1487892_H | Crohn's disease QTL GWAS1487892 (human) | | 3e-09 | intestine integrity trait (VT:0010554) | | 2 | 102046427 | 102046428 | Human |
597387720 | GWAS1483794_H | intelligence QTL GWAS1483794 (human) | | 7e-16 | intelligence | | 2 | 100208905 | 100208906 | Human |
597412296 | GWAS1508370_H | atopic asthma QTL GWAS1508370 (human) | | 8e-50 | atopic asthma | | 2 | 102343750 | 102343751 | Human |
597379532 | GWAS1475606_H | monocyte count QTL GWAS1475606 (human) | | 8e-23 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 2 | 101509468 | 101509469 | Human |
597387719 | GWAS1483793_H | intelligence QTL GWAS1483793 (human) | | 1e-14 | intelligence | | 2 | 100145707 | 100145708 | Human |
597387718 | GWAS1483792_H | intelligence QTL GWAS1483792 (human) | | 5e-17 | intelligence | | 2 | 100146475 | 100146476 | Human |
597527039 | GWAS1623113_H | hippocampal volume QTL GWAS1623113 (human) | | 3e-08 | hippocampal volume | | 2 | 104869667 | 104869668 | Human |
597051890 | GWAS1147964_H | smoking status measurement QTL GWAS1147964 (human) | | 5e-10 | smoking status measurement | | 2 | 105352905 | 105352906 | Human |
597383678 | GWAS1479752_H | cutaneous mastocytosis QTL GWAS1479752 (human) | | 3e-11 | cutaneous mastocytosis | | 2 | 103382339 | 103382340 | Human |
597260796 | GWAS1356870_H | dementia QTL GWAS1356870 (human) | | 0.0000002 | dementia | | 2 | 105852811 | 105852812 | Human |
597465594 | GWAS1561668_H | rheumatoid arthritis QTL GWAS1561668 (human) | | 2e-11 | rheumatoid arthritis | | 2 | 100190052 | 100190053 | Human |
597051889 | GWAS1147963_H | smoking status measurement QTL GWAS1147963 (human) | | 9e-17 | smoking status measurement | | 2 | 103651827 | 103651828 | Human |
597441008 | GWAS1537082_H | total blood protein measurement QTL GWAS1537082 (human) | | 8e-11 | total blood protein measurement | blood protein measurement (CMO:0000028) | 2 | 100190052 | 100190053 | Human |
407052851 | GWAS701827_H | ocular sarcoidosis QTL GWAS701827 (human) | | 0.0000009 | eye integrity trait (VT:0011107) | | 2 | 98693451 | 98693452 | Human |
597092839 | GWAS1188913_H | cognitive decline measurement QTL GWAS1188913 (human) | | 0.0000006 | cognitive behavior trait (VT:0010450) | | 2 | 101088883 | 101088884 | Human |
597498348 | GWAS1594422_H | memory performance QTL GWAS1594422 (human) | | 0.000008 | memory performance | | 2 | 104858801 | 104858802 | Human |
597318121 | GWAS1414195_H | X-12844 measurement QTL GWAS1414195 (human) | | 2e-28 | X-12844 measurement | | 2 | 102723774 | 102723775 | Human |
597371368 | GWAS1467442_H | pancreatic carcinoma QTL GWAS1467442 (human) | | 0.000007 | pancreatic carcinoma | | 2 | 104762499 | 104762500 | Human |
597391854 | GWAS1487928_H | intelligence QTL GWAS1487928 (human) | | 2e-12 | intelligence | | 2 | 100253240 | 100253241 | Human |
596965869 | GWAS1085388_H | colorectal cancer QTL GWAS1085388 (human) | | 2e-08 | colorectal cancer | | 2 | 97954621 | 97954622 | Human |
597416416 | GWAS1512490_H | autoimmune disease QTL GWAS1512490 (human) | | 4e-12 | autoimmune disease | | 2 | 100147542 | 100147543 | Human |
407278138 | GWAS927114_H | asthma QTL GWAS927114 (human) | | 1e-22 | asthma | | 2 | 102386805 | 102386806 | Human |
597420517 | GWAS1516591_H | cognitive function measurement QTL GWAS1516591 (human) | | 4e-09 | cognitive behavior trait (VT:0010450) | | 2 | 99992378 | 99992379 | Human |
597317904 | GWAS1413978_H | Glucocorticoid use measurement QTL GWAS1413978 (human) | | 3e-17 | Glucocorticoid use measurement | | 2 | 102334362 | 102334363 | Human |
597358865 | GWAS1454939_H | self reported educational attainment QTL GWAS1454939 (human) | | 4e-19 | self reported educational attainment | | 2 | 100191263 | 100191264 | Human |
597121308 | GWAS1217382_H | urate measurement QTL GWAS1217382 (human) | | 2e-10 | urate measurement | blood uric acid level (CMO:0000501) | 2 | 101011463 | 101011464 | Human |
407225038 | GWAS874014_H | systolic blood pressure QTL GWAS874014 (human) | | 0.000001 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 2 | 105998818 | 105998819 | Human |
597141787 | GWAS1237861_H | neuroimaging measurement QTL GWAS1237861 (human) | | 3e-08 | neuroimaging measurement | | 2 | 99991908 | 99991909 | Human |
597190921 | GWAS1286995_H | testosterone measurement QTL GWAS1286995 (human) | | 7e-10 | testosterone measurement | serum testosterone level (CMO:0000568) | 2 | 102722213 | 102722214 | Human |
597293324 | GWAS1389398_H | lymphocyte measurement, neutrophil measurement QTL GWAS1389398 (human) | | 2e-09 | lymphocyte measurement, neutrophil measurement | | 2 | 101113826 | 101113827 | Human |
597207301 | GWAS1303375_H | PR interval QTL GWAS1303375 (human) | | 3e-15 | PR interval | PR interval (CMO:0000233) | 2 | 102781875 | 102781876 | Human |
597403908 | GWAS1499982_H | asthma QTL GWAS1499982 (human) | | 8e-09 | asthma | | 2 | 102265885 | 102265886 | Human |
597104950 | GWAS1201024_H | neutrophil count QTL GWAS1201024 (human) | | 2e-24 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 2 | 101119371 | 101119373 | Human |
597113141 | GWAS1209215_H | bitter alcoholic beverage consumption measurement QTL GWAS1209215 (human) | | 4e-09 | cortical thickness | drink intake measurement (CMO:0000771) | 2 | 97658891 | 97658892 | Human |
597256508 | GWAS1352582_H | schizophrenia QTL GWAS1352582 (human) | | 6e-10 | schizophrenia | | 2 | 104365291 | 104365292 | Human |
597408061 | GWAS1504135_H | total blood protein measurement QTL GWAS1504135 (human) | | 3e-35 | total blood protein measurement | blood protein measurement (CMO:0000028) | 2 | 100147542 | 100147543 | Human |
597621048 | GWAS1677908_H | post-traumatic stress disorder QTL GWAS1677908 (human) | | 2e-11 | post-traumatic stress disorder | | 2 | 103655228 | 103655229 | Human |
597621049 | GWAS1677909_H | anxiety disorder QTL GWAS1677909 (human) | | 5e-13 | anxiety disorder | | 2 | 103863404 | 103863405 | Human |
407229165 | GWAS878141_H | neutrophil percentage of granulocytes QTL GWAS878141 (human) | | 1e-26 | neutrophil percentage of granulocytes | | 2 | 102435014 | 102435015 | Human |
597461302 | GWAS1557376_H | body mass index QTL GWAS1557376 (human) | | 5e-18 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104838132 | 104838133 | Human |
597166390 | GWAS1262464_H | uterine fibroid QTL GWAS1262464 (human) | | 2e-11 | uterine fibroid | | 2 | 99428722 | 99428723 | Human |
597309749 | GWAS1405823_H | cortical thickness QTL GWAS1405823 (human) | | 4e-08 | cortical thickness | | 2 | 103533012 | 103533013 | Human |
597494061 | GWAS1590135_H | insomnia QTL GWAS1590135 (human) | | 1e-08 | insomnia | | 2 | 104036624 | 104036625 | Human |
597502255 | GWAS1598329_H | BMI-adjusted hip circumference QTL GWAS1598329 (human) | | 5e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 2 | 106071000 | 106071001 | Human |
597494062 | GWAS1590136_H | insomnia QTL GWAS1590136 (human) | | 6e-09 | insomnia | | 2 | 104043360 | 104043361 | Human |
597379372 | GWAS1475446_H | allergic disease QTL GWAS1475446 (human) | | 2e-16 | allergic disease | | 2 | 102263004 | 102263005 | Human |
597076270 | GWAS1172344_H | atopic eczema QTL GWAS1172344 (human) | | 2e-13 | atopic eczema | | 2 | 102410643 | 102410644 | Human |
597092694 | GWAS1188768_H | Alzheimer disease, age at onset QTL GWAS1188768 (human) | | 4e-08 | Alzheimer disease, age at onset | | 2 | 100697607 | 100697608 | Human |
597465436 | GWAS1561510_H | asthma, allergic disease QTL GWAS1561510 (human) | | 2e-27 | asthma, allergic disease | | 2 | 102319699 | 102319700 | Human |
597285211 | GWAS1381285_H | C-reactive protein measurement QTL GWAS1381285 (human) | | 1e-13 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 2 | 102464132 | 102464133 | Human |
597465439 | GWAS1561513_H | asthma QTL GWAS1561513 (human) | | 7e-18 | asthma | | 2 | 102319699 | 102319700 | Human |
596982096 | GWAS1101615_H | memory performance QTL GWAS1101615 (human) | | 0.000008 | memory performance | | 2 | 104858801 | 104858802 | Human |
406954635 | GWAS603611_H | self reported educational attainment QTL GWAS603611 (human) | | 1e-09 | self reported educational attainment | | 2 | 100137028 | 100137029 | Human |
406954634 | GWAS603610_H | self reported educational attainment QTL GWAS603610 (human) | | 2e-11 | self reported educational attainment | | 2 | 99689916 | 99689917 | Human |
597461328 | GWAS1557402_H | rheumatoid arthritis QTL GWAS1557402 (human) | | 4e-12 | rheumatoid arthritis | | 2 | 100208905 | 100208906 | Human |
406954637 | GWAS603613_H | self reported educational attainment QTL GWAS603613 (human) | | 2e-09 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 2 | 100308360 | 100308361 | Human |
597072218 | GWAS1168292_H | albumin:globulin ratio measurement QTL GWAS1168292 (human) | | 2e-09 | albumin:globulin ratio measurement | | 2 | 102093022 | 102093023 | Human |
597113179 | GWAS1209253_H | Alzheimer disease, family history of Alzheimer’s disease QTL GWAS1209253 (human) | | 1e-12 | Alzheimer disease, family history of Alzheimer’s disease | | 2 | 105749599 | 105749600 | Human |
597526864 | GWAS1622938_H | nasal disorder QTL GWAS1622938 (human) | | 6e-12 | nasal disorder | | 2 | 102349850 | 102349851 | Human |
597526867 | GWAS1622941_H | nasal disorder QTL GWAS1622941 (human) | | 1e-16 | nasal disorder | | 2 | 102297754 | 102297755 | Human |
406954638 | GWAS603614_H | self reported educational attainment QTL GWAS603614 (human) | | 2e-08 | self reported educational attainment | | 2 | 100535368 | 100535369 | Human |
596965700 | GWAS1085219_H | colorectal cancer QTL GWAS1085219 (human) | | 2e-08 | colorectal cancer | | 2 | 97738048 | 97738049 | Human |
597526860 | GWAS1622934_H | chronic rhinosinusitis QTL GWAS1622934 (human) | | 6e-12 | chronic rhinosinusitis | | 2 | 102343547 | 102343548 | Human |
597059908 | GWAS1155982_H | intraocular pressure measurement QTL GWAS1155982 (human) | | 5e-08 | intraocular pressure measurement | | 2 | 100980158 | 100980159 | Human |
596953416 | GWAS1072935_H | dementia QTL GWAS1072935 (human) | | 0.0000002 | dementia | | 2 | 105852811 | 105852812 | Human |
597031242 | GWAS1127316_H | adverse effect, response to xenobiotic stimulus QTL GWAS1127316 (human) | | 0.0000001 | adverse effect, response to xenobiotic stimulus | | 2 | 98279575 | 98279576 | Human |
597121398 | GWAS1217472_H | blood protein measurement QTL GWAS1217472 (human) | | 1e-104 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 2 | 102000516 | 102000517 | Human |
597461374 | GWAS1557448_H | social interaction measurement QTL GWAS1557448 (human) | | 3e-11 | social interaction measurement | voluntary social interaction measurement (CMO:0002676) | 2 | 100215720 | 100215721 | Human |
407278244 | GWAS927220_H | asthma QTL GWAS927220 (human) | | 2e-08 | asthma | | 2 | 102072571 | 102072572 | Human |
597326201 | GWAS1422275_H | non-high density lipoprotein cholesterol measurement QTL GWAS1422275 (human) | | 6e-13 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 2 | 101015426 | 101015427 | Human |
597490041 | GWAS1586115_H | testosterone measurement QTL GWAS1586115 (human) | | 9e-12 | testosterone measurement | serum testosterone level (CMO:0000568) | 2 | 101019918 | 101019919 | Human |
597043582 | GWAS1139656_H | schizophrenia QTL GWAS1139656 (human) | | 1e-09 | schizophrenia | | 2 | 104367929 | 104367930 | Human |
597432695 | GWAS1528769_H | protein measurement QTL GWAS1528769 (human) | | 1e-16 | protein measurement | | 2 | 102007764 | 102007765 | Human |
597203316 | GWAS1299390_H | diet measurement QTL GWAS1299390 (human) | | 6e-09 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 2 | 103717004 | 103717005 | Human |
597449064 | GWAS1545138_H | open-angle glaucoma QTL GWAS1545138 (human) | | 7e-10 | open-angle glaucoma | | 2 | 100986287 | 100986288 | Human |
597096814 | GWAS1192888_H | testosterone measurement QTL GWAS1192888 (human) | | 7e-17 | testosterone measurement | serum testosterone level (CMO:0000568) | 2 | 102722213 | 102722214 | Human |
597059949 | GWAS1156023_H | adolescent idiopathic scoliosis QTL GWAS1156023 (human) | | 1e-17 | adolescent idiopathic scoliosis | | 2 | 102399706 | 102399707 | Human |
597465441 | GWAS1561515_H | asthma, allergic disease QTL GWAS1561515 (human) | | 4e-24 | asthma, allergic disease | | 2 | 102319699 | 102319700 | Human |
596965737 | GWAS1085256_H | puberty onset measurement QTL GWAS1085256 (human) | | 4e-08 | puberty onset measurement | | 2 | 102829501 | 102829502 | Human |
597346660 | GWAS1442734_H | eosinophil measurement QTL GWAS1442734 (human) | | 2e-15 | eosinophil measurement | | 2 | 97968803 | 97968804 | Human |
597326180 | GWAS1422254_H | pain QTL GWAS1422254 (human) | | 0.000008 | pain | | 2 | 99888137 | 99888138 | Human |
597268839 | GWAS1364913_H | facial width measurement QTL GWAS1364913 (human) | | 0.000008 | facial morphology trait (VT:0003743) | | 2 | 105203242 | 105203243 | Human |
597411994 | GWAS1508068_H | C-reactive protein measurement QTL GWAS1508068 (human) | | 2e-08 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 2 | 102299202 | 102299203 | Human |
597416089 | GWAS1512163_H | celiac disease QTL GWAS1512163 (human) | | 0.0000001 | celiac disease | | 2 | 100147542 | 100147543 | Human |
597411993 | GWAS1508067_H | C-reactive protein measurement QTL GWAS1508067 (human) | | 3e-12 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 2 | 101924618 | 101924619 | Human |
597026969 | GWAS1123043_H | blood protein measurement QTL GWAS1123043 (human) | | 7e-55 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 2 | 102000742 | 102000743 | Human |
596957316 | GWAS1076835_H | Chronic pain, response to anticonvulsant QTL GWAS1076835 (human) | | 0.000003 | Chronic pain, response to anticonvulsant | | 2 | 101560771 | 101560772 | Human |
597215371 | GWAS1311445_H | Alzheimer disease QTL GWAS1311445 (human) | | 0.000005 | Alzheimer disease | | 2 | 101857264 | 101857265 | Human |
597248131 | GWAS1344205_H | corneal resistance factor QTL GWAS1344205 (human) | | 4e-14 | corneal resistance factor | | 2 | 99730761 | 99730762 | Human |
597264573 | GWAS1360647_H | BMI-adjusted hip circumference QTL GWAS1360647 (human) | | 1e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 2 | 99673234 | 99673235 | Human |
597199036 | GWAS1295110_H | body mass index QTL GWAS1295110 (human) | | 1e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 103830594 | 103830595 | Human |
597088432 | GWAS1184506_H | type 2 diabetes mellitus QTL GWAS1184506 (human) | | 2e-08 | type 2 diabetes mellitus | | 2 | 99982264 | 99982265 | Human |
406909800 | GWAS558776_H | bipolar disorder QTL GWAS558776 (human) | | 0.000007 | bipolar disorder | | 2 | 98467429 | 98467430 | Human |
597371048 | GWAS1467122_H | attention deficit hyperactivity disorder QTL GWAS1467122 (human) | | 0.000004 | attention deficit hyperactivity disorder | | 2 | 103956547 | 103956548 | Human |
597239983 | GWAS1336057_H | retinal vasculature measurement QTL GWAS1336057 (human) | | 0.000002 | retina blood vessel morphology trait (VT:0002792) | | 2 | 99867274 | 99867275 | Human |
597371052 | GWAS1467126_H | attention deficit hyperactivity disorder QTL GWAS1467126 (human) | | 0.000003 | attention deficit hyperactivity disorder | | 2 | 104051280 | 104051281 | Human |
597104814 | GWAS1200888_H | aspartate aminotransferase measurement QTL GWAS1200888 (human) | | 5e-09 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 2 | 100962027 | 100962028 | Human |
407020414 | GWAS669390_H | AIDS QTL GWAS669390 (human) | | 0.000007 | AIDS | | 2 | 105281283 | 105281284 | Human |
597608611 | GWAS1665471_H | mood disorder QTL GWAS1665471 (human) | | 4e-12 | mood disorder | | 2 | 103853106 | 103853107 | Human |
407249671 | GWAS898647_H | inflammatory bowel disease QTL GWAS898647 (human) | | 2e-17 | inflammatory bowel disease | | 2 | 102435014 | 102435015 | Human |
597076180 | GWAS1172254_H | atopic eczema QTL GWAS1172254 (human) | | 0.0000009 | atopic eczema | | 2 | 102162001 | 102162002 | Human |
597579995 | GWAS1636855_H | eosinophil count QTL GWAS1636855 (human) | | 2e-100 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102332701 | 102332702 | Human |
596953298 | GWAS1072817_H | smoking behaviour measurement, risk-taking behaviour QTL GWAS1072817 (human) | | 6e-11 | smoking behaviour measurement, risk-taking behaviour | | 2 | 103447407 | 103447408 | Human |
597334237 | GWAS1430311_H | rheumatoid arthritis QTL GWAS1430311 (human) | | 0.000007 | rheumatoid arthritis | | 2 | 101149460 | 101149461 | Human |
596965597 | GWAS1085116_H | colorectal cancer QTL GWAS1085116 (human) | | 4e-08 | colorectal cancer | | 2 | 97737676 | 97737677 | Human |
597108958 | GWAS1205032_H | mathematical ability QTL GWAS1205032 (human) | | 2e-08 | mathematical ability | | 2 | 103834676 | 103834677 | Human |
597108957 | GWAS1205031_H | mathematical ability QTL GWAS1205031 (human) | | 3e-16 | mathematical ability | | 2 | 100322655 | 100322656 | Human |
597375185 | GWAS1471259_H | asthma QTL GWAS1471259 (human) | | 6e-08 | asthma | | 2 | 102354740 | 102354741 | Human |
597108956 | GWAS1205030_H | mathematical ability QTL GWAS1205030 (human) | | 9e-09 | mathematical ability | | 2 | 99649474 | 99649475 | Human |
597108955 | GWAS1205029_H | mathematical ability QTL GWAS1205029 (human) | | 3e-10 | mathematical ability | | 2 | 97716827 | 97716828 | Human |
597223637 | GWAS1319711_H | calcium measurement QTL GWAS1319711 (human) | | 4e-10 | calcium measurement | blood calcium level (CMO:0000502) | 2 | 97813942 | 97813944 | Human |
597223638 | GWAS1319712_H | calcium measurement QTL GWAS1319712 (human) | | 3e-10 | calcium measurement | blood calcium level (CMO:0000502) | 2 | 97925411 | 97925412 | Human |
597289161 | GWAS1385235_H | Crohn's disease QTL GWAS1385235 (human) | | 6e-18 | intestine integrity trait (VT:0010554) | | 2 | 102368211 | 102368212 | Human |
597416138 | GWAS1512212_H | rheumatoid arthritis QTL GWAS1512212 (human) | | 7e-11 | rheumatoid arthritis | | 2 | 100147542 | 100147543 | Human |
597403853 | GWAS1499927_H | neuritic plaque measurement QTL GWAS1499927 (human) | | 0.000001 | neuritic plaque measurement | | 2 | 106026098 | 106026099 | Human |
597403844 | GWAS1499918_H | dementia, Alzheimer's disease neuropathologic change QTL GWAS1499918 (human) | | 0.000005 | dementia, Alzheimer's disease neuropathologic change | | 2 | 106026098 | 106026099 | Human |
597453053 | GWAS1549127_H | body fat percentage QTL GWAS1549127 (human) | | 1e-14 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 2 | 104787763 | 104787764 | Human |
597162227 | GWAS1258301_H | lipid measurement QTL GWAS1258301 (human) | | 0.000003 | lipid measurement | blood lipid measurement (CMO:0000050) | 2 | 102158528 | 102158529 | Human |
597481716 | GWAS1577790_H | lymphocyte count QTL GWAS1577790 (human) | | 2e-17 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 2 | 102433998 | 102433999 | Human |
597084415 | GWAS1180489_H | response to ketamine QTL GWAS1180489 (human) | | 0.000003 | response to ketamine | | 2 | 106292093 | 106292094 | Human |
597489904 | GWAS1585978_H | educational attainment QTL GWAS1585978 (human) | | 6e-14 | educational attainment | | 2 | 103158977 | 103158978 | Human |
597489905 | GWAS1585979_H | educational attainment QTL GWAS1585979 (human) | | 1e-11 | educational attainment | | 2 | 103373340 | 103373341 | Human |
597477618 | GWAS1573692_H | asthma, age at onset QTL GWAS1573692 (human) | | 2e-11 | asthma, age at onset | | 2 | 102350446 | 102350447 | Human |
597489900 | GWAS1585974_H | educational attainment QTL GWAS1585974 (human) | | 8e-35 | educational attainment | | 2 | 100351049 | 100351050 | Human |
597489901 | GWAS1585975_H | educational attainment QTL GWAS1585975 (human) | | 3e-10 | educational attainment | | 2 | 100983402 | 100983403 | Human |
597489902 | GWAS1585976_H | educational attainment QTL GWAS1585976 (human) | | 3e-11 | educational attainment | | 2 | 102853521 | 102853522 | Human |
597477615 | GWAS1573689_H | asthma, age at onset QTL GWAS1573689 (human) | | 3e-08 | asthma, age at onset | | 2 | 102181785 | 102181786 | Human |
597489903 | GWAS1585977_H | educational attainment QTL GWAS1585977 (human) | | 1e-09 | educational attainment | | 2 | 102969206 | 102969207 | Human |
597489896 | GWAS1585970_H | educational attainment QTL GWAS1585970 (human) | | 5e-11 | educational attainment | | 2 | 100175768 | 100175769 | Human |
597055714 | GWAS1151788_H | respiratory system disease QTL GWAS1151788 (human) | | 1e-59 | respiratory system disease | | 2 | 102327786 | 102327787 | Human |
406954805 | GWAS603781_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS603781 (human) | | 3e-17 | intestine integrity trait (VT:0010554) | | 2 | 102358876 | 102358877 | Human |
597489897 | GWAS1585971_H | educational attainment QTL GWAS1585971 (human) | | 1e-16 | educational attainment | | 2 | 100185405 | 100185406 | Human |
597055715 | GWAS1151789_H | respiratory system disease QTL GWAS1151789 (human) | | 3e-08 | respiratory system disease | | 2 | 102553704 | 102553705 | Human |
597489898 | GWAS1585972_H | educational attainment QTL GWAS1585972 (human) | | 3e-102 | educational attainment | | 2 | 100220664 | 100220665 | Human |
597375213 | GWAS1471287_H | forced expiratory volume QTL GWAS1471287 (human) | | 0.000003 | forced expiratory volume | forced expiratory volume (CMO:0000254) | 2 | 102309902 | 102309903 | Human |
597436650 | GWAS1532724_H | allergic disease QTL GWAS1532724 (human) | | 7e-61 | allergic disease | | 2 | 102324851 | 102324852 | Human |
597489899 | GWAS1585973_H | educational attainment QTL GWAS1585973 (human) | | 2e-11 | educational attainment | | 2 | 100234643 | 100234644 | Human |
406954806 | GWAS603782_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS603782 (human) | | 1e-09 | intestine integrity trait (VT:0010554) | | 2 | 102154822 | 102154823 | Human |
597121260 | GWAS1217334_H | Cleft palate, cleft lip QTL GWAS1217334 (human) | | 0.000004 | Cleft palate, cleft lip | | 2 | 98713986 | 98713987 | Human |
597489895 | GWAS1585969_H | educational attainment QTL GWAS1585969 (human) | | 3e-22 | educational attainment | | 2 | 100173028 | 100173029 | Human |
406938431 | GWAS587407_H | cortical thickness QTL GWAS587407 (human) | | 5e-10 | cortical thickness | | 2 | 97658891 | 97658892 | Human |
597026837 | GWAS1122911_H | body mass index QTL GWAS1122911 (human) | | 5e-20 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100134688 | 100134689 | Human |
597526557 | GWAS1622631_H | rhinitis QTL GWAS1622631 (human) | | 4e-14 | rhinitis | | 2 | 102299506 | 102299507 | Human |
597207070 | GWAS1303144_H | vitamin D measurement QTL GWAS1303144 (human) | | 5e-10 | vitamin D measurement | | 2 | 100811657 | 100811658 | Human |
597370909 | GWAS1466983_H | reticulocyte measurement QTL GWAS1466983 (human) | | 4e-10 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 2 | 101160919 | 101160920 | Human |
597489690 | GWAS1585764_H | interleukin 1 receptor-like 2 measurement QTL GWAS1585764 (human) | | 1e-20 | interleukin 1 receptor-like 2 measurement | | 2 | 102179965 | 102179966 | Human |
597317651 | GWAS1413725_H | body mass index QTL GWAS1413725 (human) | | 7e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 103804400 | 103804401 | Human |
597227528 | GWAS1323602_H | anxiety measurement QTL GWAS1323602 (human) | | 3e-13 | anxiety measurement | | 2 | 103455652 | 103455653 | Human |
407249879 | GWAS898855_H | lymphocyte count QTL GWAS898855 (human) | | 4e-32 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 2 | 102431643 | 102431644 | Human |
597227529 | GWAS1323603_H | anxiety measurement QTL GWAS1323603 (human) | | 1e-08 | anxiety measurement | | 2 | 103563241 | 103563242 | Human |
597415950 | GWAS1512024_H | late-onset Alzheimers disease QTL GWAS1512024 (human) | | 1e-08 | late-onset Alzheimers disease | | 2 | 105618971 | 105618972 | Human |
597121079 | GWAS1217153_H | forced expiratory volume QTL GWAS1217153 (human) | | 3e-08 | forced expiratory volume | forced expiratory volume (CMO:0000254) | 2 | 102592151 | 102592152 | Human |
597264441 | GWAS1360515_H | insomnia QTL GWAS1360515 (human) | | 2e-09 | insomnia | | 2 | 103852954 | 103852955 | Human |
597264440 | GWAS1360514_H | insomnia QTL GWAS1360514 (human) | | 2e-08 | insomnia | | 2 | 99899672 | 99899673 | Human |
597465144 | GWAS1561218_H | colorectal cancer QTL GWAS1561218 (human) | | 0.000007 | colorectal cancer | | 2 | 97707918 | 97707919 | Human |
597370930 | GWAS1467004_H | body mass index QTL GWAS1467004 (human) | | 4e-16 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104838132 | 104838133 | Human |
597370929 | GWAS1467003_H | body mass index QTL GWAS1467003 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104788445 | 104788446 | Human |
597264439 | GWAS1360513_H | insomnia QTL GWAS1360513 (human) | | 1e-08 | insomnia | | 2 | 97776768 | 97776769 | Human |
597264438 | GWAS1360512_H | insomnia QTL GWAS1360512 (human) | | 3e-12 | insomnia | | 2 | 97726795 | 97726796 | Human |
597612590 | GWAS1669450_H | encounter with health service QTL GWAS1669450 (human) | | 1e-13 | encounter with health service | | 2 | 103774660 | 103774661 | Human |
597358639 | GWAS1454713_H | eosinophil count QTL GWAS1454713 (human) | | 5e-32 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102435014 | 102435015 | Human |
597432362 | GWAS1528436_H | protein measurement QTL GWAS1528436 (human) | | 1e-576 | protein measurement | | 2 | 102314488 | 102314489 | Human |
597358637 | GWAS1454711_H | eosinophil count QTL GWAS1454711 (human) | | 6e-93 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102352407 | 102352410 | Human |
597248033 | GWAS1344107_H | complement factor H-related protein 3 measurement QTL GWAS1344107 (human) | | 0.000006 | complement factor H-related protein 3 measurement | | 2 | 101306418 | 101306419 | Human |
597248036 | GWAS1344110_H | complement factor H-related protein 3 measurement QTL GWAS1344110 (human) | | 0.000002 | complement factor H-related protein 3 measurement | | 2 | 101411667 | 101411668 | Human |
597112873 | GWAS1208947_H | systemic lupus erythematosus QTL GWAS1208947 (human) | | 0.000004 | systemic lupus erythematosus | | 2 | 102445656 | 102445657 | Human |
596973648 | GWAS1093167_H | major depressive disorder QTL GWAS1093167 (human) | | 2e-08 | major depressive disorder | | 2 | 103835877 | 103835878 | Human |
597518421 | GWAS1614495_H | serum gamma-glutamyl transferase measurement QTL GWAS1614495 (human) | | 7e-14 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 2 | 101008427 | 101008428 | Human |
406938510 | GWAS587486_H | heel bone mineral density QTL GWAS587486 (human) | | 5e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 2 | 99332342 | 99332343 | Human |
406938512 | GWAS587488_H | heel bone mineral density QTL GWAS587488 (human) | | 2e-08 | heel bone mineral density | bone mineral density (CMO:0001226) | 2 | 101075131 | 101075132 | Human |
597588088 | GWAS1644948_H | eosinophil count QTL GWAS1644948 (human) | | 1e-213 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102334362 | 102334363 | Human |
597284976 | GWAS1381050_H | interleukin-18 receptor 1 measurement QTL GWAS1381050 (human) | | 3e-09 | interleukin-18 receptor 1 measurement | | 2 | 102472317 | 102472318 | Human |
597346420 | GWAS1442494_H | eosinophil measurement QTL GWAS1442494 (human) | | 1e-14 | eosinophil measurement | | 2 | 102358876 | 102358877 | Human |
597596270 | GWAS1653130_H | eosinophil count QTL GWAS1653130 (human) | | 5e-205 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102332010 | 102332011 | Human |
597059686 | GWAS1155760_H | reaction time measurement QTL GWAS1155760 (human) | | 6e-13 | cognitive behavior trait (VT:0010450) | | 2 | 103652804 | 103652805 | Human |
597059685 | GWAS1155759_H | reaction time measurement QTL GWAS1155759 (human) | | 3e-09 | cognitive behavior trait (VT:0010450) | | 2 | 103453326 | 103453327 | Human |
597145697 | GWAS1241771_H | posterior thigh muscle fat infiltration measurement QTL GWAS1241771 (human) | | 2e-09 | posterior thigh muscle fat infiltration measurement | | 2 | 100956752 | 100956753 | Human |
597284975 | GWAS1381049_H | interleukin-18 receptor 1 measurement QTL GWAS1381049 (human) | | 2e-51 | interleukin-18 receptor 1 measurement | | 2 | 102386583 | 102386584 | Human |
597469291 | GWAS1565365_H | juvenile idiopathic arthritis QTL GWAS1565365 (human) | | 9e-08 | juvenile idiopathic arthritis | | 2 | 100143015 | 100143016 | Human |
597284974 | GWAS1381048_H | interleukin-18 receptor 1 measurement QTL GWAS1381048 (human) | | 1e-11 | interleukin-18 receptor 1 measurement | | 2 | 102370753 | 102370754 | Human |
597194848 | GWAS1290922_H | cortical thickness QTL GWAS1290922 (human) | | 1e-11 | cortical thickness | | 2 | 97658891 | 97658892 | Human |
597194849 | GWAS1290923_H | cortical thickness QTL GWAS1290923 (human) | | 2e-10 | cortical thickness | | 2 | 97918271 | 97918272 | Human |
597084267 | GWAS1180341_H | monocyte percentage of leukocytes QTL GWAS1180341 (human) | | 1e-11 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 2 | 101504394 | 101504395 | Human |
596973675 | GWAS1093194_H | major depressive disorder QTL GWAS1093194 (human) | | 2e-11 | major depressive disorder | | 2 | 103848009 | 103848010 | Human |
596975508 | GWAS1095027_H | body height QTL GWAS1095027 (human) | | 5e-20 | body height | | 2 | 104515874 | 104515875 | Human |
597368729 | GWAS1464803_H | asthma, age at onset QTL GWAS1464803 (human) | | 3e-08 | asthma, age at onset | | 2 | 102349850 | 102349851 | Human |
597327769 | GWAS1423843_H | breast cancer QTL GWAS1423843 (human) | | 0.000002 | breast cancer | | 2 | 103209642 | 103209643 | Human |
596975507 | GWAS1095026_H | body height QTL GWAS1095026 (human) | | 1e-14 | body height | | 2 | 105373259 | 105373260 | Human |
597467027 | GWAS1563101_H | rheumatoid arthritis QTL GWAS1563101 (human) | | 9e-16 | rheumatoid arthritis | | 2 | 100143710 | 100143711 | Human |
597192599 | GWAS1288673_H | health study participation QTL GWAS1288673 (human) | | 8e-11 | health study participation | | 2 | 100203959 | 100203960 | Human |
407114834 | GWAS763810_H | heel bone mineral density QTL GWAS763810 (human) | | 1e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 2 | 99332342 | 99332343 | Human |
597114767 | GWAS1210841_H | cognitive function measurement QTL GWAS1210841 (human) | | 2e-08 | cognitive behavior trait (VT:0010450) | | 2 | 100705731 | 100705732 | Human |
597376899 | GWAS1472973_H | ankylosing spondylitis QTL GWAS1472973 (human) | | 0.0000005 | ankylosing spondylitis | | 2 | 102047167 | 102047168 | Human |
597114766 | GWAS1210840_H | cognitive function measurement QTL GWAS1210840 (human) | | 9e-17 | cognitive behavior trait (VT:0010450) | | 2 | 100254724 | 100254725 | Human |
597114765 | GWAS1210839_H | cognitive function measurement QTL GWAS1210839 (human) | | 2e-10 | cognitive behavior trait (VT:0010450) | | 2 | 99992378 | 99992379 | Human |
596975503 | GWAS1095022_H | body height QTL GWAS1095022 (human) | | 2e-09 | body height | | 2 | 105260287 | 105260288 | Human |
597491636 | GWAS1587710_H | ST2 protein measurement QTL GWAS1587710 (human) | | 8e-47 | ST2 protein measurement | | 2 | 102301534 | 102301535 | Human |
597442480 | GWAS1538554_H | open-angle glaucoma QTL GWAS1538554 (human) | | 6e-10 | open-angle glaucoma | | 2 | 100986287 | 100986288 | Human |
597421998 | GWAS1518072_H | type 1 diabetes mellitus QTL GWAS1518072 (human) | | 4e-09 | type 1 diabetes mellitus | | 2 | 100147438 | 100147439 | Human |
597118882 | GWAS1214956_H | biological sex QTL GWAS1214956 (human) | | 1e-09 | biological sex | | 2 | 103440906 | 103440907 | Human |
597409709 | GWAS1505783_H | erythrocyte count QTL GWAS1505783 (human) | | 8e-14 | erythrocyte count | red blood cell count (CMO:0000025) | 2 | 100145753 | 100145754 | Human |
597139375 | GWAS1235449_H | cinnamoylglycine measurement QTL GWAS1235449 (human) | | 0.000007 | cinnamoylglycine measurement | | 2 | 99564439 | 99564440 | Human |
597024684 | GWAS1120758_H | pursuit maintenance gain measurement QTL GWAS1120758 (human) | | 0.0000004 | eye physiology trait (VT:0005253) | | 2 | 106193504 | 106193505 | Human |
597491623 | GWAS1587697_H | ST2 protein measurement QTL GWAS1587697 (human) | | 2e-09 | ST2 protein measurement | | 2 | 101988187 | 101988188 | Human |
597057453 | GWAS1153527_H | basophil count QTL GWAS1153527 (human) | | 5e-12 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 2 | 102471181 | 102471182 | Human |
597360600 | GWAS1456674_H | cannabis dependence measurement QTL GWAS1456674 (human) | | 0.000004 | response to addictive substance trait (VT:0010488) | | 2 | 103147956 | 103147957 | Human |
597376984 | GWAS1473058_H | type 1 diabetes mellitus QTL GWAS1473058 (human) | | 0.000005 | type 1 diabetes mellitus | | 2 | 100208905 | 100208906 | Human |
597114834 | GWAS1210908_H | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1210908 (human) | | 0.0000002 | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 2 | 101025798 | 101025799 | Human |
597053392 | GWAS1149466_H | household income QTL GWAS1149466 (human) | | 8e-09 | household income | | 2 | 99674951 | 99674952 | Human |
597413843 | GWAS1509917_H | asthma QTL GWAS1509917 (human) | | 8e-10 | asthma | | 2 | 101962555 | 101962556 | Human |
597393361 | GWAS1489435_H | primary biliary cirrhosis QTL GWAS1489435 (human) | | 5e-09 | primary biliary cirrhosis | | 2 | 102249813 | 102249814 | Human |
406975501 | GWAS624477_H | inflammatory bowel disease QTL GWAS624477 (human) | | 3e-20 | inflammatory bowel disease | | 2 | 102454108 | 102454109 | Human |
597602258 | GWAS1659118_H | chloride measurement QTL GWAS1659118 (human) | | 3e-36 | chloride measurement | blood chloride level (CMO:0000497) | 2 | 102538616 | 102538617 | Human |
597082074 | GWAS1178148_H | interleukin 18 receptor 1 measurement QTL GWAS1178148 (human) | | 9e-16 | interleukin 18 receptor 1 measurement | | 2 | 102565814 | 102565815 | Human |
597061574 | GWAS1157648_H | vital capacity QTL GWAS1157648 (human) | | 2e-08 | vital capacity | | 2 | 102123999 | 102124000 | Human |
597061573 | GWAS1157647_H | vital capacity QTL GWAS1157647 (human) | | 1e-09 | vital capacity | | 2 | 99945016 | 99945017 | Human |
407274526 | GWAS923502_H | insomnia measurement QTL GWAS923502 (human) | | 1e-08 | sleep behavior trait (VT:0001501) | | 2 | 103796466 | 103796467 | Human |
597053389 | GWAS1149463_H | household income QTL GWAS1149463 (human) | | 7e-09 | household income | | 2 | 105361319 | 105361320 | Human |
597393402 | GWAS1489476_H | asthma QTL GWAS1489476 (human) | | 2e-23 | asthma | | 2 | 102316102 | 102316103 | Human |
597213182 | GWAS1309256_H | adiponectin measurement QTL GWAS1309256 (human) | | 0.000005 | adiponectin measurement | blood adiponectin level (CMO:0000485) | 2 | 98087196 | 98087197 | Human |
597487611 | GWAS1583685_H | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1583685 (human) | | 8e-12 | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 2 | 100243160 | 100243161 | Human |
597598201 | GWAS1655061_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1655061 (human) | | 3e-20 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 2 | 100956752 | 100956753 | Human |
407127087 | GWAS776063_H | reticulocyte count QTL GWAS776063 (human) | | 4e-17 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 2 | 99145424 | 99145425 | Human |
597290989 | GWAS1387063_H | forced expiratory volume, gastroesophageal reflux disease QTL GWAS1387063 (human) | | 3e-08 | forced expiratory volume, gastroesophageal reflux disease | forced expiratory volume (CMO:0000254) | 2 | 100016582 | 100016583 | Human |
596967395 | GWAS1086914_H | cortical thickness QTL GWAS1086914 (human) | | 2e-09 | cortical thickness | | 2 | 97658891 | 97658892 | Human |
407389235 | GWAS1038211_H | autosomal dominant compelling helio-ophthalmic outburst syndrome QTL GWAS1038211 (human) | | 3e-08 | autosomal dominant compelling helio-ophthalmic outburst syndrome | | 2 | 103473755 | 103473756 | Human |
597593883 | GWAS1650743_H | eosinophil count QTL GWAS1650743 (human) | | 9e-104 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102341256 | 102341257 | Human |
596958980 | GWAS1078499_H | metabolic syndrome QTL GWAS1078499 (human) | | 3e-11 | metabolic syndrome | | 2 | 104974032 | 104974033 | Human |
596958981 | GWAS1078500_H | metabolic syndrome QTL GWAS1078500 (human) | | 2e-08 | metabolic syndrome | | 2 | 105321650 | 105321651 | Human |
596958982 | GWAS1078501_H | metabolic syndrome QTL GWAS1078501 (human) | | 8e-16 | metabolic syndrome | | 2 | 105322780 | 105322781 | Human |
596958977 | GWAS1078496_H | metabolic syndrome QTL GWAS1078496 (human) | | 3e-21 | metabolic syndrome | | 2 | 100276651 | 100276652 | Human |
597614347 | GWAS1671207_H | emphysema QTL GWAS1671207 (human) | | 8e-12 | lung integrity trait (VT:0010906) | | 2 | 102732961 | 102732962 | Human |
597487369 | GWAS1583443_H | body mass index QTL GWAS1583443 (human) | | 5e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104798021 | 104798022 | Human |
596958978 | GWAS1078497_H | metabolic syndrome QTL GWAS1078497 (human) | | 6e-11 | metabolic syndrome | | 2 | 103805234 | 103805235 | Human |
596958979 | GWAS1078498_H | metabolic syndrome QTL GWAS1078498 (human) | | 3e-15 | metabolic syndrome | | 2 | 104838132 | 104838133 | Human |
597323523 | GWAS1419597_H | 3-phenylpropionate hydrocinnamate measurement QTL GWAS1419597 (human) | | 6e-08 | 3-phenylpropionate hydrocinnamate measurement | | 2 | 99597252 | 99597253 | Human |
597360387 | GWAS1456461_H | asthma QTL GWAS1456461 (human) | | 5e-31 | asthma | | 2 | 102297182 | 102297186 | Human |
597225278 | GWAS1321352_H | progressive supranuclear palsy QTL GWAS1321352 (human) | | 0.000007 | progressive supranuclear palsy | | 2 | 101082320 | 101082321 | Human |
597204799 | GWAS1300873_H | protein measurement QTL GWAS1300873 (human) | | 2e-08 | protein measurement | | 2 | 100628428 | 100628429 | Human |
597139261 | GWAS1235335_H | neuroimaging measurement QTL GWAS1235335 (human) | | 1e-18 | neuroimaging measurement | | 2 | 97658891 | 97658892 | Human |
597200691 | GWAS1296765_H | B-cell acute lymphoblastic leukemia, rheumatoid arthritis QTL GWAS1296765 (human) | | 2e-09 | leukocyte integrity trait (VT:0010898) | | 2 | 100268431 | 100268432 | Human |
407209200 | GWAS858176_H | reticulocyte measurement QTL GWAS858176 (human) | | 4e-18 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 2 | 99145424 | 99145425 | Human |
597049120 | GWAS1145194_H | intraocular pressure measurement QTL GWAS1145194 (human) | | 2e-09 | intraocular pressure measurement | | 2 | 101031432 | 101031433 | Human |
597597990 | GWAS1654850_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1654850 (human) | | 1e-13 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 2 | 100990049 | 100990050 | Human |
597376805 | GWAS1472879_H | PR interval QTL GWAS1472879 (human) | | 2e-11 | PR interval | PR interval (CMO:0000233) | 2 | 105488399 | 105488400 | Human |
597045033 | GWAS1141107_H | Abnormality of refraction QTL GWAS1141107 (human) | | 5e-15 | Abnormality of refraction | | 2 | 103827484 | 103827485 | Human |
597364569 | GWAS1460643_H | blood protein measurement QTL GWAS1460643 (human) | | 6e-134 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 2 | 102350323 | 102350324 | Human |
597602130 | GWAS1658990_H | chloride measurement QTL GWAS1658990 (human) | | 3e-41 | chloride measurement | blood chloride level (CMO:0000497) | 2 | 102538616 | 102538617 | Human |
597323595 | GWAS1419669_H | high density lipoprotein cholesterol measurement QTL GWAS1419669 (human) | | 1e-12 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 2 | 100112831 | 100112832 | Human |
597368650 | GWAS1464724_H | BMI-adjusted waist circumference QTL GWAS1464724 (human) | | 5e-10 | body size trait (VT:0100005) | | 2 | 106071000 | 106071001 | Human |
597397321 | GWAS1493395_H | cortical thickness QTL GWAS1493395 (human) | | 4e-10 | cortical thickness | | 2 | 103863404 | 103863405 | Human |
597143364 | GWAS1239438_H | C-reactive protein measurement QTL GWAS1239438 (human) | | 3e-19 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 2 | 102140679 | 102140680 | Human |
596963137 | GWAS1082656_H | interleukin-1 receptor-like 1 measurement QTL GWAS1082656 (human) | | 1e-24 | interleukin-1 receptor-like 1 measurement | | 2 | 102315366 | 102315367 | Human |
597499716 | GWAS1595790_H | body mass index QTL GWAS1595790 (human) | | 9e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104947387 | 104947388 | Human |
597499715 | GWAS1595789_H | body mass index QTL GWAS1595789 (human) | | 2e-23 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104838132 | 104838133 | Human |
597163893 | GWAS1259967_H | gut microbiome measurement QTL GWAS1259967 (human) | | 4e-08 | gut microbiome measurement | | 2 | 106278384 | 106278385 | Human |
406979750 | GWAS628726_H | intelligence QTL GWAS628726 (human) | | 2e-10 | intelligence | | 2 | 100052237 | 100052238 | Human |
597462907 | GWAS1558981_H | occupational attainment QTL GWAS1558981 (human) | | 3e-08 | occupational attainment | | 2 | 100185497 | 100185498 | Human |
597081981 | GWAS1178055_H | cognitive decline measurement QTL GWAS1178055 (human) | | 0.000009 | cognitive behavior trait (VT:0010450) | | 2 | 106342796 | 106342797 | Human |
597466993 | GWAS1563067_H | inflammatory bowel disease QTL GWAS1563067 (human) | | 5e-11 | inflammatory bowel disease | | 2 | 102322576 | 102322577 | Human |
407020717 | GWAS669693_H | pancreatic carcinoma QTL GWAS669693 (human) | | 0.000004 | pancreatic carcinoma | | 2 | 101305708 | 101305709 | Human |
597094255 | GWAS1190329_H | schizophrenia QTL GWAS1190329 (human) | | 0.000007 | schizophrenia | | 2 | 102809718 | 102809719 | Human |
597225314 | GWAS1321388_H | chronotype measurement QTL GWAS1321388 (human) | | 1e-12 | sleep behavior trait (VT:0001501) | | 2 | 100975248 | 100975249 | Human |
597143403 | GWAS1239477_H | anterior thigh muscle fat infiltration measurement QTL GWAS1239477 (human) | | 2e-09 | anterior thigh muscle fat infiltration measurement | | 2 | 100957085 | 100957086 | Human |
597053289 | GWAS1149363_H | household income QTL GWAS1149363 (human) | | 7e-10 | household income | | 2 | 100396622 | 100396623 | Human |
597507938 | GWAS1604012_H | level of Phosphatidylcholine (16:0_22:4) in blood serum QTL GWAS1604012 (human) | | 5e-09 | level of Phosphatidylcholine (16:0_22:4) in blood serum | | 2 | 101652331 | 101652332 | Human |
597434013 | GWAS1530087_H | protein measurement QTL GWAS1530087 (human) | | 9e-49 | protein measurement | | 2 | 102212553 | 102212554 | Human |
597434009 | GWAS1530083_H | protein measurement QTL GWAS1530083 (human) | | 9e-64 | protein measurement | | 2 | 102050601 | 102050602 | Human |
597462672 | GWAS1558746_H | blood protein measurement QTL GWAS1558746 (human) | | 2e-10 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 2 | 100143015 | 100143016 | Human |
597081754 | GWAS1177828_H | lymphocyte percentage of leukocytes QTL GWAS1177828 (human) | | 5e-14 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 2 | 101118471 | 101118472 | Human |
407110996 | GWAS759972_H | eosinophil count QTL GWAS759972 (human) | | 6e-12 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 101746707 | 101746708 | Human |
407369046 | GWAS1018022_H | acute myeloid leukemia QTL GWAS1018022 (human) | | 1e-09 | leukocyte integrity trait (VT:0010898) | | 2 | 99931297 | 99931298 | Human |
407110997 | GWAS759973_H | eosinophil count QTL GWAS759973 (human) | | 1e-23 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 101788512 | 101788513 | Human |
407369045 | GWAS1018021_H | acute myeloid leukemia QTL GWAS1018021 (human) | | 3e-10 | leukocyte integrity trait (VT:0010898) | | 2 | 97718216 | 97718217 | Human |
407369044 | GWAS1018020_H | acute myeloid leukemia QTL GWAS1018020 (human) | | 6e-13 | leukocyte integrity trait (VT:0010898) | | 2 | 97718216 | 97718217 | Human |
597376642 | GWAS1472716_H | eosinophil count QTL GWAS1472716 (human) | | 5e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102341256 | 102341257 | Human |
407377236 | GWAS1026212_H | unipolar depression QTL GWAS1026212 (human) | | 2e-08 | unipolar depression | | 2 | 103835877 | 103835878 | Human |
597360263 | GWAS1456337_H | age at menarche QTL GWAS1456337 (human) | | 2e-11 | age at menarche | | 2 | 105254322 | 105254323 | Human |
597327493 | GWAS1423567_H | mean fractional anisotropy measurement QTL GWAS1423567 (human) | | 3e-09 | mean fractional anisotropy measurement | | 2 | 97774892 | 97774893 | Human |
597192368 | GWAS1288442_H | cortical thickness QTL GWAS1288442 (human) | | 6e-13 | cortical thickness | | 2 | 97918271 | 97918272 | Human |
597401265 | GWAS1497339_H | schizophrenia, intelligence, self reported educational attainment QTL GWAS1497339 (human) | | 2e-15 | schizophrenia, intelligence, self reported educational attainment | | 2 | 100190052 | 100190053 | Human |
406889834 | GWAS538810_H | lymphocyte percentage of leukocytes QTL GWAS538810 (human) | | 4e-09 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 2 | 102437989 | 102437990 | Human |
597532335 | GWAS1628409_H | smoking initiation QTL GWAS1628409 (human) | | 3e-08 | smoking initiation | | 2 | 103241723 | 103241724 | Human |
407029111 | GWAS678087_H | osteoporosis QTL GWAS678087 (human) | | 0.0000001 | osteoporosis | | 2 | 101052395 | 101052396 | Human |
597192367 | GWAS1288441_H | cortical thickness QTL GWAS1288441 (human) | | 4e-15 | cortical thickness | | 2 | 97658891 | 97658892 | Human |
597081775 | GWAS1177849_H | neutrophil count QTL GWAS1177849 (human) | | 4e-30 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 2 | 101119376 | 101119377 | Human |
597335715 | GWAS1431789_H | HLA allele carrier status QTL GWAS1431789 (human) | | 0.0000002 | HLA allele carrier status | | 2 | 102177447 | 102177448 | Human |
597585570 | GWAS1642430_H | eosinophil count QTL GWAS1642430 (human) | | 6e-182 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102341256 | 102341257 | Human |
597102295 | GWAS1198369_H | neutrophil percentage of leukocytes QTL GWAS1198369 (human) | | 1e-09 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 2 | 97774654 | 97774655 | Human |
597065431 | GWAS1161505_H | congenital left-sided heart lesions QTL GWAS1161505 (human) | | 0.0000001 | congenital left-sided heart lesions | | 2 | 98648723 | 98648724 | Human |
406947084 | GWAS596060_H | hemoglobin measurement QTL GWAS596060 (human) | | 6e-11 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 2 | 100026981 | 100026982 | Human |
597102296 | GWAS1198370_H | neutrophil percentage of leukocytes QTL GWAS1198370 (human) | | 1e-15 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 2 | 101118471 | 101118472 | Human |
597053126 | GWAS1149200_H | asthma QTL GWAS1149200 (human) | | 2e-09 | asthma | | 2 | 102550572 | 102550573 | Human |
597053127 | GWAS1149201_H | asthma QTL GWAS1149201 (human) | | 2e-13 | asthma | | 2 | 102578099 | 102578100 | Human |
597053124 | GWAS1149198_H | asthma QTL GWAS1149198 (human) | | 2e-37 | asthma | | 2 | 102332701 | 102332702 | Human |
597053125 | GWAS1149199_H | asthma QTL GWAS1149199 (human) | | 2e-10 | asthma | | 2 | 102584846 | 102584847 | Human |
597225154 | GWAS1321228_H | smoking initiation QTL GWAS1321228 (human) | | 1e-09 | smoking initiation | | 2 | 100327921 | 100327922 | Human |
597225155 | GWAS1321229_H | smoking initiation QTL GWAS1321229 (human) | | 5e-22 | smoking initiation | | 2 | 103588062 | 103588063 | Human |
597176004 | GWAS1272078_H | body mass index QTL GWAS1272078 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 98929892 | 98929893 | Human |
597176005 | GWAS1272079_H | body mass index QTL GWAS1272079 (human) | | 6e-14 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100396622 | 100396623 | Human |
597356228 | GWAS1452302_H | asthma QTL GWAS1452302 (human) | | 2e-15 | asthma | | 2 | 102337157 | 102337158 | Human |
597053128 | GWAS1149202_H | asthma QTL GWAS1149202 (human) | | 3e-08 | asthma | | 2 | 102562489 | 102562490 | Human |
597176006 | GWAS1272080_H | body mass index QTL GWAS1272080 (human) | | 8e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 103750966 | 103750967 | Human |
597151432 | GWAS1247506_H | lifestyle measurement, anxiety disorder measurement QTL GWAS1247506 (human) | | 3e-12 | anxiety-related behavior trait (VT:0010716) | | 2 | 98882298 | 98882299 | Human |
597176007 | GWAS1272081_H | body mass index QTL GWAS1272081 (human) | | 6e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 105322780 | 105322781 | Human |
597487357 | GWAS1583431_H | body mass index QTL GWAS1583431 (human) | | 3e-15 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100211179 | 100211180 | Human |
597614330 | GWAS1671190_H | asthma QTL GWAS1671190 (human) | | 1e-43 | asthma | | 2 | 102344025 | 102344026 | Human |
597335797 | GWAS1431871_H | trait in response to mercaptopurine QTL GWAS1431871 (human) | | 0.000003 | trait in response to mercaptopurine | | 2 | 99783404 | 99783405 | Human |
597262070 | GWAS1358144_H | esophageal squamous cell carcinoma QTL GWAS1358144 (human) | | 0.000004 | esophageal squamous cell carcinoma | | 2 | 100436954 | 100436955 | Human |
596958951 | GWAS1078470_H | metabolic syndrome QTL GWAS1078470 (human) | | 3e-19 | metabolic syndrome | | 2 | 100134688 | 100134689 | Human |
597048850 | GWAS1144924_H | BMI-adjusted waist-hip ratio QTL GWAS1144924 (human) | | 2e-13 | body size trait (VT:0100005) | | 2 | 99657330 | 99657331 | Human |
597069328 | GWAS1165402_H | susceptibility to chronic sinus infection measurement QTL GWAS1165402 (human) | | 0.000004 | response to infection trait (VT:0010434) | | 2 | 98942654 | 98942655 | Human |
597147161 | GWAS1243235_H | COVID-19 QTL GWAS1243235 (human) | | 0.0000001 | COVID-19 | | 2 | 102625481 | 102625482 | Human |
597270027 | GWAS1366101_H | taste liking measurement QTL GWAS1366101 (human) | | 4e-10 | taste liking measurement | | 2 | 103703516 | 103703517 | Human |
597020166 | GWAS1116240_H | adiponectin measurement QTL GWAS1116240 (human) | | 0.000003 | adiponectin measurement | blood adiponectin level (CMO:0000485) | 2 | 101367200 | 101367201 | Human |
597270017 | GWAS1366091_H | taste liking measurement QTL GWAS1366091 (human) | | 7e-09 | taste liking measurement | | 2 | 103771397 | 103771398 | Human |
597020168 | GWAS1116242_H | BMI-adjusted adiponectin measurement QTL GWAS1116242 (human) | | 0.000002 | blood adiponectin amount (VT:0010545) | | 2 | 101367200 | 101367201 | Human |
597380666 | GWAS1476740_H | type 2 diabetes mellitus QTL GWAS1476740 (human) | | 5e-08 | type 2 diabetes mellitus | | 2 | 104531960 | 104531961 | Human |
597110323 | GWAS1206397_H | Inhalant adrenergic use measurement QTL GWAS1206397 (human) | | 6e-34 | Inhalant adrenergic use measurement | | 2 | 102392952 | 102392953 | Human |
596966960 | GWAS1086479_H | cortical thickness QTL GWAS1086479 (human) | | 4e-10 | cortical thickness | | 2 | 103863404 | 103863405 | Human |
597052990 | GWAS1149064_H | asthma QTL GWAS1149064 (human) | | 4e-18 | asthma | | 2 | 102236342 | 102236343 | Human |
597048892 | GWAS1144966_H | allergic rhinitis QTL GWAS1144966 (human) | | 2e-30 | allergic rhinitis | | 2 | 102316052 | 102316053 | Human |
597052988 | GWAS1149062_H | asthma QTL GWAS1149062 (human) | | 1e-39 | asthma | | 2 | 102327786 | 102327787 | Human |
406910443 | GWAS559419_H | bipolar disorder QTL GWAS559419 (human) | | 0.000001 | bipolar disorder | | 2 | 98623468 | 98623469 | Human |
597052989 | GWAS1149063_H | asthma QTL GWAS1149063 (human) | | 8e-19 | asthma | | 2 | 102475982 | 102475983 | Human |
597052987 | GWAS1149061_H | asthma QTL GWAS1149061 (human) | | 7e-11 | asthma | | 2 | 102119246 | 102119247 | Human |
597397033 | GWAS1493107_H | interleukin 1 receptor-like 1 measurement QTL GWAS1493107 (human) | | 5e-13 | interleukin 1 receptor-like 1 measurement | | 2 | 102686638 | 102686639 | Human |
597397032 | GWAS1493106_H | interleukin 1 receptor-like 1 measurement QTL GWAS1493106 (human) | | 1e-18 | interleukin 1 receptor-like 1 measurement | | 2 | 102340370 | 102340371 | Human |
407049718 | GWAS698694_H | 3-hydroxyanthranilic acid measurement QTL GWAS698694 (human) | | 0.000009 | amino acid metabolism trait (VT:0010631) | | 2 | 101355870 | 101355871 | Human |
597024303 | GWAS1120377_H | pursuit maintenance gain measurement QTL GWAS1120377 (human) | | 0.000009 | eye physiology trait (VT:0005253) | | 2 | 105524547 | 105524548 | Human |
597364314 | GWAS1460388_H | age at first birth measurement QTL GWAS1460388 (human) | | 3e-09 | age at first birth measurement | maternal age at birth of first offspring (CMO:0002510) | 2 | 100215756 | 100215757 | Human |
406988167 | GWAS637143_H | intelligence QTL GWAS637143 (human) | | 0.000006 | intelligence | | 2 | 100530994 | 100530995 | Human |
597466697 | GWAS1562771_H | albumin:globulin ratio measurement QTL GWAS1562771 (human) | | 2e-12 | albumin:globulin ratio measurement | | 2 | 100198431 | 100198432 | Human |
597343812 | GWAS1439886_H | mean fractional anisotropy measurement QTL GWAS1439886 (human) | | 6e-11 | mean fractional anisotropy measurement | | 2 | 97774892 | 97774893 | Human |
597597760 | GWAS1654620_H | serum alanine aminotransferase measurement QTL GWAS1654620 (human) | | 2e-11 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 2 | 101008009 | 101008010 | Human |
597278278 | GWAS1374352_H | alcohol drinking QTL GWAS1374352 (human) | | 1e-09 | alcohol drinking | | 2 | 100311357 | 100311358 | Human |
407389591 | GWAS1038567_H | interleukin-1 receptor-like 1 measurement QTL GWAS1038567 (human) | | 1e-24 | interleukin-1 receptor-like 1 measurement | | 2 | 102315366 | 102315367 | Human |
597032522 | GWAS1128596_H | risk-taking behaviour QTL GWAS1128596 (human) | | 8e-10 | risk-taking behaviour | | 2 | 103440906 | 103440907 | Human |
597487224 | GWAS1583298_H | interleukin 18 receptor 1 measurement QTL GWAS1583298 (human) | | 2e-13 | interleukin 18 receptor 1 measurement | | 2 | 102599713 | 102599714 | Human |
597487225 | GWAS1583299_H | interleukin 18 receptor 1 measurement QTL GWAS1583299 (human) | | 3e-12 | interleukin 18 receptor 1 measurement | | 2 | 102249415 | 102249416 | Human |
597016179 | GWAS1112253_H | intelligence QTL GWAS1112253 (human) | | 2e-08 | intelligence | | 2 | 100236272 | 100236273 | Human |
597487226 | GWAS1583300_H | interleukin 18 receptor 1 measurement QTL GWAS1583300 (human) | | 1e-26 | interleukin 18 receptor 1 measurement | | 2 | 102267158 | 102267159 | Human |
597413491 | GWAS1509565_H | myositis QTL GWAS1509565 (human) | | 0.000003 | myositis | | 2 | 98773407 | 98773408 | Human |
597487221 | GWAS1583295_H | interleukin 1 receptor-like 1 measurement QTL GWAS1583295 (human) | | 3e-69 | interleukin 1 receptor-like 1 measurement | | 2 | 102309902 | 102309903 | Human |
597487222 | GWAS1583296_H | interleukin 1 receptor-like 1 measurement QTL GWAS1583296 (human) | | 4e-76 | interleukin 1 receptor-like 1 measurement | | 2 | 102314488 | 102314489 | Human |
597581429 | GWAS1638289_H | chloride measurement QTL GWAS1638289 (human) | | 6e-25 | chloride measurement | blood chloride level (CMO:0000497) | 2 | 102538616 | 102538617 | Human |
597323370 | GWAS1419444_H | smoking initiation QTL GWAS1419444 (human) | | 5e-18 | smoking initiation | | 2 | 103533571 | 103533572 | Human |
597343850 | GWAS1439924_H | opioid use disorder QTL GWAS1439924 (human) | | 2e-10 | conditioned place preference behavior trait (VT:0010723) | | 2 | 103736037 | 103736038 | Human |
597323371 | GWAS1419445_H | smoking initiation QTL GWAS1419445 (human) | | 3e-21 | smoking initiation | | 2 | 103594216 | 103594217 | Human |
597323368 | GWAS1419442_H | smoking initiation QTL GWAS1419442 (human) | | 4e-74 | smoking initiation | | 2 | 103460197 | 103460198 | Human |
597323369 | GWAS1419443_H | smoking initiation QTL GWAS1419443 (human) | | 1e-79 | smoking initiation | | 2 | 103473485 | 103473486 | Human |
597016160 | GWAS1112234_H | intelligence QTL GWAS1112234 (human) | | 0.0000008 | intelligence | | 2 | 100236272 | 100236273 | Human |
597048931 | GWAS1145005_H | cervical carcinoma QTL GWAS1145005 (human) | | 0.000004 | cervical carcinoma | | 2 | 105183335 | 105183336 | Human |
597323362 | GWAS1419436_H | smoking initiation QTL GWAS1419436 (human) | | 3e-15 | smoking initiation | | 2 | 99354826 | 99354827 | Human |
597093998 | GWAS1190072_H | 3-hydroxypropylmercapturic acid measurement QTL GWAS1190072 (human) | | 0.0000008 | 3-hydroxypropylmercapturic acid measurement | | 2 | 100730839 | 100730840 | Human |
597323363 | GWAS1419437_H | smoking initiation QTL GWAS1419437 (human) | | 3e-27 | smoking initiation | | 2 | 100055946 | 100055947 | Human |
597323360 | GWAS1419434_H | smoking initiation QTL GWAS1419434 (human) | | 8e-10 | smoking initiation | | 2 | 97658891 | 97658892 | Human |
597323361 | GWAS1419435_H | smoking initiation QTL GWAS1419435 (human) | | 2e-09 | smoking initiation | | 2 | 98659869 | 98659870 | Human |
597323366 | GWAS1419440_H | smoking initiation QTL GWAS1419440 (human) | | 8e-27 | smoking initiation | | 2 | 103453326 | 103453327 | Human |
597040746 | GWAS1136820_H | diet measurement QTL GWAS1136820 (human) | | 7e-11 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 2 | 103483375 | 103483376 | Human |
597528160 | GWAS1624234_H | color vision disorder QTL GWAS1624234 (human) | | 0.000003 | color vision disorder | | 2 | 102920715 | 102920716 | Human |
597323367 | GWAS1419441_H | smoking initiation QTL GWAS1419441 (human) | | 7e-18 | smoking initiation | | 2 | 103456886 | 103456887 | Human |
597323364 | GWAS1419438_H | smoking initiation QTL GWAS1419438 (human) | | 5e-16 | smoking initiation | | 2 | 100254868 | 100254869 | Human |
597036648 | GWAS1132722_H | body mass index QTL GWAS1132722 (human) | | 3e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 105322780 | 105322781 | Human |
597323365 | GWAS1419439_H | smoking initiation QTL GWAS1419439 (human) | | 2e-15 | smoking initiation | | 2 | 100341779 | 100341780 | Human |
597401188 | GWAS1497262_H | 3-hydroxy-1-methylpropylmercapturic acid measurement QTL GWAS1497262 (human) | | 0.0000009 | 3-hydroxy-1-methylpropylmercapturic acid measurement | | 2 | 100975599 | 100975600 | Human |
597360027 | GWAS1456101_H | response to antineoplastic agent QTL GWAS1456101 (human) | | 0.000008 | response to antineoplastic agent | | 2 | 104542180 | 104542181 | Human |
407111232 | GWAS760208_H | eosinophil count QTL GWAS760208 (human) | | 5e-11 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 105817452 | 105817453 | Human |
597417373 | GWAS1513447_H | extranodal nasal NK/T cell lymphoma QTL GWAS1513447 (human) | | 3e-16 | extranodal nasal NK/T cell lymphoma | | 2 | 102355405 | 102355406 | Human |
597491092 | GWAS1587166_H | neuroimaging measurement QTL GWAS1587166 (human) | | 1e-20 | neuroimaging measurement | | 2 | 104849547 | 104849548 | Human |
597400981 | GWAS1497055_H | neutrophil count QTL GWAS1497055 (human) | | 8e-10 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 2 | 101923475 | 101923477 | Human |
597392788 | GWAS1488862_H | hematocrit QTL GWAS1488862 (human) | | 6e-11 | hematocrit | hematocrit (CMO:0000037) | 2 | 100178478 | 100178479 | Human |
597613969 | GWAS1670829_H | asthma QTL GWAS1670829 (human) | | 6e-18 | asthma | | 2 | 102344025 | 102344026 | Human |
597417345 | GWAS1513419_H | mathematical ability QTL GWAS1513419 (human) | | 1e-10 | mathematical ability | | 2 | 103901432 | 103901433 | Human |
597417344 | GWAS1513418_H | mathematical ability QTL GWAS1513418 (human) | | 6e-10 | mathematical ability | | 2 | 102957679 | 102957680 | Human |
597462463 | GWAS1558537_H | body mass index QTL GWAS1558537 (human) | | 1e-17 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104835868 | 104835869 | Human |
597478833 | GWAS1574907_H | self reported educational attainment QTL GWAS1574907 (human) | | 5e-09 | self reported educational attainment | | 2 | 100217755 | 100217756 | Human |
597511596 | GWAS1607670_H | self reported educational attainment QTL GWAS1607670 (human) | | 1e-57 | self reported educational attainment | | 2 | 100205083 | 100205084 | Human |
597073319 | GWAS1169393_H | chronic rhinosinusitis with nasal polyps QTL GWAS1169393 (human) | | 0.000001 | chronic rhinosinusitis with nasal polyps | | 2 | 101471908 | 101471909 | Human |
597167530 | GWAS1263604_H | aspartate aminotransferase measurement QTL GWAS1263604 (human) | | 1e-08 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 2 | 102440583 | 102440584 | Human |
597126564 | GWAS1222638_H | total hip arthroplasty, osteoarthritis QTL GWAS1222638 (human) | | 3e-11 | total hip arthroplasty, osteoarthritis | | 2 | 106073280 | 106073281 | Human |
597487018 | GWAS1583092_H | mean corpuscular hemoglobin QTL GWAS1583092 (human) | | 1e-08 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 2 | 100147663 | 100147664 | Human |
597425571 | GWAS1521645_H | eosinophil count QTL GWAS1521645 (human) | | 0.0000008 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102341256 | 102341257 | Human |
597061034 | GWAS1157108_H | reaction time measurement QTL GWAS1157108 (human) | | 5e-09 | cognitive behavior trait (VT:0010450) | | 2 | 103737774 | 103737775 | Human |
597061033 | GWAS1157107_H | reaction time measurement QTL GWAS1157107 (human) | | 6e-09 | cognitive behavior trait (VT:0010450) | | 2 | 103442825 | 103442826 | Human |
597429725 | GWAS1525799_H | erythrocyte count QTL GWAS1525799 (human) | | 3e-15 | erythrocyte count | red blood cell count (CMO:0000025) | 2 | 100159458 | 100159459 | Human |
597237212 | GWAS1333286_H | eosinophil count QTL GWAS1333286 (human) | | 6e-45 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102349607 | 102349608 | Human |
597532115 | GWAS1628189_H | atopic eczema QTL GWAS1628189 (human) | | 2e-10 | atopic eczema | | 2 | 102350323 | 102350324 | Human |
597327305 | GWAS1423379_H | inflammatory bowel disease QTL GWAS1423379 (human) | | 0.000007 | inflammatory bowel disease | | 2 | 101904152 | 101904153 | Human |
597102018 | GWAS1198092_H | Obsessive-compulsive trait QTL GWAS1198092 (human) | | 0.0000008 | Obsessive-compulsive trait | | 2 | 100928112 | 100928113 | Human |
596962754 | GWAS1082273_H | forced expiratory volume, inflammatory bowel disease QTL GWAS1082273 (human) | | 3e-08 | forced expiratory volume, inflammatory bowel disease | | 2 | 99947131 | 99947132 | Human |
597265858 | GWAS1361932_H | N-2-furoylglycine measurement QTL GWAS1361932 (human) | | 6e-24 | N-2-furoylglycine measurement | | 2 | 101359690 | 101359691 | Human |
597376454 | GWAS1472528_H | platelet count QTL GWAS1472528 (human) | | 7e-15 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 2 | 105577095 | 105577096 | Human |
597179846 | GWAS1275920_H | Nasal Cavity Polyp QTL GWAS1275920 (human) | | 2e-13 | Nasal Cavity Polyp | | 2 | 102458191 | 102458192 | Human |
597110262 | GWAS1206336_H | atypical femoral fracture, response to bisphosphonate QTL GWAS1206336 (human) | | 0.000001 | atypical femoral fracture, response to bisphosphonate | | 2 | 102513902 | 102513903 | Human |
597110261 | GWAS1206335_H | atypical femoral fracture, response to bisphosphonate QTL GWAS1206335 (human) | | 7e-09 | atypical femoral fracture, response to bisphosphonate | | 2 | 102371840 | 102371841 | Human |
597499381 | GWAS1595455_H | body mass index QTL GWAS1595455 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104054503 | 104054504 | Human |
597499380 | GWAS1595454_H | body mass index QTL GWAS1595454 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 101185189 | 101185190 | Human |
597179889 | GWAS1275963_H | interleukin-1 receptor-like 2 measurement QTL GWAS1275963 (human) | | 9e-82 | interleukin-1 receptor-like 2 measurement | | 2 | 102162001 | 102162002 | Human |
597179890 | GWAS1275964_H | interleukin-1 receptor type 1 measurement QTL GWAS1275964 (human) | | 5e-20 | interleukin-1 receptor type 1 measurement | | 2 | 102157594 | 102157595 | Human |
597499379 | GWAS1595453_H | body mass index QTL GWAS1595453 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100977729 | 100977730 | Human |
597233129 | GWAS1329203_H | multisite chronic pain QTL GWAS1329203 (human) | | 2e-08 | multisite chronic pain | | 2 | 99886934 | 99886936 | Human |
597106146 | GWAS1202220_H | reticulocyte count QTL GWAS1202220 (human) | | 5e-13 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 2 | 99145424 | 99145425 | Human |
597179885 | GWAS1275959_H | interleukin-1 receptor-like 1 measurement QTL GWAS1275959 (human) | | 3e-257 | interleukin-1 receptor-like 1 measurement | | 2 | 102340831 | 102340832 | Human |
597106145 | GWAS1202219_H | reticulocyte count QTL GWAS1202219 (human) | | 2e-13 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 2 | 97756543 | 97756544 | Human |
597179887 | GWAS1275961_H | interleukin-1 receptor-like 2 measurement QTL GWAS1275961 (human) | | 7e-63 | interleukin-1 receptor-like 2 measurement | | 2 | 102188371 | 102188372 | Human |
407111229 | GWAS760205_H | eosinophil count QTL GWAS760205 (human) | | 5e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102545057 | 102545058 | Human |
407111230 | GWAS760206_H | eosinophil count QTL GWAS760206 (human) | | 2e-12 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102673992 | 102673993 | Human |
407111231 | GWAS760207_H | eosinophil count QTL GWAS760207 (human) | | 1e-12 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102778250 | 102778251 | Human |
407111226 | GWAS760202_H | eosinophil count QTL GWAS760202 (human) | | 3e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102116028 | 102116029 | Human |
407111227 | GWAS760203_H | eosinophil count QTL GWAS760203 (human) | | 5e-82 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102227789 | 102227790 | Human |
597122323 | GWAS1218397_H | blood protein measurement QTL GWAS1218397 (human) | | 1e-16 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 2 | 106178024 | 106178025 | Human |
597060890 | GWAS1156964_H | hypothyroidism QTL GWAS1156964 (human) | | 9e-10 | hypothyroidism | | 2 | 97756543 | 97756544 | Human |
597519633 | GWAS1615707_H | body mass index QTL GWAS1615707 (human) | | 6e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104966269 | 104966271 | Human |
596974872 | GWAS1094391_H | sex interaction measurement, ascorbic acid 2-sulfate measurement QTL GWAS1094391 (human) | | 0.000006 | sex interaction measurement, ascorbic acid 2-sulfate measurement | | 2 | 101241563 | 101241564 | Human |
407230152 | GWAS879128_H | basophil count, eosinophil count QTL GWAS879128 (human) | | 8e-32 | basophil count, eosinophil count | | 2 | 102435014 | 102435015 | Human |
597163289 | GWAS1259363_H | glucuronate measurement QTL GWAS1259363 (human) | | 0.0000002 | glucuronate measurement | | 2 | 102022876 | 102022877 | Human |
597089542 | GWAS1185616_H | mean reticulocyte volume QTL GWAS1185616 (human) | | 3e-11 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 2 | 100127030 | 100127031 | Human |
597179656 | GWAS1275730_H | interleukin-18 receptor 1 measurement QTL GWAS1275730 (human) | | 1e-80 | interleukin-18 receptor 1 measurement | | 2 | 102365816 | 102365817 | Human |
597179657 | GWAS1275731_H | protein measurement QTL GWAS1275731 (human) | | 3e-23 | protein measurement | | 2 | 102399583 | 102399584 | Human |
597232910 | GWAS1328984_H | appendicular lean mass QTL GWAS1328984 (human) | | 4e-11 | appendicular lean mass | | 2 | 105373259 | 105373260 | Human |
597478661 | GWAS1574735_H | systemic lupus erythematosus QTL GWAS1574735 (human) | | 0.0000001 | systemic lupus erythematosus | | 2 | 102434684 | 102434685 | Human |
597110029 | GWAS1206103_H | atypical femoral fracture, response to bisphosphonate QTL GWAS1206103 (human) | | 0.000007 | atypical femoral fracture, response to bisphosphonate | | 2 | 102371840 | 102371841 | Human |
597515580 | GWAS1611654_H | FEV/FVC ratio QTL GWAS1611654 (human) | | 2e-14 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 2 | 102309902 | 102309903 | Human |
597028148 | GWAS1124222_H | body mass index QTL GWAS1124222 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 105361319 | 105361320 | Human |
597237051 | GWAS1333125_H | lymphocyte:monocyte ratio QTL GWAS1333125 (human) | | 3e-10 | leukocyte quantity (VT:0000217) | | 2 | 102443853 | 102443854 | Human |
597314872 | GWAS1410946_H | cortical thickness QTL GWAS1410946 (human) | | 5e-09 | cortical thickness | | 2 | 104160323 | 104160324 | Human |
597028145 | GWAS1124219_H | body mass index QTL GWAS1124219 (human) | | 3e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 99506568 | 99506569 | Human |
597028144 | GWAS1124218_H | body mass index QTL GWAS1124218 (human) | | 3e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 97658891 | 97658892 | Human |
597028147 | GWAS1124221_H | body mass index QTL GWAS1124221 (human) | | 1e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 103804400 | 103804401 | Human |
597028146 | GWAS1124220_H | body mass index QTL GWAS1124220 (human) | | 3e-18 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100276651 | 100276652 | Human |
597417276 | GWAS1513350_H | gout QTL GWAS1513350 (human) | | 6e-13 | gout | | 2 | 102087791 | 102087792 | Human |
597151038 | GWAS1247112_H | smoking status measurement QTL GWAS1247112 (human) | | 2e-08 | smoking status measurement | | 2 | 103460197 | 103460198 | Human |
597445941 | GWAS1542015_H | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement QTL GWAS1542015 (human) | | 7e-12 | body fat mass (VT:0010482) | blood high density lipoprotein cholesterol level (CMO:0000052) | 2 | 104787763 | 104787764 | Human |
597191990 | GWAS1288064_H | free androgen index QTL GWAS1288064 (human) | | 2e-09 | free androgen index | | 2 | 105251362 | 105251363 | Human |
597097764 | GWAS1193838_H | diverticular disease QTL GWAS1193838 (human) | | 2e-10 | diverticular disease | | 2 | 98612512 | 98612513 | Human |
407123702 | GWAS772678_H | diabetic nephropathy QTL GWAS772678 (human) | | 1e-08 | kidney integrity trait (VT:0010580) | | 2 | 99844192 | 99844193 | Human |
597048622 | GWAS1144696_H | anxiety QTL GWAS1144696 (human) | | 9e-09 | anxiety | | 2 | 103455652 | 103455653 | Human |
407123704 | GWAS772680_H | diabetic nephropathy QTL GWAS772680 (human) | | 0.0000003 | kidney integrity trait (VT:0010580) | | 2 | 99844192 | 99844193 | Human |
597437790 | GWAS1533864_H | allergic disease QTL GWAS1533864 (human) | | 4e-26 | allergic disease | | 2 | 102309902 | 102309903 | Human |
597101909 | GWAS1197983_H | schizophrenia, intelligence, self reported educational attainment QTL GWAS1197983 (human) | | 7e-09 | schizophrenia, intelligence, self reported educational attainment | | 2 | 105306623 | 105306624 | Human |
597101908 | GWAS1197982_H | schizophrenia, intelligence, self reported educational attainment QTL GWAS1197982 (human) | | 1e-10 | schizophrenia, intelligence, self reported educational attainment | | 2 | 103486682 | 103486683 | Human |
597253468 | GWAS1349542_H | age at first birth measurement QTL GWAS1349542 (human) | | 1e-13 | age at first birth measurement | maternal age at birth of first offspring (CMO:0002510) | 2 | 100260166 | 100260167 | Human |
597142865 | GWAS1238939_H | educational attainment QTL GWAS1238939 (human) | | 3e-08 | educational attainment | | 2 | 100322455 | 100322456 | Human |
597310812 | GWAS1406886_H | vaginal microbiome measurement QTL GWAS1406886 (human) | | 0.000007 | vaginal microbiome measurement | | 2 | 102136292 | 102136293 | Human |
597609808 | GWAS1666668_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1666668 (human) | | 3e-25 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 2 | 100956752 | 100956753 | Human |
597077337 | GWAS1173411_H | age at first sexual intercourse measurement QTL GWAS1173411 (human) | | 3e-08 | age at first sexual intercourse measurement | | 2 | 103452725 | 103452726 | Human |
596962628 | GWAS1082147_H | forced expiratory volume, gastroesophageal reflux disease QTL GWAS1082147 (human) | | 3e-08 | forced expiratory volume, gastroesophageal reflux disease | | 2 | 100016582 | 100016583 | Human |
407377560 | GWAS1026536_H | asthma QTL GWAS1026536 (human) | | 8e-13 | asthma | | 2 | 101671373 | 101671374 | Human |
597208392 | GWAS1304466_H | sleep apnea measurement QTL GWAS1304466 (human) | | 1e-08 | sleep behavior trait (VT:0001501) | | 2 | 102538616 | 102538617 | Human |
597413194 | GWAS1509268_H | vitamin D measurement QTL GWAS1509268 (human) | | 1e-10 | vitamin D measurement | | 2 | 100823689 | 100823690 | Human |
597151042 | GWAS1247116_H | smoking status measurement QTL GWAS1247116 (human) | | 3e-08 | smoking status measurement | | 2 | 98896953 | 98896954 | Human |
597093699 | GWAS1189773_H | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis QTL GWAS1189773 (human) | | 9e-08 | intestine integrity trait (VT:0010554) | | 2 | 102464132 | 102464133 | Human |
597208397 | GWAS1304471_H | sleep apnea measurement QTL GWAS1304471 (human) | | 8e-09 | sleep behavior trait (VT:0001501) | | 2 | 102553355 | 102553356 | Human |
597224783 | GWAS1320857_H | pneumonia, COVID-19 QTL GWAS1320857 (human) | | 0.00001 | pneumonia, COVID-19 | | 2 | 101031668 | 101031669 | Human |
597208391 | GWAS1304465_H | sleep apnea measurement QTL GWAS1304465 (human) | | 2e-09 | sleep behavior trait (VT:0001501) | | 2 | 102538616 | 102538617 | Human |
596970869 | GWAS1090388_H | major depressive disorder QTL GWAS1090388 (human) | | 0.000002 | major depressive disorder | | 2 | 105194762 | 105194763 | Human |
597269883 | GWAS1365957_H | taste liking measurement QTL GWAS1365957 (human) | | 4e-10 | taste liking measurement | | 2 | 103543925 | 103543926 | Human |
597224827 | GWAS1320901_H | BMI-adjusted waist circumference QTL GWAS1320901 (human) | | 7e-10 | body size trait (VT:0100005) | | 2 | 99672016 | 99672017 | Human |
597417343 | GWAS1513417_H | mathematical ability QTL GWAS1513417 (human) | | 2e-09 | mathematical ability | | 2 | 100190257 | 100190258 | Human |
597241213 | GWAS1337287_H | C-reactive protein measurement QTL GWAS1337287 (human) | | 2e-21 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 2 | 102140679 | 102140680 | Human |
597097841 | GWAS1193915_H | protein measurement QTL GWAS1193915 (human) | | 1e-08 | protein measurement | | 2 | 101768774 | 101768775 | Human |
597216639 | GWAS1312713_H | BMI-adjusted waist circumference QTL GWAS1312713 (human) | | 0.0000003 | body size trait (VT:0100005) | | 2 | 101847192 | 101847193 | Human |
597147005 | GWAS1243079_H | age at last pregnancy measurement QTL GWAS1243079 (human) | | 2e-10 | age at last pregnancy measurement | maternal age at birth of last offspring (CMO:0000391) | 2 | 100260166 | 100260167 | Human |
597405046 | GWAS1501120_H | body weight QTL GWAS1501120 (human) | | 1e-08 | body mass (VT:0001259) | body weight (CMO:0000012) | 2 | 104822552 | 104822553 | Human |
597343605 | GWAS1439679_H | mean fractional anisotropy measurement QTL GWAS1439679 (human) | | 4e-09 | mean fractional anisotropy measurement | | 2 | 97774892 | 97774893 | Human |
406886210 | GWAS535186_H | posterior cortical atrophy, Alzheimer disease QTL GWAS535186 (human) | | 0.000001 | posterior cortical atrophy, Alzheimer disease | | 2 | 97728623 | 97728624 | Human |
597511327 | GWAS1607401_H | interleukin 1 receptor-like 2 measurement QTL GWAS1607401 (human) | | 2e-12 | interleukin 1 receptor-like 2 measurement | | 2 | 101981141 | 101981142 | Human |
597363864 | GWAS1459938_H | self reported educational attainment QTL GWAS1459938 (human) | | 9e-28 | self reported educational attainment | | 2 | 100205086 | 100205087 | Human |
597511318 | GWAS1607392_H | eosinophil count QTL GWAS1607392 (human) | | 2e-87 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102349850 | 102349851 | Human |
597068935 | GWAS1165009_H | susceptibility to pneumonia measurement QTL GWAS1165009 (human) | | 0.000009 | response to infection trait (VT:0010434) | | 2 | 103473485 | 103473486 | Human |
597236876 | GWAS1332950_H | Vertigo QTL GWAS1332950 (human) | | 0.0000009 | Vertigo | | 2 | 101411089 | 101411090 | Human |
597376130 | GWAS1472204_H | PR interval QTL GWAS1472204 (human) | | 7e-14 | PR interval | PR interval (CMO:0000233) | 2 | 105488399 | 105488400 | Human |
597355648 | GWAS1451722_H | rheumatoid arthritis QTL GWAS1451722 (human) | | 2e-08 | rheumatoid arthritis | | 2 | 100190478 | 100190479 | Human |
597396608 | GWAS1492682_H | body mass index QTL GWAS1492682 (human) | | 3e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 104849547 | 104849548 | Human |
406898524 | GWAS547500_H | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia QTL GWAS547500 (human) | | 0.000003 | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | | 2 | 102047167 | 102047168 | Human |
597355707 | GWAS1451781_H | self reported educational attainment QTL GWAS1451781 (human) | | 2e-09 | self reported educational attainment | | 2 | 100190052 | 100190053 | Human |
597396671 | GWAS1492745_H | interleukin 1 receptor-like 1 measurement QTL GWAS1492745 (human) | | 2e-19 | interleukin 1 receptor-like 1 measurement | | 2 | 102281279 | 102281280 | Human |
597396670 | GWAS1492744_H | interleukin 1 receptor-like 1 measurement QTL GWAS1492744 (human) | | 3e-20 | interleukin 1 receptor-like 1 measurement | | 2 | 102272105 | 102272106 | Human |
597396669 | GWAS1492743_H | interleukin 1 receptor-like 1 measurement QTL GWAS1492743 (human) | | 3e-21 | interleukin 1 receptor-like 1 measurement | | 2 | 102301397 | 102301398 | Human |
597392573 | GWAS1488647_H | asthma QTL GWAS1488647 (human) | | 8e-15 | asthma | | 2 | 102341256 | 102341257 | Human |
597458093 | GWAS1554167_H | educational attainment QTL GWAS1554167 (human) | | 1e-12 | educational attainment | | 2 | 100226176 | 100226177 | Human |
597417121 | GWAS1513195_H | asthma QTL GWAS1513195 (human) | | 4e-51 | asthma | | 2 | 102319699 | 102319700 | Human |
407304058 | GWAS953034_H | intelligence QTL GWAS953034 (human) | | 6e-08 | intelligence | | 2 | 98973196 | 98973197 | Human |
597359780 | GWAS1455854_H | eosinophil percentage of leukocytes QTL GWAS1455854 (human) | | 1e-95 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 2 | 102352407 | 102352410 | Human |
597077160 | GWAS1173234_H | smoking initiation QTL GWAS1173234 (human) | | 9e-14 | smoking initiation | | 2 | 103534433 | 103534434 | Human |
597359781 | GWAS1455855_H | eosinophil percentage of leukocytes QTL GWAS1455855 (human) | | 1e-27 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 2 | 102435014 | 102435015 | Human |
407099139 | GWAS748115_H | drug dependence QTL GWAS748115 (human) | | 1e-11 | drug dependence | | 2 | 105840835 | 105840836 | Human |
407099140 | GWAS748116_H | drug dependence QTL GWAS748116 (human) | | 2e-11 | drug dependence | | 2 | 105822480 | 105822481 | Human |
597355730 | GWAS1451804_H | psychosis QTL GWAS1451804 (human) | | 0.0000005 | psychosis | | 2 | 102959630 | 102959631 | Human |
597069004 | GWAS1165078_H | susceptibility to pneumonia measurement QTL GWAS1165078 (human) | | 0.0000003 | response to infection trait (VT:0010434) | | 2 | 103701478 | 103701480 | Human |
597580997 | GWAS1637857_H | mean corpuscular hemoglobin concentration QTL GWAS1637857 (human) | | 8e-16 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 2 | 102538616 | 102538617 | Human |
597302469 | GWAS1398543_H | acute graft vs. host disease, donor genotype effect measurement QTL GWAS1398543 (human) | | 0.0000005 | acute graft vs. host disease, donor genotype effect measurement | | 2 | 97846727 | 97846728 | Human |
597273851 | GWAS1369925_H | interleukin 1 receptor-like 2 measurement QTL GWAS1369925 (human) | | 2e-32 | interleukin 1 receptor-like 2 measurement | | 2 | 101998874 | 101998875 | Human |
597273850 | GWAS1369924_H | interleukin 1 receptor-like 2 measurement QTL GWAS1369924 (human) | | 5e-53 | interleukin 1 receptor-like 2 measurement | | 2 | 102007764 | 102007765 | Human |
597503225 | GWAS1599299_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1599299 (human) | | 7e-13 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 2 | 100425660 | 100425661 | Human |
597503226 | GWAS1599300_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1599300 (human) | | 3e-08 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 2 | 103623747 | 103623748 | Human |
596954361 | GWAS1073880_H | cognitive function measurement QTL GWAS1073880 (human) | | 2e-08 | cognitive function measurement | | 2 | 99725106 | 99725107 | Human |
597331189 | GWAS1427263_H | Tinnitus QTL GWAS1427263 (human) | | 2e-09 | Tinnitus | | 2 | 97738048 | 97738049 | Human |
407136048 | GWAS785024_H | asthma QTL GWAS785024 (human) | | 0.000002 | asthma | | 2 | 102350089 | 102350090 | Human |
597429483 | GWAS1525557_H | protein measurement QTL GWAS1525557 (human) | | 5e-611 | protein measurement | | 2 | 102314488 | 102314489 | Human |
597531882 | GWAS1627956_H | systolic blood pressure QTL GWAS1627956 (human) | | 6e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 2 | 104589093 | 104589094 | Human |
597179618 | GWAS1275692_H | rhinitis QTL GWAS1275692 (human) | | 6e-11 | rhinitis | | 2 | 102447060 | 102447061 | Human |
407128007 | GWAS776983_H | asthma QTL GWAS776983 (human) | | 3e-09 | asthma | | 2 | 102369762 | 102369763 | Human |
597105682 | GWAS1201756_H | cerebral white matter volume change measurement, age at assessment QTL GWAS1201756 (human) | | 0.000007 | cerebral white matter volume change measurement, age at assessment | | 2 | 103731870 | 103731871 | Human |
597228574 | GWAS1324648_H | self reported educational attainment QTL GWAS1324648 (human) | | 4e-13 | self reported educational attainment | | 2 | 103443545 | 103443546 | Human |
406968263 | GWAS617239_H | platelet component distribution width QTL GWAS617239 (human) | | 1e-09 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 2 | 105842350 | 105842351 | Human |
597228575 | GWAS1324649_H | self reported educational attainment QTL GWAS1324649 (human) | | 1e-16 | self reported educational attainment | | 2 | 103825088 | 103825089 | Human |
597122079 | GWAS1218153_H | cognitive function measurement, self reported educational attainment QTL GWAS1218153 (human) | | 3e-10 | cognitive behavior trait (VT:0010450) | | 2 | 99992378 | 99992379 | Human |
597122078 | GWAS1218152_H | cognitive function measurement, self reported educational attainment QTL GWAS1218152 (human) | | 1e-08 | cognitive behavior trait (VT:0010450) | | 2 | 99672640 | 99672641 | Human |
597093383 | GWAS1189457_H | Crohn's disease QTL GWAS1189457 (human) | | 3e-16 | intestine integrity trait (VT:0010554) | | 2 | 102446909 | 102446910 | Human |
597269515 | GWAS1365589_H | facial height measurement QTL GWAS1365589 (human) | | 0.0000009 | facial morphology trait (VT:0003743) | | 2 | 100980162 | 100980163 | Human |
597183499 | GWAS1279573_H | UDP-glucuronic acid decarboxylase 1 measurement QTL GWAS1279573 (human) | | 2e-21 | UDP-glucuronic acid decarboxylase 1 measurement | | 2 | 106189215 | 106189216 | Human |
597269516 | GWAS1365590_H | facial height measurement QTL GWAS1365590 (human) | | 0.000003 | facial morphology trait (VT:0003743) | | 2 | 100963517 | 100963518 | Human |
406902744 | GWAS551720_H | pulse pressure measurement QTL GWAS551720 (human) | | 1e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 2 | 100962027 | 100962028 | Human |
597347331 | GWAS1443405_H | body mass index QTL GWAS1443405 (human) | | 1e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 103476496 | 103476497 | Human |
597056524 | GWAS1152598_H | eosinophil count QTL GWAS1152598 (human) | | 1e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 105815399 | 105815400 | Human |
597150731 | GWAS1246805_H | endometriosis QTL GWAS1246805 (human) | | 7e-09 | endometriosis | | 2 | 99891923 | 99891924 | Human |
597392391 | GWAS1488465_H | risk-taking behaviour QTL GWAS1488465 (human) | | 5e-08 | risk-taking behaviour | | 2 | 104132646 | 104132647 | Human |
597072905 | GWAS1168979_H | rheumatoid arthritis QTL GWAS1168979 (human) | | 7e-08 | rheumatoid arthritis | | 2 | 100056230 | 100056231 | Human |
597240889 | GWAS1336963_H | educational attainment QTL GWAS1336963 (human) | | 8e-11 | educational attainment | | 2 | 103825088 | 103825089 | Human |
597183549 | GWAS1279623_H | creativity measurement QTL GWAS1279623 (human) | | 3e-08 | behavior trait (VT:0010442) | | 2 | 100574987 | 100574988 | Human |
597482554 | GWAS1578628_H | mathematical ability QTL GWAS1578628 (human) | | 2e-11 | mathematical ability | | 2 | 99490335 | 99490336 | Human |
597494842 | GWAS1590916_H | interleukin-1 receptor type 2 measurement QTL GWAS1590916 (human) | | 6e-20 | interleukin-1 receptor type 2 measurement | | 2 | 102283274 | 102283275 | Human |
597494839 | GWAS1590913_H | ST2 protein measurement QTL GWAS1590913 (human) | | 1e-135 | ST2 protein measurement | | 2 | 102316102 | 102316103 | Human |
597388342 | GWAS1484416_H | erythrocyte count QTL GWAS1484416 (human) | | 2e-12 | erythrocyte count | red blood cell count (CMO:0000025) | 2 | 100145753 | 100145754 | Human |
597048376 | GWAS1144450_H | autoimmune disease QTL GWAS1144450 (human) | | 2e-09 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 2 | 97756543 | 97756544 | Human |
597392429 | GWAS1488503_H | smoking status measurement QTL GWAS1488503 (human) | | 5e-08 | cognitive behavior trait (VT:0010450) | | 2 | 103863404 | 103863405 | Human |
597122080 | GWAS1218154_H | cognitive function measurement, self reported educational attainment QTL GWAS1218154 (human) | | 2e-16 | cognitive behavior trait (VT:0010450) | | 2 | 100254724 | 100254725 | Human |
597228576 | GWAS1324650_H | self reported educational attainment QTL GWAS1324650 (human) | | 2e-12 | self reported educational attainment | | 2 | 105352905 | 105352906 | Human |
597392473 | GWAS1488547_H | asthma QTL GWAS1488547 (human) | | 4e-61 | asthma | | 2 | 102319699 | 102319700 | Human |
597433435 | GWAS1529509_H | protein measurement QTL GWAS1529509 (human) | | 1e-08 | protein measurement | | 2 | 101988040 | 101988041 | Human |
597064785 | GWAS1160859_H | celiac disease QTL GWAS1160859 (human) | | 1e-16 | celiac disease | | 2 | 102470310 | 102470311 | Human |
597277777 | GWAS1373851_H | interleukin 18 receptor 1 measurement QTL GWAS1373851 (human) | | 1e-15 | interleukin 18 receptor 1 measurement | | 2 | 102489875 | 102489876 | Human |
597105757 | GWAS1201831_H | esophageal carcinoma, gastric carcinoma QTL GWAS1201831 (human) | | 1e-08 | stomach integrity trait (VT:0010603) | | 2 | 106071382 | 106071383 | Human |
597191765 | GWAS1287839_H | lung disease severity measurement QTL GWAS1287839 (human) | | 0.000003 | lung integrity trait (VT:0010906) | | 2 | 99928010 | 99928011 | Human |
597347403 | GWAS1443477_H | body fat percentage QTL GWAS1443477 (human) | | 6e-09 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 2 | 100266998 | 100266999 | Human |
597277771 | GWAS1373845_H | interleukin 18 receptor 1 measurement QTL GWAS1373845 (human) | | 3e-48 | interleukin 18 receptor 1 measurement | | 2 | 102397854 | 102397855 | Human |
597277770 | GWAS1373844_H | interleukin 18 receptor 1 measurement QTL GWAS1373844 (human) | | 1e-133 | interleukin 18 receptor 1 measurement | | 2 | 102416687 | 102416688 | Human |
597277773 | GWAS1373847_H | interleukin 18 receptor 1 measurement QTL GWAS1373847 (human) | | 1e-24 | interleukin 18 receptor 1 measurement | | 2 | 102623087 | 102623088 | Human |
597277772 | GWAS1373846_H | interleukin 18 receptor 1 measurement QTL GWAS1373846 (human) | | 4e-25 | interleukin 18 receptor 1 measurement | | 2 | 102591692 | 102591693 | Human |
597277775 | GWAS1373849_H | interleukin 18 receptor 1 measurement QTL GWAS1373849 (human) | | 2e-22 | interleukin 18 receptor 1 measurement | | 2 | 102114729 | 102114730 | Human |
597392461 | GWAS1488535_H | asthma, Eczematoid dermatitis, allergic rhinitis QTL GWAS1488535 (human) | | 1e-78 | asthma, Eczematoid dermatitis, allergic rhinitis | | 2 | 102319699 | 102319700 | Human |
597347404 | GWAS1443478_H | body fat percentage QTL GWAS1443478 (human) | | 2e-08 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 2 | 103830594 | 103830595 | Human |
597339212 | GWAS1435286_H | major depressive disorder QTL GWAS1435286 (human) | | 4e-08 | major depressive disorder | | 2 | 105482561 | 105482562 | Human |
597277774 | GWAS1373848_H | interleukin 18 receptor 1 measurement QTL GWAS1373848 (human) | | 3e-24 | interleukin 18 receptor 1 measurement | | 2 | 102311718 | 102311719 | Human |
597457988 | GWAS1554062_H | eosinophil count QTL GWAS1554062 (human) | | 4e-190 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 2 | 102354740 | 102354741 | Human |
597326971 | GWAS1423045_H | Parkinson disease QTL GWAS1423045 (human) | | 2e-12 | Parkinson disease | | 2 | 101780501 | 101780502 | Human |
597056628 | GWAS1152702_H | Eczematoid dermatitis QTL GWAS1152702 (human) | | 4e-09 | Eczematoid dermatitis | | 2 | 102391163 | 102391164 | Human |
596962430 | GWAS1081949_H | FEV/FVC ratio, inflammatory bowel disease QTL GWAS1081949 (human) | | 4e-09 | FEV/FVC ratio, inflammatory bowel disease | | 2 | 102315366 | 102315367 | Human |
407005101 | GWAS654077_H | neutrophil count QTL GWAS654077 (human) | | 2e-27 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 2 | 101119376 | 101119377 | Human |
597281910 | GWAS1377984_H | X-12844 measurement QTL GWAS1377984 (human) | | 5e-38 | X-12844 measurement | | 2 | 102722213 | 102722214 | Human |
597027948 | GWAS1124022_H | body mass index QTL GWAS1124022 (human) | | 2e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 103692087 | 103692088 | Human |
597388385 | GWAS1484459_H | intelligence QTL GWAS1484459 (human) | | 5e-10 | intelligence | | 2 | 100428333 | 100428334 | Human |
597159020 | GWAS1255094_H | dementia QTL GWAS1255094 (human) | | 0.000003 | dementia | | 2 | 105852811 | 105852812 | Human |
597466209 | GWAS1562283_H | body mass index QTL GWAS1562283 (human) | | 2e-16 | body mass index | body mass index (BMI) (CMO:0000105) | 2 | 100137627 | 100137628 | Human |